≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Systemic sclerosis

DOID EFO Endpoint Browser PheWeb

M13_SYSTSLCE

systemic scleroderma: A chronic disorder, possibly autoimmune, marked by excessive production of collagen which results in hardening and thickening of body tissues. The two types of systemic scleroderma, limited cutaneous and diffuse cutaneous are classified with focus on the extent of affected skin. A relationship exists between the extent of skin area affected and degree of internal organ/system involvement. Systemic scleroderma can manifest itself in pulmonary fibrosis, Raynaud's syndrome, digestive system telangiectasias, renal hypertension and/or pulmonary hypertension.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — M34
  • Hospital discharge: ICD-9 — 7101
  • Hospital discharge: ICD-8 — 7340
  • Cause of death: ICD-10 — M34
  • Cause of death: ICD-9 — 7101
  • Cause of death: ICD-8 — 7340

2 out of 7 registries used, show all original rules.

937

4. Check minimum number of events

None

937

5. Include endpoints

None

937

6. Filter based on genotype QC (FinnGen only)

904

Control definitions (FinnGen only)

Control exclude
M13_SYSTCONNECT

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
M30-M36
Name in latin
Sclerosis systemica

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 4561 3620 887
Only index persons 3885 3150 735
Unadjusted period prevalence (%)
Whole population 0.09 0.10 0.02
Only index persons 0.10 0.12 0.03
Median age at first event (years)
Whole population 56.25 56.54 55.13
Only index persons 55.13 55.34 54.21

-FinnGen-

Key figures

All Female Male
Number of individuals 904 745 159
Unadjusted period prevalence (%) 0.23 0.26 0.07
Median age at first event (years) 55.58 55.23 57.20

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
937
Matched controls
9370
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L04AA06
ATC
mycophenolic acid; systemic
59.7
307.7
187
39
L04AX03
ATC
methotrexate; systemic
13.8
307.7
419
518
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
29.1
307.7
611
567
M34.9
ICD-10 Finland
Systemic sclerosis, unspecified
6771.9
307.7
411
*
P01BA02
ATC
hydroxychloroquine; oral
26.8
307.7
521
419
C08CA05
ATC
nifedipine; systemic
29.1
307.7
405
239
M34.1
ICD-10 Finland
CR(E)ST syndrome
+∞
307.7
589
*
XX9XE
NOMESCO Finland
Other ultrasound examination
116.2
307.7
194
21
I73.0
ICD-10 Finland
Raynaud syndrome
59.2
307.7
268
63
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
99.1
232.6
121
14
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
11.5
223.1
272
323
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
2419.7
197.0
184
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
12.4
195.6
216
221
M34.0
ICD-10 Finland
Progressive systemic sclerosis
+∞
190.3
176
*
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
8.1
182.0
306
529
G04BE03
ATC
sildenafil; oral
50.2
169.8
99
22
L04AX01
ATC
azathioprine; systemic
13.7
164.6
165
144
L88
ICPC
Rheumatoid/seropositive arthritis
11.0
149.0
174
190
L94.0
ICD-10 Finland
Localized scleroderma [morphea]
45.8
121.2
72
17
M34.8
ICD-10 Finland
Other forms of systemic sclerosis
+∞
120.5
113
*
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
9.8
119.5
150
179
XPX04
NOMESCO Finland
Angioscopy
266.9
116.7
117
5
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
4.3
106.1
505
2015
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
7.6
103.9
164
256
XG410
NOMESCO Finland
Flow-volume spirometry
9.3
98.4
127
156
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
11.8
94.8
101
95
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.2
90.7
662
3430
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
3.9
88.6
391
1444
XQ841
NOMESCO Finland
Examination of dermatosis with microscope
907.8
86.0
83
*
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
10.2
85.1
100
108
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
5.8
81.9
171
350
R4120
NOMESCO Finland
Occupational therapy
5.7
78.1
164
337
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
13.8
77.6
74
58
C08CA02
ATC
felodipine; oral
5.0
74.5
187
448
M35.1
ICD-10 Finland
Other overlap syndromes
+∞
72.9
69
*
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
17.4
70.8
59
36
QC6S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in hand
356.7
67.4
67
*
GD1AD
NOMESCO Finland
Thorax CT examination
5.4
63.3
138
291
NH3EA
NOMESCO Finland
Feet X-ray examination with load
9.6
63.1
77
87
H02AB06
ATC
prednisolone; systemic
3.1
61.5
605
3435
K74.3
ICD-10 Finland
Primary biliary cirrhosis
25.0
60.5
43
18
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
4.1
59.9
191
546
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
4.0
58.9
196
577
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.4
58.6
272
1000
L01BA01
ATC
methotrexate; systemic
6.9
57.4
94
150
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
10.2
56.3
65
68
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.8
53.9
496
2653
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
8.4
53.4
72
92
M34
ICD-10 Finland
Systemic sclerosis
+∞
52.6
50
*
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
4.3
52.4
154
412
L04AD01
ATC
ciclosporin; systemic
11.2
51.9
56
53
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
8.1
49.8
69
91
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.8
46.2
162
490
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
17.2
45.5
38
23
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
161.0
44.2
46
*
SBA10
NOMESCO Finland
Measurement of salivary flow rate
12.9
42.0
41
33
J99.1*M34.8
ICD-10 Finland
Respiratory disorders in systemic: sclerosis
+∞
42.0
40
*
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
7.7
42.0
60
82
L04AA01
ATC
[U] ciclosporin
11.8
41.6
43
38
TGC00
NOMESCO Finland
Bronchial lavation
7.1
39.9
62
93
C02KX01
ATC
bosentan; oral
+∞
37.8
36
*
WZA10
NOMESCO Finland
Extensive medical or dental certificate
9.6
37.7
45
49
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
4.5
37.4
98
238
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.4
36.3
149
496
A05AA02
ATC
ursodeoxycholic acid; oral
8.3
35.2
47
59
I27.2
ICD-10 Finland
Other secondary pulmonary hypertension
42.8
33.3
41
10
C08CA01
ATC
amlodipine; oral
2.3
32.6
447
2687
Z01.8
ICD-10 Finland
Other specified special examinations
2.4
31.1
295
1511
E0000UV, ,
ATC
2.2
30.2
485
3080
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
6.1
29.9
53
91
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
6.7
29.7
48
75
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
3.6
29.1
104
315
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
3.7
28.5
98
289
L99
ICPC
Musculoskeletal disease other
5.9
28.5
52
92
C02KX04
ATC
macitentan; oral
+∞
28.3
27
*
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.1
27.8
520
3463
J01FF01
ATC
clindamycin; systemic
2.2
27.6
322
1786
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.3
26.7
276
1453
7101A
ICD-9 Finland
Diffuse diseases of connective tissue, Systemic sclerosis[SCLERODERMA]
+∞
26.2
25
*
R06.0
ICD-10 Finland
Dyspnoea
2.2
25.9
329
1877
H02AB07
ATC
prednisone; oral
2.6
25.9
176
766
G73.7*M34.8
ICD-10 Finland
Myopathy in scleroderma
267.7
25.8
26
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.3
25.7
259
1346
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
4.8
25.5
59
129
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
3.5
25.2
91
277
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
3.0
25.1
122
445
H04.10
ICD-10 Finland
Dry eye syndrome
2.5
24.8
181
814
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.2
23.6
102
347
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.9
23.6
122
460
XJC02
NOMESCO Finland
Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter
55.5
23.2
27
5
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
4.0
22.4
65
170
RT172, ,
NOMESCO Finland
64.1
21.9
25
*
M35.8
ICD-10 Finland
Other specified systemic involvement of connective tissue
225.0
21.7
22
*
K22.4
ICD-10 Finland
Dyskinesia of oesophagus
18.0
21.4
33
19
NDR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of wrist or hand
7.7
21.3
30
40
RT160, ,
NOMESCO Finland
61.5
21.0
24
*
A02BC02
ATC
pantoprazole; systemic
2.1
20.9
709
5588
K62.3
ICD-10 Finland
Rectal prolapse
6.5
20.7
34
54
K22.7
ICD-10 Finland
Barrett oesophagus
7.3
20.4
30
42
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.8
20.4
111
429
M01CC01
ATC
penicillamine; oral
58.9
20.0
23
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.4
19.6
152
699
K22.1
ICD-10 Finland
Ulcer of oesophagus
7.1
19.2
29
42
NHQ40
NOMESCO Finland
Amputation of toe
7.7
19.2
27
36
A02BC01
ATC
omeprazole; systemic
2.0
19.2
293
1755
M32.8
ICD-10 Finland
Other forms of systemic lupus erythematosus
+∞
18.8
18
*
RT274, ,
NOMESCO Finland
39.3
18.6
23
6
UJF32
NOMESCO Finland
Coloscopy
2.0
18.5
288
1733
R4190
NOMESCO Finland
Nutritional therapy
3.7
18.3
59
166
I27.0
ICD-10 Finland
Primary pulmonary hypertension
45.0
18.3
22
5
UJF30
NOMESCO Finland
Ileoscopy through colon
2.4
18.1
137
622
C03CA01
ATC
furosemide; systemic
1.9
17.9
286
1731
M05BA07
ATC
risedronic acid; oral
3.8
17.4
54
148
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
4.9
17.2
38
80
R15
ICD-10 Finland
Faecal incontinence
3.6
17.1
58
169
ZX120
NOMESCO Finland
Intravenous
2.5
17.0
116
501
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.7
16.9
96
379
M05BA04
ATC
alendronic acid; oral
2.5
16.8
115
497
L95
ICPC
Osteoporosis
3.1
16.8
74
254
M32.1
ICD-10 Finland
Systemic lupus erythematosus with organ or system involvement
+∞
16.7
16
*
XQ860
NOMESCO Finland
Laser Doppler measurement/scan of capillary perfusion
+∞
16.7
16
*
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.6
16.5
105
439
R50.9
ICD-10 Finland
Fever, unspecified
2.2
16.4
163
828
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
5.3
16.4
33
64
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.8
16.1
418
2921
J01MA12
ATC
levofloxacin; systemic
2.1
15.9
189
1028
L03.0
ICD-10 Finland
Cellulitis of finger and toe
2.5
15.8
110
480
K11.2
ICD-10 Finland
Sialoadenitis
3.6
15.5
51
146
R4180
NOMESCO Finland
Podiatric therapy
6.6
15.4
25
39
RT271, ,
NOMESCO Finland
38.8
15.4
19
5
S97
ICPC
Chronic ulcer skin
2.8
15.4
78
290
M05BX04
ATC
denosumab; parenteral
2.6
15.0
92
377
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.7
14.9
83
324
I27.8
ICD-10 Finland
Other specified pulmonary heart diseases
32.3
14.8
19
6
N02AX02
ATC
tramadol; systemic, rectal
1.7
14.8
421
3000
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.2
14.7
134
656
M79.0
ICD-10 Finland
Rheumatism, unspecified
3.4
14.6
54
167
E000001, ,
ATC
1.9
14.5
210
1219
M13.9
ICD-10 Finland
Arthritis, unspecified
2.6
14.3
87
355
R4110
NOMESCO Finland
Physiotherapy
1.8
14.3
293
1896
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.3
14.2
114
529
D64.9
ICD-10 Finland
Anaemia, unspecified
2.3
14.2
110
503
PD4AC
NOMESCO Finland
Arterigography of lower extremity with X-ray
6.5
14.1
23
36
A02BC05
ATC
esomeprazole; systemic
1.7
14.0
427
3087
J01DB01
ATC
cefalexin; oral
2.0
13.9
795
6863
Z3226
NOMESCO Finland
Physiotherapist
1.9
13.7
195
1124
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.3
13.7
111
517
M32.0
ICD-10 Finland
Drug-induced systemic lupus erythematosus
+∞
13.6
13
*
7100A
ICD-9 Finland
Diffuse diseases of connective tissue, Systemic lupus erythematosus
+∞
13.6
13
*
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.1
13.4
58
197
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
4.2
13.4
36
89
M35.7
ICD-10 Finland
Hypermobility syndrome
21.5
13.4
19
9
TNH11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in ankle joint or foot joint
6.4
13.3
22
35
J96.1
ICD-10 Finland
Chronic respiratory failure
5.0
13.2
28
57
M81.9
ICD-10 Finland
Osteoporosis, unspecified
2.7
13.0
71
274
I27.9
ICD-10 Finland
Pulmonary heart disease, unspecified
28.8
13.0
17
6
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.2
13.0
119
583
RT272, ,
NOMESCO Finland
19.4
12.9
19
10
PF1AT
NOMESCO Finland
Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)
22.9
12.9
18
8
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.9
12.9
60
213
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
3.4
12.6
46
141
C02DE02, ,
ATC
11.2
12.6
23
21
R13
ICD-10 Finland
Dysphagia
2.4
12.5
91
404
NDQ20
NOMESCO Finland
Amputation of finger
24.7
12.5
17
7
J02AC01
ATC
fluconazole; systemic
1.6
12.5
441
3282
M33.2
ICD-10 Finland
Polymyositis
131.7
12.5
13
*
NG1AE
NOMESCO Finland
Knee joint ultrasound exmination
4.9
12.4
27
56
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.2
12.4
115
566
A06AC01
ATC
ispaghula (psylla seeds); oral
1.7
12.3
292
1958
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.0
12.0
134
707
N03AX16
ATC
[U] pregabalin
1.8
12.0
240
1530
S09
ICPC
Infected finger/toe
3.3
11.9
46
146
D06BX01
ATC
metronidazole; topical
2.0
11.9
136
724
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
4.0
11.9
34
88
RT231, ,
NOMESCO Finland
47.3
11.9
14
*
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.8
11.8
61
229
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
3.5
11.6
40
118
73409
ICD-8 Finland
Diffuse diseases of connective tissue, Sclerosis systematica NUD
+∞
11.5
11
*
WZC00
NOMESCO Finland
Treatment plan or consultation
1.6
11.4
364
2624
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.9
11.3
149
833
RT310, ,
NOMESCO Finland
35.5
11.3
14
*
A03FA02
ATC
cisapride; oral, rectal
2.4
11.3
82
364
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.7
11.3
297
2038
S01XA18
ATC
ciclosporin; ophthalmic
8.2
11.1
24
30
S18
ICPC
Laceration/cut
1.6
11.1
454
3470
SPAT1263
SPAT
Sampling
1.6
11.0
392
2894
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.8
11.0
195
1199
K11.71
ICD-10 Finland
Xerostomy (dry mouth)
5.2
10.8
22
43
SBB00
NOMESCO Finland
Clinical photography of mouth and teeth
3.3
10.8
41
129
GX1K5
NOMESCO Finland
Diffusion capacity
9.7
10.8
21
22
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
3.0
10.7
49
172
TEA00
NOMESCO Finland
Biopsy of lip
8.6
10.6
22
26
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
4.4
10.6
26
60
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.7
10.6
220
1414
GX1D5
NOMESCO Finland
Flow volume spirometry
14.4
10.5
17
12
XG466
NOMESCO Finland
Sleep oxymetry
3.5
10.5
36
106
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.8
10.5
187
1149
B80
ICPC
Iron deficiency anaemia
3.7
10.4
33
92
J99.1
ICD-10 Finland
Respiratory disorders in other diffuse connective tissue disorders
+∞
10.4
10
*
I73.1
ICD-10 Finland
Thromboangiitis obliterans [Buerger]
+∞
10.4
10
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.0
10.4
125
677
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
2.8
10.3
52
193
SHA03
NOMESCO Finland
Stomatognathic treatment, demanding
3.0
10.3
44
149
B02.9
ICD-10 Finland
Zoster without complication
2.3
10.2
81
373
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.9
10.1
129
713
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
3.0
10.1
45
156
R1250
NOMESCO Finland
Evaluation of functional capability
3.3
10.1
37
114
JGC01
NOMESCO Finland
Laparoscopic rectopexy
5.1
10.1
21
42
GD2SN
NOMESCO Finland
Lung ventilation SPECT
9.3
10.0
20
22
R02
ICPC
Shortness of breath/dyspnoea
1.9
10.0
141
805
PB1BC
NOMESCO Finland
Extensive angiography of upper extremity with X-ray
40.5
10.0
12
*
J01MA02
ATC
ciprofloxacin; systemic
1.6
9.9
341
2483
K23.8*B37.8
ICD-10 Finland
Esophagitis caused by candidiasis
16.9
9.9
15
9
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.4
9.9
66
282
TPH04, ,
SPAT
5.0
9.8
21
43
D07AC01
ATC
betamethasone; topical
1.6
9.7
348
2556
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.8
9.7
163
983
M35
ICD-10 Finland
Other systemic involvement of connective tissue
55.6
9.7
11
*
JC2AB
NOMESCO Finland
Oesophagus X-ray examination with contrast
5.1
9.6
20
40
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
8.5
9.6
20
24
SAA03
NOMESCO Finland
Extended examination of mouth
1.6
9.5
374
2804
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.5
9.5
58
238
I78.8
ICD-10 Finland
Other diseases of capillaries
101.0
9.4
10
*
G73.7
ICD-10 Finland
Myopathy in other diseases classified elsewhere
101.0
9.4
10
*
R76.0
ICD-10 Finland
Raised antibody titre
17.7
9.4
14
8
A02BC03
ATC
lansoprazole; oral
1.6
9.4
285
2009
M34.2
ICD-10 Finland
Systemic sclerosis induced by drugs and chemicals
+∞
9.4
9
*
M31.4
ICD-10 Finland
Aortic arch syndrome [Takayasu]
+∞
9.4
9
*
B01AC27
ATC
selexipag; oral
+∞
9.4
9
*
383
Kela drug reimbursment
Selexipag
+∞
9.4
9
*
R22.3
ICD-10 Finland
Localized swelling, mass and lump, upper limb
3.5
9.4
32
94
K07.65
ICD-10 Finland
Temporomandibular joint-pain-dysfunction syndrome
5.2
9.4
19
37
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
10.8
9.3
17
16
SPAT1255
SPAT
Intravenous administration of medicine
2.4
9.1
62
267
L84
ICD-10 Finland
Corns and callosities
2.9
9.1
43
154
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.0
9.1
103
545
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.8
9.0
147
877
SPAT1249
SPAT
Treatment-related counselling outside office
1.5
9.0
364
2734
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
3.5
9.0
31
92
Z2221
NOMESCO Finland
Medical doctor
1.6
8.9
266
1863
J01MA14
ATC
moxifloxacin; systemic
2.1
8.9
92
472
WX002
NOMESCO Finland
Sedation and analgesia
1.7
8.8
182
1162
C08DB01
ATC
diltiazem; oral
2.6
8.7
51
205
PD4BC
NOMESCO Finland
Extensive arterigography of lower extremity with X-ray
6.7
8.7
21
32
XF614
NOMESCO Finland
Measurement of pulmonary artery pressure
50.5
8.7
10
*
M31.5
ICD-10 Finland
Giant cell arteritis with polymyalgia rheumatica
50.5
8.7
10
*
TQW80
NOMESCO Finland
Local dermatologic skincare
3.4
8.7
30
89
M25.5
ICD-10 Finland
Pain in joint
1.5
8.6
340
2536
WZC30
NOMESCO Finland
Teaching
1.7
8.6
162
1008
A06AC51
ATC
ispaghula, combinations; oral
2.4
8.6
56
237
G04BE08
ATC
tadalafil; oral
27.8
8.5
11
*
XF622
NOMESCO Finland
Measurement of minute volume of heart
27.8
8.5
11
*
O99.89
ICD-10 Finland
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
4.2
8.5
22
53
NDQ48
NOMESCO Finland
Revision or amputation or exarticulation of finger
20.2
8.5
12
6
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.7
8.5
160
996
L12
ICPC
Hand/finger symptom/complaint
1.7
8.4
186
1207
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
2.1
8.4
76
370
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
3.4
8.4
30
91
NJ3CG
NOMESCO Finland
Extensive MRI examination of extremities with median high magnet
12.9
8.4
14
11
286
Kela drug reimbursment
Ciclosporin eye drop
+∞
8.3
8
*
M43.9
ICD-10 Finland
Deforming dorsopathy, unspecified
+∞
8.3
8
*
M32
ICD-10 Finland
Systemic lupus erythematosus
+∞
8.3
8
*
C02KX02
ATC
ambrisentan; oral
+∞
8.3
8
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.8
8.3
140
843
NF1AA
NOMESCO Finland
Hip X-ray examination
2.0
8.3
93
491
B01AC04
ATC
clopidogrel; oral
1.8
8.3
136
813
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.6
8.2
273
1955
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
4.3
8.2
21
50
SPAT1360
SPAT
Extensive global examination
2.2
8.2
67
313
L04AA13
ATC
[U] leflunomide
3.2
8.1
31
98
A10BA02
ATC
metformin; oral
0.5
8.1
104
1758
A03
ICPC
Fever
1.7
8.1
157
984
C03DA01
ATC
spironolactone; oral
1.9
8.1
113
643
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.9
8.1
113
643
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
3.2
8.0
31
99
SFA00
NOMESCO Finland
Small restoration
1.7
8.0
144
884
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
2.9
8.0
36
126
H03AA01
ATC
levothyroxine sodium; systemic
1.6
7.9
256
1820
E000006, ,
ATC
2.1
7.9
77
386
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
4.7
7.9
18
39
J05AB01
ATC
aciclovir; systemic
1.6
7.9
226
1563
M43.0
ICD-10 Finland
Spondylolysis
3.8
7.8
23
61
M05BB03
ATC
alendronic acid and colecalciferol; oral
3.1
7.8
32
106
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
2.7
7.8
42
162
XQ848
NOMESCO Finland
Dermatological photography
3.0
7.8
34
117
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.2
7.8
68
327
J01CA04
ATC
amoxicillin; systemic
1.6
7.7
759
6784
EBA10
NOMESCO Finland
Operative extraction of tooth
1.9
7.7
102
569
L01AA01
ATC
cyclophosphamide; systemic
15.2
7.7
12
8
GDG10
NOMESCO Finland
Bilateral transplantation of lung
45.4
7.7
9
*
Z94.2
ICD-10 Finland
Lung transplant status
45.4
7.7
9
*
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.1
7.7
74
369
E000003, ,
ATC
2.5
7.7
48
199
D02AX
ATC
Other emollients and protectives
2.9
7.7
36
129
SPAT1254
SPAT
Administration of medicine
1.8
7.6
128
770
R60.0
ICD-10 Finland
Localized oedema
1.8
7.6
126
755
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
3.3
7.6
28
87
M35.3
ICD-10 Finland
Polymyalgia rheumatica
3.4
7.6
26
77
NFQ20
NOMESCO Finland
Amputation of femur
8.9
7.6
15
17
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
10.1
7.5
14
14
Z3229
NOMESCO Finland
Other healthcare associate professional
2.1
7.5
76
386
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.5
7.5
363
2803
I50.9
ICD-10 Finland
Heart failure, unspecified
1.9
7.5
102
575
R81
ICPC
Pneumonia
2.7
7.4
39
149
PD4AD
NOMESCO Finland
CT of lower extremity arteries
6.9
7.3
17
25
NA1BA
NOMESCO Finland
Cervical spine extensive X-ray examination without contrast
6.9
7.3
17
25
E000007, ,
ATC
2.2
7.3
58
268
73401
ICD-8 Finland
Diffuse diseases of connective tissue, Sclerosis systematica acrosclerotica
+∞
7.3
7
*
M31.1
ICD-10 Finland
Thrombotic microangiopathy
+∞
7.3
7
*
73410
ICD-8 Finland
Diffuse diseases of connective tissue, Systemic lupus erythematosus
+∞
7.3
7
*
L94.3
ICD-10 Finland
Sclerodactyly
+∞
7.3
7
*
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
4.2
7.3
19
46
JN3AD
NOMESCO Finland
Abdominal CT examination
1.8
7.2
122
734
SPAT1211
SPAT
Application of soft bandage
2.0
7.2
83
442
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
1.7
7.2
125
758
K74.5
ICD-10 Finland
Biliary cirrhosis, unspecified
30.3
7.2
9
*
JDA52
NOMESCO Finland
Other endoscopic procedure using diathermy or heat in stomach or pylorus
30.3
7.2
9
*
J01FA06
ATC
roxithromycin; oral
1.5
7.1
378
2965
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.6
7.1
170
1122
H19.3*M35.0
ICD-10 Finland
Keratoconjunctivitis sicca
20.2
7.1
10
5
M86.9
ICD-10 Finland
Osteomyelitis, unspecified
8.0
7.1
15
19
I34.09
ICD-10 Finland
Mitral (valve) insufficiency
2.5
7.1
42
170
ZX108
NOMESCO Finland
Inhalation
12.1
7.1
12
10
J01DA01
ATC
[U] cefalexin
1.5
7.1
572
4855
RJ420, ,
NOMESCO Finland
10.1
7.0
13
13
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
2.5
7.0
45
189
M70.2
ICD-10 Finland
Olecranon bursitis
3.0
7.0
30
102
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.8
7.0
103
596
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.8
7.0
111
657
E000002, ,
ATC
1.8
7.0
101
581
D50.8
ICD-10 Finland
Other iron deficiency anaemias
4.0
6.9
19
48
K11.70
ICD-10 Finland
Hypoptyalism
7.6
6.9
15
20
JCA55
NOMESCO Finland
Endoscopic dilatation of oesophagus
6.8
6.8
16
24
K73.2
ICD-10 Finland
Chronic active hepatitis, not elsewhere classified
11.0
6.8
12
11
RK220, ,
NOMESCO Finland
11.0
6.8
12
11
N02BE01
ATC
paracetamol; systemic, rectal
1.8
6.8
843
7806
L17
ICPC
Foot/toe symptom/complaint
1.5
6.8
297
2240
JJ1LE
NOMESCO Finland
Ultrasound elastography of liver
5.7
6.8
18
32
K76.9
ICD-10 Finland
Liver disease, unspecified
3.7
6.8
21
58
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
4.3
6.8
17
40
L94.9
ICD-10 Finland
Localized connective tissue disorder, unspecified
40.3
6.8
8
*
TPH07
NOMESCO Finland
Cathetrisation of artery
1.8
6.8
99
571
NXL00
NOMESCO Finland
Biopsy of muscle
16.8
6.8
10
6
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.5
6.7
259
1903
TQW99
NOMESCO Finland
Other minor procedure on skin
2.3
6.7
52
238
Z3231
NOMESCO Finland
Registered nurse
1.5
6.7
238
1720
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.6
6.7
153
999
ADA20
NOMESCO Finland
Thoracal sympathectomy
22.7
6.7
9
*
RT171, ,
NOMESCO Finland
22.7
6.7
9
*
NH1AE
NOMESCO Finland
Ankle joint ultrasound examination
6.5
6.7
16
25
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
6.5
6.7
16
25
J01AA04
ATC
lymecycline; systemic
1.7
6.6
121
744
SPAT1229
SPAT
Assessment of need for aid
2.0
6.6
70
362
SPAT1312
SPAT
General health counselling
1.5
6.6
274
2042
A46
ICD-10 Finland
Erysipelas
1.7
6.6
120
737
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prosthodontic work
2.4
6.6
44
189
C01DA14
ATC
isosorbide mononitrate; oral
1.8
6.6
111
668
A07AA09
ATC
vancomycin; oral
4.2
6.6
17
41
SHA04
NOMESCO Finland
Stomatognathic treatment, very demanding
4.2
6.6
17
41
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.6
6.6
150
979
L93.0
ICD-10 Finland
Discoid lupus erythematosus
8.8
6.6
13
15
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.7
6.6
134
850
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.1
6.5
64
322
SHB00
NOMESCO Finland
Preparing and fitting the occlusal splint in the mouth
1.8
6.5
103
608
D02AE01
ATC
carbamide; topical
2.1
6.5
63
316
S20
ICPC
Corn/callosity
3.2
6.5
25
80
UJF92
NOMESCO Finland
Capsular endoscopy
3.3
6.4
23
70
M35.4
ICD-10 Finland
Diffuse (eosinophilic) fasciitis
70.3
6.4
7
*
G73.7*M35.0
ICD-10 Finland
Myopathy in sicca syndrome [Sjögren]
70.3
6.4
7
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
6.4
163
1091
SAA04
NOMESCO Finland
Special examination of mouth
2.2
6.4
51
236
I50.0
ICD-10 Finland
Congestive heart failure
2.1
6.4
57
276
M43.1
ICD-10 Finland
Spondylolisthesis
2.3
6.4
49
223
TNB11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in shoulder joint
7.5
6.4
14
19
SXC02
NOMESCO Finland
Other oral or dental procedure, restricted
2.9
6.4
29
102
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.0
6.4
73
388
A07AA02
ATC
nystatin; oral
2.1
6.4
62
311
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.6
6.4
140
905
ZY010
NOMESCO Finland
Hospital outpatient
2.2
6.3
52
244
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
2.7
6.3
32
120
I83.9
ICD-10 Finland
Varicose veins of lower extremities without ulcer or inflammation
1.7
6.3
111
676
J94.8
ICD-10 Finland
Other specified pleural conditions
3.9
6.3
18
47
XQ844
NOMESCO Finland
Other microscope or electron microscope examination
+∞
6.3
6
*
N08.5*M32.1
ICD-10 Finland
Glomerular disorders in systemic lupus erythematosus
+∞
6.3
6
*
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.7
6.3
131
836
GD1CQ
NOMESCO Finland
Lung circulation SPECT with low dose CT
26.9
6.2
8
*
GD1UN
NOMESCO Finland
Lung circulation SPECT
7.1
6.2
14
20
SPAT1070
SPAT
Doppler ultrasound examination of blood flow in arteries of lower extremity
3.6
6.2
20
57
SBB10
NOMESCO Finland
Dental impressions
2.0
6.2
63
322
NDL52
NOMESCO Finland
Tenosynovectomy of hand
5.4
6.2
17
32
N02AA05
ATC
oxycodone; systemic
1.6
6.1
159
1069
K29.7
ICD-10 Finland
Gastritis, unspecified
2.4
6.1
40
170
A01AB09
ATC
miconazole; local oral
1.8
6.1
88
505
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
2.2
6.1
49
228
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.6
6.1
104
1639
PF1BT
NOMESCO Finland
Extensive PTA of arteries of knee, lower leg and ankle
12.6
6.1
10
8
N02BF02
ATC
pregabalin; oral
1.9
6.1
73
395
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
2.8
6.1
30
111
XG499
NOMESCO Finland
Other fysiological examination of respiatory function
10.1
6.0
11
11
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
2.7
6.0
31
117
WX203
NOMESCO Finland
Infraclavicular plexus blockade
2.9
6.0
28
100
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.5
6.0
184
1284
PHD76
NOMESCO Finland
Resection of long saphenous vein
2.2
6.0
51
243

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Rheumatology
66 [38004491]
2.1e+00
3.1e+00
3.7e+00
—
5.0e+00
5.0e+00
4.5e+00
cases:18.63%
controls:2.82%
cases:26.98%
controls:1.60%
cases:12.24%
controls:0.34%
—
—
cases:27.66%
controls:0.26%
cases:70.26%
controls:1.56%
cases:74.94%
controls:3.18%
172
260
751
8970
249
148
674
9082
113
31
810
9199
—
255
24
667
9198
633
142
268
8948
607
264
203
8042
nifedipine; oral, parenteral
C08CA05 [21601751]
2.8e+00
3.4e+00
3.6e+00
1.0e+50
4.6e+00
4.2e+00
4.2e+00
cases:10.51%
controls:0.70%
cases:11.16%
controls:0.42%
cases:4.01%
controls:0.12%
cases:4.01%
controls:0.00%
cases:7.70%
controls:0.09%
cases:20.75%
controls:0.40%
cases:27.53%
controls:0.54%
97
65
826
9165
103
39
820
9191
37
11
886
9219
37
0
886
9230
71
8
851
9214
187
36
714
9054
223
45
587
8261
hydroxychloroquine; oral
P01BA02 [21604889]
2.4e+00
3.0e+00
2.8e+00
1.0e+50
3.9e+00
4.1e+00
4.0e+00
cases:10.83%
controls:1.06%
cases:15.17%
controls:0.90%
cases:3.58%
controls:0.22%
cases:6.61%
controls:0.00%
cases:11.06%
controls:0.26%
cases:33.19%
controls:0.84%
cases:40.37%
controls:1.24%
100
98
823
9132
140
83
783
9147
33
20
890
9210
61
0
862
9230
102
24
820
9198
299
76
602
9014
327
103
483
8203
ursodeoxycholic acid; oral
A05AA02 [21600513]
2.6e+00
2.8e+00
2.9e+00
—
2.6e+00
3.2e+00
3.0e+00
cases:2.06%
controls:0.16%
cases:2.38%
controls:0.15%
cases:0.98%
controls:0.05%
—
—
cases:0.87%
controls:0.07%
cases:3.11%
controls:0.13%
cases:4.20%
controls:0.22%
19
15
904
9215
22
14
901
9216
9
5
914
9225
—
8
6
914
9216
28
12
873
9078
34
18
776
8288
mycophenolic acid; oral, parenteral
L04AA06 [21603896]
1.4e+00
1.8e+00
2.9e+00
1.0e+50
3.6e+00
3.7e+00
4.2e+00
cases:0.76%
controls:0.20%
cases:1.19%
controls:0.20%
cases:0.98%
controls:0.05%
cases:0.87%
controls:0.00%
cases:2.71%
controls:0.08%
cases:6.55%
controls:0.18%
cases:10.37%
controls:0.18%
7
18
916
9212
11
18
912
9212
9
5
914
9225
8
0
915
9230
25
7
897
9215
59
16
842
9074
84
15
726
8291
SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
26975-3 [3025245]
2.8e+00
5.5e+00
—
1.0e+50
1.0e+50
4.0e+00
3.4e+00
cases:2.17%
controls:0.13%
cases:11.92%
controls:0.05%
—
—
cases:0.76%
controls:0.00%
cases:1.95%
controls:0.00%
cases:4.00%
controls:0.08%
cases:9.75%
controls:0.36%
20
12
903
9218
110
5
813
9225
—
7
0
916
9230
18
0
904
9222
36
7
865
9083
79
30
731
8276
Smith extractable nuclear Ab [Units/volume] in Serum
11090-8 [3016921]
2.9e+00
5.3e+00
—
1.0e+50
1.0e+50
3.8e+00
3.2e+00
cases:3.14%
controls:0.17%
cases:13.76%
controls:0.08%
—
—
cases:0.65%
controls:0.00%
cases:1.30%
controls:0.00%
cases:3.88%
controls:0.09%
cases:9.88%
controls:0.45%
29
16
894
9214
127
7
796
9223
—
6
0
917
9230
12
0
910
9222
35
8
866
9082
80
37
730
8269
Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
29374-6 [3006999]
2.8e+00
5.3e+00
—
1.0e+50
1.0e+50
3.8e+00
3.2e+00
cases:3.03%
controls:0.18%
cases:13.76%
controls:0.08%
—
—
cases:0.65%
controls:0.00%
cases:1.30%
controls:0.00%
cases:3.88%
controls:0.09%
cases:9.88%
controls:0.45%
28
17
895
9213
127
7
796
9223
—
6
0
917
9230
12
0
910
9222
35
8
866
9082
80
37
730
8269
Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
35333-4 [3036086]
2.7e+00
5.2e+00
—
1.0e+50
1.0e+50
3.9e+00
3.1e+00
cases:2.38%
controls:0.16%
cases:8.99%
controls:0.05%
—
—
cases:0.65%
controls:0.00%
cases:2.28%
controls:0.00%
cases:4.22%
controls:0.09%
cases:7.16%
controls:0.34%
22
15
901
9215
83
5
840
9225
—
6
0
917
9230
21
0
901
9222
38
8
863
9082
58
28
752
8278
Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
17791-5 [3027450]
2.7e+00
5.2e+00
—
1.0e+50
1.0e+50
3.8e+00
3.2e+00
cases:3.14%
controls:0.23%
cases:13.87%
controls:0.09%
—
—
cases:0.65%
controls:0.00%
cases:1.30%
controls:0.00%
cases:3.88%
controls:0.09%
cases:10.37%
controls:0.46%
29
21
894
9209
128
8
795
9222
—
6
0
917
9230
12
0
910
9222
35
8
866
9082
84
38
726
8268
Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
17792-3 [3023939]
2.7e+00
5.3e+00
—
1.0e+50
—
3.8e+00
3.1e+00
cases:2.93%
controls:0.21%
cases:11.16%
controls:0.07%
—
—
cases:0.54%
controls:0.00%
—
—
cases:3.22%
controls:0.08%
cases:7.53%
controls:0.35%
27
19
896
9211
103
6
820
9224
—
5
0
918
9230
—
29
7
872
9083
61
29
749
8277
Outpatient Visit
OP [9202]
5.3e-01
1.0e+00
1.3e+00
6.0e+00
1.7e+00
2.0e+00
1.7e+00
cases:78.33%
controls:68.13%
cases:71.72%
controls:47.32%
cases:28.93%
controls:9.83%
cases:63.60%
controls:0.43%
cases:37.64%
controls:10.27%
cases:86.79%
controls:46.70%
cases:94.57%
controls:76.56%
723
6288
200
2942
662
4368
261
4862
267
907
656
8323
587
40
336
9190
347
947
575
8275
782
4245
119
4845
766
6359
44
1947
methotrexate; oral, parenteral
L04AX03 [21603929]
1.3e+00
1.7e+00
2.1e+00
—
2.8e+00
3.1e+00
3.0e+00
cases:6.83%
controls:2.02%
cases:7.91%
controls:1.52%
cases:3.68%
controls:0.48%
—
—
cases:8.35%
controls:0.55%
cases:25.97%
controls:1.62%
cases:31.73%
controls:2.23%
63
186
860
9044
73
140
850
9090
34
44
889
9186
—
77
51
845
9171
234
147
667
8943
257
185
553
8121
methotrexate
L01BA01 [21601423]
1.3e+00
1.7e+00
2.1e+00
—
2.8e+00
3.1e+00
3.0e+00
cases:6.83%
controls:2.02%
cases:7.91%
controls:1.52%
cases:3.68%
controls:0.48%
—
—
cases:8.35%
controls:0.55%
cases:25.97%
controls:1.62%
cases:31.73%
controls:2.23%
63
186
860
9044
73
140
850
9090
34
44
889
9186
—
77
51
845
9171
234
147
667
8943
257
185
553
8121
Other interstitial pulmonary diseases with fibrosis
J84.1 [45557630]
2.8e+00
3.4e+00
—
1.0e+50
—
3.6e+00
3.7e+00
cases:1.41%
controls:0.09%
cases:1.63%
controls:0.05%
—
—
cases:0.98%
controls:0.00%
—
—
cases:1.89%
controls:0.06%
cases:3.83%
controls:0.10%
13
8
910
9222
15
5
908
9225
—
9
0
914
9230
—
17
5
884
9085
31
8
779
8298
Connective tissue diseases, rheumatoid arthritis and comparable disease
202 [2001600200]
2.2e+00
3.4e+00
—
—
—
4.9e+00
2.8e+00
cases:6.18%
controls:0.75%
cases:4.55%
controls:0.16%
—
—
—
—
—
—
cases:13.32%
controls:0.11%
cases:7.65%
controls:0.51%
57
69
866
9161
42
15
881
9215
—
—
—
120
10
781
9080
62
42
748
8264
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
6.3e-01
2.2e+00
4.2e+00
1.0e+50
2.8e+00
2.1e+00
1.4e+00
cases:7.26%
controls:3.99%
cases:11.48%
controls:1.46%
cases:8.88%
controls:0.15%
cases:0.65%
controls:0.00%
cases:2.39%
controls:0.15%
cases:10.54%
controls:1.46%
cases:19.38%
controls:5.80%
67
368
856
8862
106
135
817
9095
82
14
841
9216
6
0
917
9230
22
14
900
9208
95
133
806
8957
157
482
653
7824
Primary biliary cirrhosis
K74.3 [45557676]
3.2e+00
3.2e+00
—
1.0e+50
—
3.2e+00
3.5e+00
cases:2.17%
controls:0.09%
cases:2.17%
controls:0.09%
—
—
cases:1.08%
controls:0.00%
—
—
cases:2.33%
controls:0.10%
cases:3.46%
controls:0.11%
20
8
903
9222
20
8
903
9222
—
10
0
913
9230
—
21
9
880
9081
28
9
782
8297
Complement C3 [Mass/volume] in Serum or Plasma
4485-9 [3000620]
1.7e+00
4.0e+00
—
—
—
4.3e+00
3.1e+00
cases:2.06%
controls:0.38%
cases:5.09%
controls:0.10%
—
—
—
—
—
—
cases:4.44%
controls:0.07%
cases:8.89%
controls:0.45%
19
35
904
9195
47
9
876
9221
—
—
—
40
6
861
9084
72
37
738
8269
Complement C4 [Mass/volume] in Serum or Plasma
4498-2 [3017766]
1.8e+00
3.8e+00
1.0e+50
—
—
4.3e+00
3.1e+00
cases:2.06%
controls:0.34%
cases:5.09%
controls:0.12%
cases:7.04%
controls:0.00%
—
—
—
—
cases:4.44%
controls:0.07%
cases:9.01%
controls:0.45%
19
31
904
9199
47
11
876
9219
65
0
858
9230
—
—
40
6
861
9084
73
37
737
8269
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
3.2e-01
1.4e+00
3.1e+00
2.6e+00
1.8e+00
2.1e+00
1.7e+00
cases:13.33%
controls:10.03%
cases:20.37%
controls:5.95%
cases:25.35%
controls:1.46%
cases:0.76%
controls:0.05%
cases:8.46%
controls:1.51%
cases:33.85%
controls:6.07%
cases:49.26%
controls:14.76%
123
926
800
8304
188
549
735
8681
234
135
689
9095
7
5
916
9225
78
139
844
9083
305
552
596
8538
399
1226
411
7080
DNA double strand Ab [Units/volume] in Serum
5130-0 [3023420]
2.1e+00
4.7e+00
1.0e+50
1.0e+50
1.0e+50
3.2e+00
2.7e+00
cases:3.36%
controls:0.41%
cases:12.57%
controls:0.13%
cases:10.18%
controls:0.00%
cases:0.54%
controls:0.00%
cases:1.84%
controls:0.00%
cases:3.55%
controls:0.15%
cases:9.38%
controls:0.70%
31
38
892
9192
116
12
807
9218
94
0
829
9230
5
0
918
9230
17
0
905
9222
32
14
869
9076
76
58
734
8248
Difficulties in perfomrming procedure
ZXD30 [2001311389]
1.6e+00
3.2e+00
1.0e+50
1.0e+50
—
4.2e+00
3.5e+00
cases:1.95%
controls:0.39%
cases:2.17%
controls:0.09%
cases:1.30%
controls:0.00%
cases:1.73%
controls:0.00%
—
—
cases:5.11%
controls:0.08%
cases:7.16%
controls:0.23%
18
36
905
9194
20
8
903
9222
12
0
911
9230
16
0
907
9230
—
46
7
855
9083
58
19
752
8287
azathioprine; oral, parenteral
L04AX01 [21603927]
2.0e+00
2.4e+00
2.1e+00
1.0e+50
—
3.1e+00
3.0e+00
cases:3.25%
controls:0.43%
cases:2.60%
controls:0.25%
cases:0.87%
controls:0.11%
cases:1.19%
controls:0.00%
—
—
cases:6.66%
controls:0.31%
cases:7.78%
controls:0.43%
30
40
893
9190
24
23
899
9207
8
10
915
9220
11
0
912
9230
—
60
28
841
9062
63
36
747
8270
prednisone
A07EA03 [21600655]
1.3e+00
2.2e+00
2.5e+00
—
2.4e+00
2.2e+00
1.9e+00
cases:4.55%
controls:1.32%
cases:4.23%
controls:0.50%
cases:1.08%
controls:0.09%
—
—
cases:1.08%
controls:0.10%
cases:4.33%
controls:0.50%
cases:7.28%
controls:1.22%
42
122
881
9108
39
46
884
9184
10
8
913
9222
—
10
9
912
9213
39
45
862
9045
59
101
751
8205
prednisone; oral
H02AB07 [21602735]
1.3e+00
2.2e+00
2.5e+00
—
2.4e+00
2.2e+00
1.9e+00
cases:4.55%
controls:1.32%
cases:4.23%
controls:0.50%
cases:1.08%
controls:0.09%
—
—
cases:1.08%
controls:0.10%
cases:4.33%
controls:0.50%
cases:7.28%
controls:1.22%
42
122
881
9108
39
46
884
9184
10
8
913
9222
—
10
9
912
9213
39
45
862
9045
59
101
751
8205
Nuclear Ab [Titer] in Serum
29953-7 [3037522]
1.0e+00
4.0e+00
—
—
3.2e+00
2.4e+00
1.8e+00
cases:5.53%
controls:2.02%
cases:22.97%
controls:0.54%
—
—
—
—
cases:1.52%
controls:0.07%
cases:5.88%
controls:0.56%
cases:14.81%
controls:2.88%
51
186
872
9044
212
50
711
9180
—
—
14
6
908
9216
53
51
848
9039
120
239
690
8067
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
33762-6 [3029187]
5.2e-01
1.4e+00
3.8e+00
1.0e+50
2.6e+00
2.4e+00
2.0e+00
cases:5.09%
controls:3.08%
cases:7.80%
controls:2.06%
cases:9.97%
controls:0.25%
cases:1.52%
controls:0.00%
cases:3.69%
controls:0.28%
cases:17.76%
controls:1.98%
cases:34.44%
controls:6.63%
47
284
876
8946
72
190
851
9040
92
23
831
9207
14
0
909
9230
34
26
888
9196
160
180
741
8910
279
551
531
7755
Extensive structural and functional ultrasound examination of heart
FM1EE [2001303307]
6.1e-01
1.4e+00
2.9e+00
1.0e+50
2.8e+00
2.5e+00
1.7e+00
cases:4.12%
controls:2.28%
cases:3.79%
controls:0.96%
cases:0.98%
controls:0.05%
cases:0.54%
controls:0.00%
cases:2.17%
controls:0.13%
cases:10.77%
controls:0.98%
cases:15.19%
controls:3.06%
38
210
885
9020
35
89
888
9141
9
5
914
9225
5
0
918
9230
20
12
902
9210
97
89
804
9001
123
254
687
8052
Monocytes [#/volume] in Blood
26484-6 [3001604]
5.1e-01
1.6e+00
3.6e+00
—
2.2e+00
2.2e+00
1.8e+00
cases:12.46%
controls:7.87%
cases:19.93%
controls:4.63%
cases:25.57%
controls:0.96%
—
—
cases:7.48%
controls:0.93%
cases:32.63%
controls:4.98%
cases:48.27%
controls:12.85%
115
726
808
8504
184
427
739
8803
236
89
687
9141
—
69
86
853
9136
294
453
607
8637
391
1067
419
7239
Natriuretic peptide B [Mass/volume] in Serum or Plasma
30934-4 [3011960]
4.5e-01
1.4e+00
3.2e+00
—
2.4e+00
2.7e+00
2.1e+00
cases:1.63%
controls:1.04%
cases:2.28%
controls:0.55%
cases:2.71%
controls:0.11%
—
—
cases:0.87%
controls:0.08%
cases:5.22%
controls:0.39%
cases:9.75%
controls:1.26%
15
96
908
9134
21
51
902
9179
25
10
898
9220
—
8
7
914
9215
47
35
854
9055
79
105
731
8201
Rheumatoid/seropositive arthritis
L88 [2002000707]
1.5e+00
1.9e+00
—
—
2.9e+00
3.1e+00
2.6e+00
cases:1.52%
controls:0.34%
cases:1.73%
controls:0.27%
—
—
—
—
cases:1.30%
controls:0.08%
cases:4.66%
controls:0.22%
cases:8.64%
controls:0.72%
14
31
909
9199
16
25
907
9205
—
—
12
7
910
9215
42
20
859
9070
70
60
740
8246
Basophils [#/volume] in Blood
26444-0 [3006315]
5.1e-01
1.6e+00
3.6e+00
—
2.1e+00
2.2e+00
1.8e+00
cases:12.46%
controls:7.87%
cases:20.04%
controls:4.67%
cases:25.57%
controls:0.96%
—
—
cases:7.48%
controls:0.95%
cases:32.74%
controls:5.03%
cases:48.40%
controls:12.88%
115
726
808
8504
185
431
738
8799
236
89
687
9141
—
69
88
853
9134
295
457
606
8633
392
1070
418
7236
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
4.9e-01
1.6e+00
3.6e+00
—
2.1e+00
2.2e+00
1.8e+00
cases:12.78%
controls:8.26%
cases:20.26%
controls:4.88%
cases:25.35%
controls:0.95%
—
—
cases:7.48%
controls:0.97%
cases:32.85%
controls:5.29%
cases:48.27%
controls:13.28%
118
762
805
8468
187
450
736
8780
234
88
689
9142
—
69
89
853
9133
296
481
605
8609
391
1103
419
7203
Eosinophils [#/volume] in Blood
26449-9 [3013115]
5.4e-01
1.6e+00
3.5e+00
—
2.1e+00
2.2e+00
1.8e+00
cases:13.33%
controls:8.26%
cases:20.48%
controls:4.80%
cases:25.68%
controls:1.07%
—
—
cases:7.48%
controls:1.02%
cases:33.30%
controls:5.31%
cases:49.38%
controls:13.52%
123
762
800
8468
189
443
734
8787
237
99
686
9131
—
69
94
853
9128
300
483
601
8607
400
1123
410
7183
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
8.3e-01
1.6e+00
3.5e+00
—
2.2e+00
1.9e+00
1.5e+00
cases:6.39%
controls:2.88%
cases:8.23%
controls:1.72%
cases:8.45%
controls:0.27%
—
—
cases:2.39%
controls:0.26%
cases:12.10%
controls:1.94%
cases:21.23%
controls:5.83%
59
266
864
8964
76
159
847
9071
78
25
845
9205
—
22
24
900
9198
109
176
792
8914
172
484
638
7822
Extractable nuclear Ab [Units/volume] in Serum
30342-0 [3015171]
1.8e+00
4.6e+00
1.0e+50
—
—
2.7e+00
2.5e+00
cases:3.36%
controls:0.57%
cases:9.32%
controls:0.11%
cases:6.83%
controls:0.00%
—
—
—
—
cases:2.22%
controls:0.15%
cases:7.04%
controls:0.60%
31
53
892
9177
86
10
837
9220
63
0
860
9230
—
—
20
14
881
9076
57
50
753
8256
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
4.8e-01
1.6e+00
3.5e+00
—
2.0e+00
2.2e+00
1.8e+00
cases:11.70%
controls:7.57%
cases:18.31%
controls:4.34%
cases:22.32%
controls:0.87%
—
—
cases:6.51%
controls:0.91%
cases:29.19%
controls:4.48%
cases:43.46%
controls:11.63%
108
699
815
8531
169
401
754
8829
206
80
717
9150
—
60
84
862
9138
263
407
638
8683
352
966
458
7340
Basophils/Leukocytes in Blood
30180-4 [3022096]
4.7e-01
1.6e+00
3.5e+00
—
2.0e+00
2.2e+00
1.8e+00
cases:11.59%
controls:7.58%
cases:18.31%
controls:4.32%
cases:22.32%
controls:0.88%
—
—
cases:6.51%
controls:0.91%
cases:29.08%
controls:4.49%
cases:43.33%
controls:11.62%
107
700
816
8530
169
399
754
8831
206
81
717
9149
—
60
84
862
9138
262
408
639
8682
351
965
459
7341
Monocytes/Leukocytes in Blood
26485-3 [3019069]
4.6e-01
1.6e+00
3.5e+00
—
2.0e+00
2.2e+00
1.8e+00
cases:11.59%
controls:7.66%
cases:18.20%
controls:4.39%
cases:22.32%
controls:0.88%
—
—
cases:6.51%
controls:0.91%
cases:29.08%
controls:4.46%
cases:43.58%
controls:11.61%
107
707
816
8523
168
405
755
8825
206
81
717
9149
—
60
84
862
9138
262
405
639
8685
353
964
457
7342
ciclosporin; oral, parenteral
L04AD01 [21603924]
1.4e+00
1.4e+00
2.2e+00
—
2.2e+00
2.6e+00
3.0e+00
cases:1.19%
controls:0.30%
cases:0.98%
controls:0.24%
cases:0.65%
controls:0.08%
—
—
cases:0.87%
controls:0.10%
cases:3.22%
controls:0.24%
cases:5.31%
controls:0.28%
11
28
912
9202
9
22
914
9208
6
7
917
9223
—
8
9
914
9213
29
22
872
9068
43
23
767
8283
Other specified interstitial pulmonary diseases
J84.8 [45548126]
2.2e+00
2.5e+00
—
—
—
3.4e+00
3.3e+00
cases:0.65%
controls:0.08%
cases:0.76%
controls:0.07%
—
—
—
—
—
—
cases:1.55%
controls:0.06%
cases:2.35%
controls:0.08%
6
7
917
9223
7
6
916
9224
—
—
—
14
5
887
9085
19
7
791
8299
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
4.1e-01
1.5e+00
3.5e+00
—
2.1e+00
2.1e+00
1.7e+00
cases:11.27%
controls:7.75%
cases:17.88%
controls:4.56%
cases:22.32%
controls:0.89%
—
—
cases:6.62%
controls:0.90%
cases:28.75%
controls:4.64%
cases:42.84%
controls:12.08%
104
715
819
8515
165
421
758
8809
206
82
717
9148
—
61
83
861
9139
259
422
642
8668
347
1003
463
7303
Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]
7.0e-01
1.6e+00
2.4e+00
—
2.9e+00
2.1e+00
1.5e+00
cases:7.80%
controls:4.03%
cases:5.85%
controls:1.29%
cases:1.30%
controls:0.12%
—
—
cases:2.82%
controls:0.15%
cases:8.88%
controls:1.19%
cases:16.67%
controls:4.17%
72
372
851
8858
54
119
869
9111
12
11
911
9219
—
26
14
896
9208
80
108
821
8982
135
346
675
7960
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
4.4e-01
1.5e+00
3.4e+00
—
2.0e+00
2.1e+00
1.7e+00
cases:11.38%
controls:7.64%
cases:17.77%
controls:4.42%
cases:21.45%
controls:0.88%
—
—
cases:6.29%
controls:0.91%
cases:28.41%
controls:4.65%
cases:42.22%
controls:11.88%
105
705
818
8525
164
408
759
8822
198
81
725
9149
—
58
84
864
9138
256
423
645
8667
342
987
468
7319
Differential panel, method unspecified - Blood
69738-3 [42870588]
4.8e-01
1.4e+00
3.3e+00
—
2.0e+00
2.1e+00
1.8e+00
cases:8.13%
controls:5.17%
cases:11.92%
controls:3.10%
cases:16.03%
controls:0.67%
—
—
cases:4.88%
controls:0.67%
cases:20.53%
controls:3.11%
cases:30.99%
controls:7.09%
75
477
848
8753
110
286
813
8944
148
62
775
9168
—
45
62
877
9160
185
283
716
8807
251
589
559
7717
Medical doctor
Z2221 [2001311556]
5.3e-01
1.7e+00
2.6e+00
1.0e+50
2.4e+00
2.2e+00
1.5e+00
cases:7.80%
controls:4.76%
cases:6.28%
controls:1.24%
cases:2.93%
controls:0.22%
cases:2.38%
controls:0.00%
cases:1.74%
controls:0.16%
cases:9.77%
controls:1.18%
cases:11.60%
controls:2.97%
72
439
851
8791
58
114
865
9116
27
20
896
9210
22
0
901
9230
16
15
906
9207
88
107
813
8983
94
247
716
8059
Thorax X-ray examination
GD1AA [2001303617]
7.1e-01
1.8e+00
2.0e+00
1.0e+50
2.8e+00
1.8e+00
1.6e+00
cases:11.92%
controls:6.22%
cases:11.70%
controls:2.11%
cases:2.06%
controls:0.27%
cases:10.08%
controls:0.00%
cases:2.71%
controls:0.16%
cases:11.99%
controls:2.13%
cases:27.41%
controls:7.16%
110
574
813
8656
108
195
815
9035
19
25
904
9205
93
0
830
9230
25
15
897
9207
108
194
793
8896
222
595
588
7711
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
3.8e-01
1.8e+00
3.7e+00
—
1.7e+00
1.9e+00
1.3e+00
cases:19.83%
controls:14.44%
cases:31.42%
controls:7.10%
cases:27.74%
controls:0.94%
—
—
cases:5.75%
controls:1.06%
cases:35.52%
controls:7.62%
cases:51.60%
controls:22.66%
183
1333
740
7897
290
655
633
8575
256
87
667
9143
—
53
98
869
9124
320
693
581
8397
418
1882
392
6424
prednisolone; oral, parenteral
H02AB06 [21602734]
7.9e-01
1.6e+00
2.1e+00
—
2.5e+00
2.2e+00
1.5e+00
cases:19.39%
controls:9.83%
cases:17.01%
controls:3.81%
cases:5.42%
controls:0.68%
—
—
cases:8.57%
controls:0.75%
cases:27.41%
controls:4.15%
cases:33.83%
controls:10.59%
179
907
744
8323
157
352
766
8878
50
63
873
9167
—
79
69
843
9153
247
377
654
8713
274
880
536
7426
prednisolone
A07EA01 [21600653]
7.8e-01
1.6e+00
2.1e+00
—
2.5e+00
2.2e+00
1.5e+00
cases:19.39%
controls:9.95%
cases:17.01%
controls:3.82%
cases:5.42%
controls:0.68%
—
—
cases:8.57%
controls:0.75%
cases:27.41%
controls:4.17%
cases:33.95%
controls:10.65%
179
918
744
8312
157
353
766
8877
50
63
873
9167
—
79
69
843
9153
247
379
654
8711
275
885
535
7421
Myelocytes/Leukocytes in Blood
26498-6 [3017181]
1.0e+00
1.7e+00
4.1e+00
—
1.9e+00
2.2e+00
1.7e+00
cases:1.95%
controls:0.73%
cases:2.71%
controls:0.53%
cases:3.03%
controls:0.05%
—
—
cases:0.65%
controls:0.10%
cases:5.44%
controls:0.63%
cases:9.51%
controls:1.85%
18
67
905
9163
25
49
898
9181
28
5
895
9225
—
6
9
916
9213
49
57
852
9033
77
154
733
8152
Physiotherapist
Z3226 [2001311560]
4.3e-01
1.7e+00
2.2e+00
1.0e+50
3.2e+00
2.1e+00
1.5e+00
cases:3.79%
controls:2.49%
cases:3.03%
controls:0.60%
cases:0.65%
controls:0.08%
cases:1.19%
controls:0.00%
cases:1.84%
controls:0.08%
cases:5.11%
controls:0.66%
cases:6.79%
controls:1.65%
35
230
888
9000
28
55
895
9175
6
7
917
9223
11
0
912
9230
17
7
905
9215
46
60
855
9030
55
137
755
8169
Cyclic citrullinated peptide Ab [Units/volume] in Serum
53027-9 [3041942]
8.0e-01
2.9e+00
4.7e+00
—
2.2e+00
4.1e-01
9.6e-02
cases:5.20%
controls:2.41%
cases:11.70%
controls:0.69%
cases:5.42%
controls:0.05%
—
—
cases:0.65%
controls:0.08%
cases:1.22%
controls:0.81%
cases:4.20%
controls:3.83%
48
222
875
9008
108
64
815
9166
50
5
873
9225
—
6
7
916
9215
11
74
890
9016
34
318
776
7988
IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]
9.4e-01
2.6e+00
—
—
2.5e+00
2.5e+00
1.9e+00
cases:2.49%
controls:0.99%
cases:3.90%
controls:0.29%
—
—
—
—
cases:0.76%
controls:0.07%
cases:4.44%
controls:0.39%
cases:8.02%
controls:1.24%
23
91
900
9139
36
27
887
9203
—
—
7
6
915
9216
40
35
861
9055
65
103
745
8203
Metamyelocytes/Leukocytes in Blood
28541-1 [3002179]
9.9e-01
1.6e+00
3.9e+00
—
—
2.2e+00
1.8e+00
cases:1.73%
controls:0.65%
cases:2.49%
controls:0.50%
cases:2.49%
controls:0.05%
—
—
—
—
cases:4.77%
controls:0.57%
cases:9.38%
controls:1.67%
16
60
907
9170
23
46
900
9184
23
5
900
9225
—
—
43
52
858
9038
76
139
734
8167
U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
59026-5 [40762119]
3.3e+00
—
—
—
1.0e+50
3.7e+00
3.3e+00
cases:1.41%
controls:0.05%
—
—
—
—
—
—
cases:1.41%
controls:0.00%
cases:2.22%
controls:0.06%
cases:4.69%
controls:0.18%
13
5
910
9225
—
—
—
13
0
909
9222
20
5
881
9085
38
15
772
8291
Centromere protein B Ab [Units/volume] in Serum
53982-5 [3039162]
2.6e+00
—
—
1.0e+50
1.0e+50
4.1e+00
3.6e+00
cases:1.95%
controls:0.14%
—
—
—
—
cases:0.76%
controls:0.00%
cases:0.54%
controls:0.00%
cases:3.11%
controls:0.06%
cases:6.30%
controls:0.19%
18
13
905
9217
—
—
7
0
916
9230
5
0
917
9222
28
5
873
9085
51
16
759
8290
Gastroenterology
10 [38004455]
9.4e-01
1.4e+00
1.8e+00
—
2.6e+00
2.1e+00
1.4e+00
cases:10.73%
controls:4.47%
cases:8.02%
controls:2.03%
cases:2.38%
controls:0.40%
—
—
cases:4.12%
controls:0.33%
cases:14.43%
controls:2.10%
cases:20.62%
controls:5.85%
99
413
824
8817
74
187
849
9043
22
37
901
9193
—
38
30
884
9192
130
191
771
8899
167
486
643
7820
FEV1/FVC
19926-5 [3011505]
1.2e+00
2.3e+00
—
—
—
3.2e+00
3.3e+00
cases:6.07%
controls:1.87%
cases:4.88%
controls:0.53%
—
—
—
—
—
—
cases:12.21%
controls:0.55%
cases:22.59%
controls:1.04%
56
173
867
9057
45
49
878
9181
—
—
—
110
50
791
9040
183
86
627
8220
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
1.2e+00
2.3e+00
—
—
—
3.2e+00
3.3e+00
cases:6.07%
controls:1.87%
cases:4.88%
controls:0.53%
—
—
—
—
—
—
cases:12.21%
controls:0.55%
cases:22.59%
controls:1.04%
56
173
867
9057
45
49
878
9181
—
—
—
110
50
791
9040
183
86
627
8220
FEV1
20150-9 [3024653]
1.2e+00
2.3e+00
—
—
—
3.2e+00
3.3e+00
cases:6.07%
controls:1.87%
cases:4.88%
controls:0.53%
—
—
—
—
—
—
cases:12.21%
controls:0.55%
cases:22.59%
controls:1.04%
56
173
867
9057
45
49
878
9181
—
—
—
110
50
791
9040
183
86
627
8220
Gastro-oesophageal reflux disease with oesophagitis
K21.0 [45543296]
1.2e+00
2.3e+00
—
—
2.4e+00
2.4e+00
1.6e+00
cases:2.93%
controls:0.92%
cases:3.03%
controls:0.31%
—
—
—
—
cases:0.98%
controls:0.09%
cases:3.44%
controls:0.32%
cases:5.19%
controls:1.08%
27
85
896
9145
28
29
895
9201
—
—
9
8
913
9214
31
29
870
9061
42
90
768
8216
Diffusion capacity of lung
54715006 [4182985]
1.3e+00
2.8e+00
—
1.0e+50
—
3.8e+00
3.1e+00
cases:0.87%
controls:0.23%
cases:0.87%
controls:0.05%
—
—
cases:0.65%
controls:0.00%
—
—
cases:3.22%
controls:0.08%
cases:5.19%
controls:0.24%
8
21
915
9209
8
5
915
9225
—
6
0
917
9230
—
29
7
872
9083
42
20
768
8286
Promyelocytes/Leukocytes in Blood
26524-9 [3021440]
9.0e-01
1.6e+00
4.1e+00
—
1.9e+00
2.2e+00
1.7e+00
cases:1.73%
controls:0.72%
cases:2.60%
controls:0.52%
cases:3.03%
controls:0.05%
—
—
cases:0.65%
controls:0.10%
cases:5.33%
controls:0.61%
cases:9.26%
controls:1.75%
16
66
907
9164
24
48
899
9182
28
5
895
9225
—
6
9
916
9213
48
55
853
9035
75
145
735
8161
Blasts/Leukocytes in Blood
26446-5 [3025159]
8.7e-01
1.6e+00
3.9e+00
—
1.8e+00
2.2e+00
1.7e+00
cases:1.52%
controls:0.64%
cases:2.60%
controls:0.53%
cases:3.25%
controls:0.07%
—
—
cases:0.65%
controls:0.11%
cases:5.55%
controls:0.65%
cases:9.14%
controls:1.76%
14
59
909
9171
24
49
899
9181
30
6
893
9224
—
6
10
916
9212
50
59
851
9031
74
146
736
8160
Hip joint ultrasound examination
NF1AE [2001307895]
1.6e+00
2.5e+00
—
1.0e+50
—
2.3e+00
3.0e+00
cases:1.08%
controls:0.22%
cases:0.65%
controls:0.05%
—
—
cases:1.52%
controls:0.00%
—
—
cases:1.11%
controls:0.11%
cases:3.95%
controls:0.20%
10
20
913
9210
6
5
917
9225
—
14
0
909
9230
—
10
10
891
9080
32
17
778
8289
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]
7.7e-01
1.5e+00
1.9e+00
1.0e+50
2.0e+00
1.8e+00
1.4e+00
cases:12.68%
controls:6.29%
cases:11.38%
controls:2.76%
cases:3.47%
controls:0.52%
cases:2.82%
controls:0.00%
cases:3.80%
controls:0.53%
cases:14.21%
controls:2.67%
cases:24.44%
controls:7.33%
117
581
806
8649
105
255
818
8975
32
48
891
9182
26
0
897
9230
35
49
887
9173
128
243
773
8847
198
609
612
7697
Urate [Moles/volume] in Serum or Plasma
14933-6 [3026493]
4.3e-01
1.5e+00
3.3e+00
—
1.5e+00
1.7e+00
1.2e+00
cases:5.42%
controls:3.60%
cases:6.83%
controls:1.57%
cases:5.53%
controls:0.21%
—
—
cases:1.08%
controls:0.24%
cases:7.88%
controls:1.47%
cases:15.68%
controls:5.44%
50
332
873
8898
63
145
860
9085
51
19
872
9211
—
10
22
912
9200
71
134
830
8956
127
452
683
7854
Raynaud syndrome
I73.0 [45533498]
4.4e+00
—
1.0e+50
1.0e+50
—
1.0e+50
4.8e+00
cases:5.63%
controls:0.08%
—
—
cases:5.63%
controls:0.00%
cases:6.28%
controls:0.00%
—
—
cases:9.88%
controls:0.00%
cases:10.74%
controls:0.10%
52
7
871
9223
—
52
0
871
9230
58
0
865
9230
—
89
0
812
9090
87
8
723
8298
Pulmonary Disease
29 [38004472]
4.9e-01
1.2e+00
2.2e+00
—
2.1e+00
1.8e+00
1.3e+00
cases:11.16%
controls:7.12%
cases:10.62%
controls:3.55%
cases:4.44%
controls:0.51%
—
—
cases:4.34%
controls:0.53%
cases:17.20%
controls:3.28%
cases:24.44%
controls:7.84%
103
657
820
8573
98
328
825
8902
41
47
882
9183
—
40
49
882
9173
155
298
746
8792
198
651
612
7655
Physical Medicine And Rehabilitation
25 [38004468]
6.0e-01
9.6e-01
1.3e+00
—
2.8e+00
1.9e+00
1.5e+00
cases:11.48%
controls:6.62%
cases:5.63%
controls:2.23%
cases:1.84%
controls:0.50%
—
—
cases:6.07%
controls:0.38%
cases:14.10%
controls:2.35%
cases:23.70%
controls:6.43%
106
611
817
8619
52
206
871
9024
17
46
906
9184
—
56
35
866
9187
127
214
774
8876
192
534
618
7772
Nuclear Ab [Presence] in Serum
8061-4 [3004616]
2.0e+00
4.3e+00
1.0e+50
—
1.0e+50
—
2.9e+00
cases:0.76%
controls:0.11%
cases:3.79%
controls:0.05%
cases:2.38%
controls:0.00%
—
—
cases:0.98%
controls:0.00%
—
—
cases:3.21%
controls:0.18%
7
10
916
9220
35
5
888
9225
22
0
901
9230
—
9
0
913
9222
—
26
15
784
8291
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1.1e-01
9.8e-01
2.7e+00
2.3e+00
1.2e+00
1.2e+00
7.5e-01
cases:25.14%
controls:23.16%
cases:31.42%
controls:14.62%
cases:29.36%
controls:2.83%
cases:1.63%
controls:0.17%
cases:8.24%
controls:2.52%
cases:38.85%
controls:15.84%
cases:55.06%
controls:36.58%
232
2138
691
7092
290
1349
633
7881
271
261
652
8969
15
16
908
9214
76
232
846
8990
350
1440
551
7650
446
3038
364
5268
Hand and fingers X-ray examination
ND2AA [2001307607]
1.3e+00
2.7e+00
—
1.0e+50
—
2.9e+00
2.2e+00
cases:2.60%
controls:0.75%
cases:3.03%
controls:0.22%
—
—
cases:5.74%
controls:0.00%
—
—
cases:3.77%
controls:0.21%
cases:8.02%
controls:0.94%
24
69
899
9161
28
20
895
9210
—
53
0
870
9230
—
34
19
867
9071
65
78
745
8228
FEV1 percent change
69983-5 [42868472]
1.2e+00
2.0e+00
—
—
—
2.8e+00
3.0e+00
cases:5.42%
controls:1.65%
cases:3.36%
controls:0.47%
—
—
—
—
—
—
cases:7.88%
controls:0.51%
cases:16.42%
controls:0.95%
50
152
873
9078
31
43
892
9187
—
—
—
71
46
830
9044
133
79
677
8227
FVC percent change Respiratory system
69982-7 [42868471]
1.2e+00
2.0e+00
—
—
—
2.8e+00
3.0e+00
cases:5.42%
controls:1.65%
cases:3.36%
controls:0.47%
—
—
—
—
—
—
cases:7.88%
controls:0.51%
cases:16.42%
controls:0.95%
50
152
873
9078
31
43
892
9187
—
—
—
71
46
830
9044
133
79
677
8227
FEV1 --post bronchodilation
20155-8 [3023550]
1.2e+00
2.0e+00
—
—
—
2.8e+00
3.0e+00
cases:5.42%
controls:1.65%
cases:3.36%
controls:0.47%
—
—
—
—
—
—
cases:7.88%
controls:0.51%
cases:16.42%
controls:0.95%
50
152
873
9078
31
43
892
9187
—
—
—
71
46
830
9044
133
79
677
8227
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
1.2e+00
2.0e+00
—
—
—
2.8e+00
3.0e+00
cases:5.42%
controls:1.65%
cases:3.36%
controls:0.47%
—
—
—
—
—
—
cases:7.88%
controls:0.51%
cases:16.42%
controls:0.95%
50
152
873
9078
31
43
892
9187
—
—
—
71
46
830
9044
133
79
677
8227
FEV1/FVC --post bronchodilation
69970-2 [42868459]
1.2e+00
2.0e+00
—
—
—
2.8e+00
3.0e+00
cases:5.42%
controls:1.65%
cases:3.36%
controls:0.47%
—
—
—
—
—
—
cases:7.88%
controls:0.51%
cases:16.42%
controls:0.95%
50
152
873
9078
31
43
892
9187
—
—
—
71
46
830
9044
133
79
677
8227
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
9.4e-02
1.3e+00
3.5e+00
—
1.4e+00
1.6e+00
1.2e+00
cases:14.52%
controls:13.39%
cases:21.13%
controls:6.68%
cases:21.89%
controls:0.88%
—
—
cases:4.23%
controls:1.06%
cases:28.41%
controls:7.08%
cases:44.32%
controls:19.48%
134
1236
789
7994
195
617
728
8613
202
81
721
9149
—
39
98
883
9124
256
644
645
8446
359
1618
451
6688
Mitochondria Ab [Titer] in Serum
20483-4 [3034770]
1.4e+00
3.0e+00
—
—
—
2.6e+00
2.0e+00
cases:1.41%
controls:0.36%
cases:1.30%
controls:0.07%
—
—
—
—
—
—
cases:1.55%
controls:0.12%
cases:2.96%
controls:0.42%
13
33
910
9197
12
6
911
9224
—
—
—
14
11
887
9079
24
35
786
8271
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
-6.7e-03
6.1e-01
2.5e+00
3.0e+00
1.4e+00
8.8e-01
4.9e-01
cases:26.00%
controls:26.13%
cases:30.99%
controls:19.58%
cases:29.14%
controls:3.22%
cases:1.08%
controls:0.05%
cases:12.69%
controls:3.38%
cases:39.84%
controls:21.56%
cases:56.42%
controls:44.14%
240
2412
683
6818
286
1807
637
7423
269
297
654
8933
10
5
913
9225
117
312
805
8910
359
1960
542
7130
457
3666
353
4640
Office Visit
OMOP4822458 [581477]
5.4e-01
1.2e+00
1.2e+00
—
2.8e+00
1.9e+00
1.3e+00
cases:13.00%
controls:8.03%
cases:7.37%
controls:2.39%
cases:1.30%
controls:0.39%
—
—
cases:4.56%
controls:0.30%
cases:12.65%
controls:2.20%
cases:19.75%
controls:6.33%
120
741
803
8489
68
221
855
9009
12
36
911
9194
—
42
28
880
9194
114
200
787
8890
160
526
650
7780
Occupational therapy
R4120 [2001310234]
1.0e+00
1.9e+00
—
1.0e+50
—
3.6e+00
2.2e+00
cases:1.63%
controls:0.61%
cases:0.87%
controls:0.13%
—
—
cases:0.54%
controls:0.00%
—
—
cases:4.66%
controls:0.13%
cases:6.05%
controls:0.70%
15
56
908
9174
8
12
915
9218
—
5
0
918
9230
—
42
12
859
9078
49
58
761
8248
Rheumatoid factor [Units/volume] in Serum or Plasma
11572-5 [3021614]
7.5e-01
3.3e+00
4.6e+00
—
2.0e+00
5.4e-01
2.5e-01
cases:5.74%
controls:2.80%
cases:16.03%
controls:0.73%
cases:6.07%
controls:0.07%
—
—
cases:0.54%
controls:0.08%
cases:1.44%
controls:0.85%
cases:5.31%
controls:4.17%
53
258
870
8972
148
67
775
9163
56
6
867
9224
—
5
7
917
9215
13
77
888
9013
43
346
767
7960
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
1.9e-01
1.3e+00
3.3e+00
—
1.4e+00
1.5e+00
9.9e-01
cases:9.43%
controls:7.90%
cases:14.30%
controls:4.30%
cases:15.17%
controls:0.64%
—
—
cases:2.39%
controls:0.62%
cases:18.76%
controls:5.08%
cases:33.09%
controls:15.51%
87
729
836
8501
132
397
791
8833
140
59
783
9171
—
22
57
900
9165
169
462
732
8628
268
1288
542
7018
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
1.7e-01
1.3e+00
3.4e+00
—
1.3e+00
1.5e+00
9.8e-01
cases:8.99%
controls:7.71%
cases:13.76%
controls:4.17%
cases:15.17%
controls:0.62%
—
—
cases:2.28%
controls:0.63%
cases:18.42%
controls:4.93%
cases:32.47%
controls:15.29%
83
712
840
8518
127
385
796
8845
140
57
783
9173
—
21
58
901
9164
166
448
735
8642
263
1270
547
7036
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
1.7e-01
1.3e+00
3.3e+00
—
1.4e+00
1.5e+00
9.8e-01
cases:9.43%
controls:8.04%
cases:14.08%
controls:4.34%
cases:15.38%
controls:0.66%
—
—
cases:2.39%
controls:0.62%
cases:18.65%
controls:5.05%
cases:32.84%
controls:15.52%
87
742
836
8488
130
401
793
8829
142
61
781
9169
—
22
57
900
9165
168
459
733
8631
266
1289
544
7017
Joint ultrasound examination not elsewhere classified
NK4XE [2001308469]
1.0e+00
1.9e+00
2.0e+00
1.0e+50
—
2.7e+00
2.8e+00
cases:2.06%
controls:0.76%
cases:2.28%
controls:0.36%
cases:0.54%
controls:0.08%
cases:2.71%
controls:0.00%
—
—
cases:5.33%
controls:0.37%
cases:11.73%
controls:0.81%
19
70
904
9160
21
33
902
9197
5
7
918
9223
25
0
898
9230
—
48
34
853
9056
95
67
715
8239
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
1.8e-01
1.1e+00
3.1e+00
—
1.3e+00
1.6e+00
1.2e+00
cases:17.33%
controls:14.90%
cases:22.86%
controls:9.05%
cases:26.22%
controls:1.56%
—
—
cases:6.07%
controls:1.66%
cases:34.74%
controls:9.90%
cases:51.85%
controls:23.74%
160
1375
763
7855
211
835
712
8395
242
144
681
9086
—
56
153
866
9069
313
900
588
8190
420
1972
390
6334
Hemoglobin [Presence] in Urine by Test strip
5794-3 [3011397]
1.9e-01
1.1e+00
3.4e+00
—
1.4e+00
1.5e+00
8.3e-01
cases:4.12%
controls:3.42%
cases:5.85%
controls:2.02%
cases:8.13%
controls:0.30%
—
—
cases:1.19%
controls:0.29%
cases:9.99%
controls:2.33%
cases:14.94%
controls:7.09%
38
316
885
8914
54
186
869
9044
75
28
848
9202
—
11
27
911
9195
90
212
811
8878
121
589
689
7717
Supplier / Service Provider
OMOP5117446 [33004]
-8.7e-01
-4.3e-02
1.7e+00
—
—
3.6e+00
3.8e+00
cases:13.65%
controls:27.40%
cases:8.02%
controls:8.34%
cases:4.23%
controls:0.81%
—
—
—
—
cases:16.20%
controls:0.55%
cases:31.23%
controls:1.04%
126
2529
797
6701
74
770
849
8460
39
75
884
9155
—
—
146
50
755
9040
253
86
557
8220
Normoblasts [#/volume] in Blood
715-3 [3021589]
2.7e-01
1.1e+00
2.8e+00
—
1.5e+00
1.5e+00
1.3e+00
cases:8.23%
controls:6.40%
cases:13.11%
controls:4.89%
cases:15.38%
controls:1.11%
—
—
cases:4.99%
controls:1.16%
cases:20.31%
controls:5.34%
cases:31.48%
controls:11.56%
76
591
847
8639
121
451
802
8779
142
102
781
9128
—
46
107
876
9115
183
485
718
8605
255
960
555
7346
Pharmacy visit
OMOP4822462 [581458]
4.4e-01
1.3e+00
6.8e-01
2.5e+00
1.0e+00
1.5e+00
1.1e+00
cases:95.56%
controls:93.27%
cases:95.02%
controls:84.04%
cases:61.00%
controls:44.13%
cases:21.78%
controls:2.16%
cases:69.09%
controls:44.50%
cases:96.45%
controls:85.60%
cases:98.52%
controls:95.79%
882
8609
41
621
877
7757
46
1473
563
4073
360
5157
201
199
722
9031
637
4104
285
5118
869
7781
32
1309
798
7956
12
350
Protein [Presence] in Urine by Test strip
20454-5 [3014051]
3.2e-01
1.4e+00
3.3e+00
—
1.5e+00
1.3e+00
5.9e-01
cases:4.44%
controls:3.25%
cases:6.18%
controls:1.67%
cases:6.83%
controls:0.26%
—
—
cases:1.08%
controls:0.25%
cases:7.88%
controls:2.24%
cases:12.72%
controls:7.50%
41
300
882
8930
57
154
866
9076
63
24
860
9206
—
10
23
912
9199
71
204
830
8886
103
623
707
7683
Cardiology
6 [38004451]
4.3e-01
9.3e-01
1.6e+00
—
2.0e+00
1.8e+00
1.4e+00
cases:10.62%
controls:7.19%
cases:8.34%
controls:3.47%
cases:2.60%
controls:0.54%
—
—
cases:3.69%
controls:0.53%
cases:17.65%
controls:3.55%
cases:27.65%
controls:9.01%
98
664
825
8566
77
320
846
8910
24
50
899
9180
—
34
49
888
9173
159
323
742
8767
224
748
586
7558
Telephone, letter or other consultation without direct patient contact
ZY020 [2001311600]
1.1e+00
2.1e+00
—
—
—
2.9e+00
1.9e+00
cases:1.73%
controls:0.56%
cases:1.41%
controls:0.17%
—
—
—
—
—
—
cases:3.00%
controls:0.18%
cases:3.95%
controls:0.63%
16
52
907
9178
13
16
910
9214
—
—
—
27
16
874
9074
32
52
778
8254
Erythrocytes [Presence] in Urine by Automated
53292-9 [3041096]
1.9e-01
1.3e+00
3.1e+00
—
1.4e+00
1.2e+00
8.8e-01
cases:5.31%
controls:4.43%
cases:7.26%
controls:2.06%
cases:6.28%
controls:0.29%
—
—
cases:1.08%
controls:0.27%
cases:7.77%
controls:2.43%
cases:16.79%
controls:7.69%
49
409
874
8821
67
190
856
9040
58
27
865
9203
—
10
25
912
9197
70
221
831
8869
136
639
674
7667
Arthrocentesis, unspecified region, unspecified region
TNX10 [2001308560]
1.1e+00
1.7e+00
—
1.0e+50
—
2.5e+00
2.6e+00
cases:2.28%
controls:0.78%
cases:1.95%
controls:0.36%
—
—
cases:0.76%
controls:0.00%
—
—
cases:3.00%
controls:0.25%
cases:7.41%
controls:0.58%
21
72
902
9158
18
33
905
9197
—
7
0
916
9230
—
27
23
874
9067
60
48
750
8258
pH of Urine
2756-5 [3015736]
1.5e-01
1.2e+00
3.2e+00
—
1.4e+00
1.3e+00
8.0e-01
cases:7.69%
controls:6.68%
cases:10.18%
controls:3.39%
cases:10.62%
controls:0.47%
—
—
cases:1.63%
controls:0.42%
cases:13.32%
controls:3.88%
cases:23.70%
controls:12.26%
71
617
852
8613
94
313
829
8917
98
43
825
9187
—
15
39
907
9183
120
353
781
8737
192
1018
618
7288
Internal Medicine
11 [38004456]
5.6e-01
1.2e+00
1.6e+00
—
1.9e+00
1.5e+00
1.1e+00
cases:30.23%
controls:19.82%
cases:22.75%
controls:7.82%
cases:5.85%
controls:1.28%
—
—
cases:8.68%
controls:1.40%
cases:25.42%
controls:7.21%
cases:38.64%
controls:17.63%
279
1829
644
7401
210
722
713
8508
54
118
869
9112
—
80
129
842
9093
229
655
672
8435
313
1464
497
6842
Extensive high resolution CT examination of lungs
GD1ED [2001303637]
2.1e+00
2.2e+00
—
—
1.0e+50
—
3.6e+00
cases:1.30%
controls:0.16%
cases:0.65%
controls:0.08%
—
—
—
—
cases:0.54%
controls:0.00%
—
—
cases:3.70%
controls:0.11%
12
15
911
9215
6
7
917
9223
—
—
5
0
917
9222
—
30
9
780
8297
Biopsy of skin and subcutaneous tissue
TQX10 [2001310152]
1.1e+00
2.5e+00
—
—
—
2.3e+00
1.9e+00
cases:2.28%
controls:0.77%
cases:2.49%
controls:0.21%
—
—
—
—
—
—
cases:1.89%
controls:0.20%
cases:4.69%
controls:0.72%
21
71
902
9159
23
19
900
9211
—
—
—
17
18
884
9072
38
60
772
8246
Leukocytes [#/volume] in Urine
30405-5 [3018095]
1.4e-01
1.0e+00
3.1e+00
—
1.3e+00
1.3e+00
9.3e-01
cases:5.63%
controls:4.94%
cases:6.50%
controls:2.38%
cases:7.37%
controls:0.35%
—
—
cases:1.63%
controls:0.46%
cases:10.54%
controls:3.03%
cases:19.88%
controls:8.91%
52
456
871
8774
60
220
863
9010
68
32
855
9198
—
15
42
907
9180
95
275
806
8815
161
740
649
7566
Protein [Mass/volume] in Serum or Plasma
2885-2 [3020630]
2.5e-01
2.7e+00
2.8e+00
—
—
2.2e+00
6.3e-01
cases:1.08%
controls:0.85%
cases:3.90%
controls:0.27%
cases:0.87%
controls:0.05%
—
—
—
—
cases:2.66%
controls:0.30%
cases:2.59%
controls:1.40%
10
78
913
9152
36
25
887
9205
8
5
915
9225
—
—
24
27
877
9063
21
116
789
8190
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
5.2e-03
4.7e-01
2.0e+00
2.9e+00
1.0e+00
6.7e-01
4.6e-01
cases:17.88%
controls:17.80%
cases:21.99%
controls:14.97%
cases:17.88%
controls:2.75%
cases:1.41%
controls:0.08%
cases:7.48%
controls:2.79%
cases:27.86%
controls:16.48%
cases:44.20%
controls:33.28%
165
1643
758
7587
203
1382
720
7848
165
254
758
8976
13
7
910
9223
69
257
853
8965
251
1498
650
7592
358
2764
452
5542
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
7.9e-02
1.0e+00
2.9e+00
—
1.6e+00
1.3e+00
9.0e-01
cases:5.74%
controls:5.33%
cases:6.39%
controls:2.43%
cases:5.42%
controls:0.33%
—
—
cases:1.95%
controls:0.41%
cases:9.32%
controls:2.83%
cases:17.28%
controls:7.86%
53
492
870
8738
59
224
864
9006
50
30
873
9200
—
18
38
904
9184
84
257
817
8833
140
653
670
7653
Other specified special examinations
Z01.8 [45581003]
7.2e-01
1.3e+00
2.3e+00
—
2.5e+00
2.0e+00
1.1e+00
cases:5.20%
controls:2.60%
cases:2.82%
controls:0.75%
cases:0.54%
controls:0.05%
—
—
cases:0.76%
controls:0.07%
cases:5.66%
controls:0.80%
cases:8.40%
controls:3.08%
48
240
875
8990
26
69
897
9161
5
5
918
9225
—
7
6
915
9216
51
73
850
9017
68
256
742
8050
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]
1.2e-01
1.1e+00
3.1e+00
—
1.3e+00
1.2e+00
8.1e-01
cases:7.58%
controls:6.81%
cases:9.75%
controls:3.45%
cases:9.53%
controls:0.46%
—
—
cases:1.63%
controls:0.44%
cases:12.21%
controls:4.00%
cases:23.70%
controls:12.14%
70
629
853
8601
90
318
833
8912
88
42
835
9188
—
15
41
907
9181
110
364
791
8726
192
1008
618
7298
Reticulocytes/Erythrocytes in Blood
4679-7 [3027945]
3.8e-01
1.5e+00
2.3e+00
—
1.6e+00
1.3e+00
8.0e-01
cases:1.63%
controls:1.12%
cases:2.93%
controls:0.66%
cases:0.65%
controls:0.07%
—
—
cases:0.87%
controls:0.17%
cases:2.33%
controls:0.63%
cases:4.32%
controls:2.00%
15
103
908
9127
27
61
896
9169
6
6
917
9224
—
8
16
914
9206
21
57
880
9033
35
166
775
8140
Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
3181-5 [3009041]
9.2e-01
3.1e+00
1.0e+50
—
—
2.9e+00
1.5e+00
cases:0.54%
controls:0.22%
cases:1.19%
controls:0.05%
cases:0.54%
controls:0.00%
—
—
—
—
cases:1.00%
controls:0.06%
cases:1.11%
controls:0.24%
5
20
918
9210
11
5
912
9225
5
0
918
9230
—
—
9
5
892
9085
9
20
801
8286
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 [3030306]
4.2e-01
1.0e+00
2.7e+00
—
1.9e+00
1.2e+00
7.3e-01
cases:2.28%
controls:1.51%
cases:2.49%
controls:0.93%
cases:1.63%
controls:0.11%
—
—
cases:0.98%
controls:0.15%
cases:3.66%
controls:1.12%
cases:7.41%
controls:3.71%
21
139
902
9091
23
86
900
9144
15
10
908
9220
—
9
14
913
9208
33
102
868
8988
60
308
750
7998
Bilateral hand X-ray examination
ND2DA [2001307619]
—
2.2e+00
—
1.0e+50
—
3.0e+00
2.3e+00
—
—
cases:0.65%
controls:0.08%
—
—
cases:0.98%
controls:0.00%
—
—
cases:1.11%
controls:0.06%
cases:1.23%
controls:0.12%
—
6
7
917
9223
—
9
0
914
9230
—
10
5
891
9085
10
10
800
8296
Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
44448-9 [3044355]
9.7e-01
3.2e+00
1.0e+50
—
—
2.5e+00
1.7e+00
cases:0.54%
controls:0.21%
cases:1.30%
controls:0.05%
cases:0.65%
controls:0.00%
—
—
—
—
cases:0.67%
controls:0.06%
cases:1.23%
controls:0.22%
5
19
918
9211
12
5
911
9225
6
0
917
9230
—
—
6
5
895
9085
10
18
800
8288
Flexible bronchoscopy
UGC12 [2001303610]
1.2e+00
2.6e+00
—
—
—
2.2e+00
1.3e+00
cases:1.73%
controls:0.54%
cases:1.30%
controls:0.10%
—
—
—
—
—
—
cases:1.33%
controls:0.14%
cases:2.10%
controls:0.55%
16
50
907
9180
12
9
911
9221
—
—
—
12
13
889
9077
17
46
793
8260
Leukocytes [Presence] in Urine
33052-2 [3045414]
—
1.8e+00
2.8e+00
—
—
1.5e+00
1.2e+00
—
—
cases:1.63%
controls:0.26%
cases:1.08%
controls:0.07%
—
—
—
—
cases:1.22%
controls:0.29%
cases:5.56%
controls:1.75%
—
15
24
908
9206
10
6
913
9224
—
—
11
26
890
9064
45
145
765
8161
Iron [Moles/volume] in Serum or Plasma
14798-3 [3022948]
3.1e-01
1.3e+00
2.4e+00
—
1.7e+00
1.2e+00
6.8e-01
cases:2.28%
controls:1.68%
cases:3.14%
controls:0.91%
cases:0.87%
controls:0.08%
—
—
cases:0.98%
controls:0.17%
cases:3.22%
controls:0.99%
cases:6.67%
controls:3.50%
21
155
902
9075
29
84
894
9146
8
7
915
9223
—
9
16
913
9206
29
90
872
9000
54
291
756
8015
Standard cardiac ultrasound examination
FM1AE [2001303278]
6.2e-01
1.1e+00
—
1.0e+50
2.4e+00
2.3e+00
1.5e+00
cases:3.79%
controls:2.07%
cases:2.71%
controls:0.92%
—
—
cases:0.87%
controls:0.00%
cases:0.98%
controls:0.09%
cases:6.77%
controls:0.73%
cases:9.14%
controls:2.28%
35
191
888
9039
25
85
898
9145
—
8
0
915
9230
9
8
913
9214
61
66
840
9024
74
189
736
8117
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
1.1e-02
5.1e-01
2.2e+00
2.5e+00
1.1e+00
7.3e-01
3.8e-01
cases:27.52%
controls:27.30%
cases:32.18%
controls:22.18%
cases:28.71%
controls:4.45%
cases:1.73%
controls:0.15%
cases:11.06%
controls:4.16%
cases:40.07%
controls:24.35%
cases:55.68%
controls:46.15%
254
2520
669
6710
297
2047
626
7183
265
411
658
8819
16
14
907
9216
102
384
820
8838
361
2213
540
6877
451
3833
359
4473
Rheumatism, unspecified
M79.0 [45567658]
1.3e+00
2.1e+00
—
1.0e+50
—
2.2e+00
1.7e+00
cases:1.52%
controls:0.42%
cases:0.87%
controls:0.11%
—
—
cases:0.76%
controls:0.00%
—
—
cases:0.89%
controls:0.10%
cases:1.48%
controls:0.28%
14
39
909
9191
8
10
915
9220
—
7
0
916
9230
—
8
9
893
9081
12
23
798
8283
Bilateral foot X-ray examination
NH3DA [2001308279]
—
2.0e+00
—
1.0e+50
—
2.9e+00
2.3e+00
—
—
cases:0.65%
controls:0.09%
—
—
cases:0.87%
controls:0.00%
—
—
cases:1.00%
controls:0.06%
cases:1.11%
controls:0.11%
—
6
8
917
9222
—
8
0
915
9230
—
9
5
892
9085
9
9
801
8297
Cells panel - Urine sediment
58434-2 [40761535]
4.9e-02
1.1e+00
3.5e+00
—
—
1.5e+00
1.1e+00
cases:1.63%
controls:1.55%
cases:1.73%
controls:0.59%
cases:2.49%
controls:0.08%
—
—
—
—
cases:3.22%
controls:0.75%
cases:5.56%
controls:1.83%
15
143
908
9087
16
54
907
9176
23
7
900
9223
—
—
29
68
872
9022
45
152
765
8154
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
68438-1 [40771025]
1.1e-01
9.3e-01
2.8e+00
—
1.5e+00
1.2e+00
7.8e-01
cases:7.15%
controls:6.46%
cases:8.23%
controls:3.42%
cases:4.88%
controls:0.30%
—
—
cases:1.52%
controls:0.35%
cases:11.65%
controls:3.81%
cases:23.95%
controls:12.67%
66
596
857
8634
76
316
847
8914
45
28
878
9202
—
14
32
908
9190
105
346
796
8744
194
1052
616
7254
Transferrin [Mass/volume] in Serum or Plasma
3034-6 [3004789]
2.8e-01
1.3e+00
2.3e+00
—
1.8e+00
1.2e+00
6.0e-01
cases:2.06%
controls:1.57%
cases:2.71%
controls:0.78%
cases:0.76%
controls:0.08%
—
—
cases:0.98%
controls:0.16%
cases:2.89%
controls:0.89%
cases:5.80%
controls:3.26%
19
145
904
9085
25
72
898
9158
7
7
916
9223
—
9
15
913
9207
26
81
875
9009
47
271
763
8035
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
8.3e-02
8.4e-01
2.8e+00
—
1.6e+00
1.0e+00
9.1e-01
cases:4.12%
controls:3.80%
cases:4.01%
controls:1.77%
cases:3.47%
controls:0.23%
—
—
cases:1.30%
controls:0.27%
cases:5.44%
controls:2.01%
cases:13.33%
controls:5.82%
38
351
885
8879
37
163
886
9067
32
21
891
9209
—
12
25
910
9197
49
183
852
8907
108
483
702
7823
Dermatitis, unspecified
L30.9 [45572271]
5.2e-01
1.3e+00
2.1e+00
—
1.9e+00
9.4e-01
7.9e-01
cases:3.14%
controls:1.89%
cases:2.71%
controls:0.74%
cases:1.19%
controls:0.14%
—
—
cases:0.87%
controls:0.13%
cases:2.33%
controls:0.92%
cases:6.67%
controls:3.15%
29
174
894
9056
25
68
898
9162
11
13
912
9217
—
8
12
914
9210
21
84
880
9006
54
262
756
8044
Albumin [Presence] in Urine by Test strip
50949-7 [3029937]
9.9e-02
1.2e+00
3.3e+00
—
1.2e+00
1.5e+00
1.1e+00
cases:5.31%
controls:4.83%
cases:7.80%
controls:2.57%
cases:8.45%
controls:0.34%
—
—
cases:1.19%
controls:0.35%
cases:10.88%
controls:2.73%
cases:21.60%
controls:8.19%
49
446
874
8784
72
237
851
8993
78
31
845
9199
—
11
32
911
9190
98
248
803
8842
175
680
635
7626
Proteinase 3 Ab [Units/volume] in Serum
6968-2 [3009445]
9.5e-01
3.6e+00
1.0e+50
—
—
2.2e+00
1.1e+00
cases:1.19%
controls:0.47%
cases:3.14%
controls:0.09%
cases:1.73%
controls:0.00%
—
—
—
—
cases:0.89%
controls:0.10%
cases:1.98%
controls:0.64%
11
43
912
9187
29
8
894
9222
16
0
907
9230
—
—
8
9
893
9081
16
53
794
8253
Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
50797-0 [3029379]
—
3.2e+00
—
—
—
2.4e+00
1.3e+00
—
—
cases:1.52%
controls:0.07%
—
—
—
—
—
—
cases:1.00%
controls:0.09%
cases:1.36%
controls:0.36%
—
14
6
909
9224
—
—
—
9
8
892
9082
11
30
799
8276
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]
3.0e-01
1.3e+00
1.9e+00
—
1.7e+00
1.1e+00
9.0e-01
cases:1.52%
controls:1.13%
cases:2.17%
controls:0.57%
cases:0.76%
controls:0.12%
—
—
cases:0.98%
controls:0.18%
cases:1.78%
controls:0.57%
cases:4.44%
controls:1.85%
14
104
909
9126
20
53
903
9177
7
11
916
9219
—
9
17
913
9205
16
52
885
9038
36
154
774
8152
High resolution CT examination of lungs
GD1DD [2001303632]
1.1e+00
—
—
1.0e+50
1.0e+50
3.4e+00
3.4e+00
cases:0.87%
controls:0.30%
—
—
—
—
cases:1.52%
controls:0.00%
cases:1.30%
controls:0.00%
cases:3.33%
controls:0.11%
cases:8.02%
controls:0.29%
8
28
915
9202
—
—
14
0
909
9230
12
0
910
9222
30
10
871
9080
65
24
745
8282
Other diagnostic examination of periferal vessel
XPX99 [2001309755]
5.4e-01
1.6e+00
—
1.0e+50
—
2.9e+00
2.4e+00
cases:0.76%
controls:0.44%
cases:0.87%
controls:0.17%
—
—
cases:1.08%
controls:0.00%
—
—
cases:3.77%
controls:0.22%
cases:6.54%
controls:0.66%
7
41
916
9189
8
16
915
9214
—
10
0
913
9230
—
34
20
867
9070
53
55
757
8251
IgM [Mass/volume] in Serum or Plasma
2472-9 [3028026]
9.1e-01
2.8e+00
—
—
—
2.5e+00
1.6e+00
cases:1.84%
controls:0.75%
cases:3.14%
controls:0.21%
—
—
—
—
—
—
cases:3.00%
controls:0.26%
cases:4.44%
controls:0.90%
17
69
906
9161
29
19
894
9211
—
—
—
27
24
874
9066
36
75
774
8231
Neutrophils [#/volume] in Blood
26499-4 [3017732]
-1.7e-01
1.5e+00
2.7e+00
—
1.8e+00
1.4e+00
1.2e+00
cases:0.65%
controls:0.77%
cases:2.82%
controls:0.64%
cases:1.63%
controls:0.11%
—
—
cases:0.54%
controls:0.09%
cases:3.00%
controls:0.74%
cases:8.02%
controls:2.65%
6
71
917
9159
26
59
897
9171
15
10
908
9220
—
5
8
917
9214
27
67
874
9023
65
220
745
8086
Short blood count panel - Blood
55429-5 [40758558]
7.3e-02
6.5e-01
2.5e+00
—
1.3e+00
1.3e+00
1.0e+00
cases:4.98%
controls:4.65%
cases:4.44%
controls:2.36%
cases:4.98%
controls:0.42%
—
—
cases:1.84%
controls:0.49%
cases:7.88%
controls:2.38%
cases:15.19%
controls:5.90%
46
429
877
8801
41
218
882
9012
46
39
877
9191
—
17
45
905
9177
71
216
830
8874
123
490
687
7816
Polymyalgia rheumatica
M35.3 [45533830]
2.1e+00
1.0e+50
—
—
—
2.7e+00
2.1e+00
cases:0.76%
controls:0.10%
cases:0.76%
controls:0.00%
—
—
—
—
—
—
cases:0.78%
controls:0.06%
cases:1.23%
controls:0.16%
7
9
916
9221
7
0
916
9230
—
—
—
7
5
894
9085
10
13
800
8293
Stomach Pathology biopsy report
66114-0 [40768797]
3.2e-01
1.1e+00
—
—
2.8e+00
1.9e+00
9.1e-01
cases:2.82%
controls:2.06%
cases:2.38%
controls:0.77%
—
—
—
—
cases:0.87%
controls:0.05%
cases:3.88%
controls:0.59%
cases:6.42%
controls:2.70%
26
190
897
9040
22
71
901
9159
—
—
8
5
914
9217
35
54
866
9036
52
224
758
8082
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
3.1e-01
9.7e-01
2.7e+00
—
2.0e+00
1.1e+00
4.1e-01
cases:2.17%
controls:1.60%
cases:2.28%
controls:0.88%
cases:1.41%
controls:0.10%
—
—
cases:1.08%
controls:0.15%
cases:3.00%
controls:1.01%
cases:4.94%
controls:3.32%
20
148
903
9082
21
81
902
9149
13
9
910
9221
—
10
14
912
9208
27
92
874
8998
40
276
770
8030
pH of Serum or Plasma
2753-2 [3018418]
2.5e-01
8.9e-01
2.5e+00
—
1.7e+00
8.1e-01
8.3e-01
cases:5.31%
controls:4.18%
cases:5.53%
controls:2.34%
cases:3.68%
controls:0.33%
—
—
cases:1.84%
controls:0.34%
cases:5.33%
controls:2.44%
cases:14.69%
controls:6.98%
49
386
874
8844
51
216
872
9014
34
30
889
9200
—
17
31
905
9191
48
222
853
8868
119
580
691
7726
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
2.7e-02
5.8e-01
2.2e+00
1.7e+00
1.0e+00
7.4e-01
4.3e-01
cases:18.85%
controls:18.44%
cases:23.62%
controls:14.79%
cases:23.73%
controls:3.23%
cases:0.87%
controls:0.16%
cases:8.46%
controls:3.13%
cases:29.30%
controls:16.51%
cases:42.72%
controls:32.76%
174
1702
749
7528
218
1365
705
7865
219
298
704
8932
8
15
915
9215
78
289
844
8933
264
1501
637
7589
346
2721
464
5585
Microorganisms panel - Urine sediment
58435-9 [40761536]
2.5e-01
1.3e+00
2.9e+00
—
2.0e+00
1.2e+00
1.2e+00
cases:1.73%
controls:1.35%
cases:1.95%
controls:0.54%
cases:1.63%
controls:0.09%
—
—
cases:0.54%
controls:0.08%
cases:1.55%
controls:0.45%
cases:5.06%
controls:1.57%
16
125
907
9105
18
50
905
9180
15
8
908
9222
—
5
7
917
9215
14
41
887
9049
41
130
769
8176
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
-1.5e-02
5.3e-01
2.1e+00
2.1e+00
1.1e+00
6.3e-01
2.6e-01
cases:30.01%
controls:30.33%
cases:36.62%
controls:25.36%
cases:30.77%
controls:5.37%
cases:1.95%
controls:0.25%
cases:14.43%
controls:5.24%
cases:41.95%
controls:27.80%
cases:57.04%
controls:50.47%
277
2799
646
6431
338
2341
585
6889
284
496
639
8734
18
23
905
9207
133
483
789
8739
378
2527
523
6563
462
4192
348
4114
Platelets [#/volume] in Blood
26515-7 [3007461]
-1.0e-02
5.3e-01
2.1e+00
2.1e+00
1.1e+00
6.3e-01
2.7e-01
cases:30.01%
controls:30.23%
cases:36.51%
controls:25.28%
cases:30.77%
controls:5.36%
cases:1.95%
controls:0.25%
cases:14.32%
controls:5.23%
cases:41.95%
controls:27.76%
cases:57.04%
controls:50.46%
277
2790
646
6440
337
2333
586
6897
284
495
639
8735
18
23
905
9207
132
482
790
8740
378
2523
523
6567
462
4191
348
4115
Leukocytes [#/volume] in Blood
26464-8 [3010813]
-1.6e-02
5.3e-01
2.1e+00
2.1e+00
1.1e+00
6.3e-01
2.7e-01
cases:30.01%
controls:30.35%
cases:36.62%
controls:25.43%
cases:30.88%
controls:5.38%
cases:1.95%
controls:0.25%
cases:14.43%
controls:5.25%
cases:41.95%
controls:27.84%
cases:57.16%
controls:50.54%
277
2801
646
6429
338
2347
585
6883
285
497
638
8733
18
23
905
9207
133
484
789
8738
378
2531
523
6559
463
4198
347
4108
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
-1.2e-02
5.3e-01
2.1e+00
2.1e+00
1.1e+00
6.2e-01
2.6e-01
cases:30.12%
controls:30.37%
cases:36.73%
controls:25.38%
cases:30.88%
controls:5.38%
cases:1.95%
controls:0.25%
cases:14.43%
controls:5.24%
cases:41.95%
controls:27.90%
cases:57.04%
controls:50.59%
278
2803
645
6427
339
2343
584
6887
285
497
638
8733
18
23
905
9207
133
483
789
8739
378
2536
523
6554
462
4202
348
4104
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
-1.5e-02
5.3e-01
2.1e+00
2.1e+00
1.1e+00
6.3e-01
2.6e-01
cases:30.01%
controls:30.34%
cases:36.62%
controls:25.36%
cases:30.88%
controls:5.38%
cases:1.95%
controls:0.25%
cases:14.43%
controls:5.25%
cases:41.95%
controls:27.84%
cases:57.04%
controls:50.52%
277
2800
646
6430
338
2341
585
6889
285
497
638
8733
18
23
905
9207
133
484
789
8738
378
2531
523
6559
462
4196
348
4110
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
-1.4e-02
5.3e-01
2.1e+00
2.1e+00
1.1e+00
6.2e-01
2.6e-01
cases:30.01%
controls:30.31%
cases:36.51%
controls:25.36%
cases:30.88%
controls:5.37%
cases:1.95%
controls:0.25%
cases:14.21%
controls:5.24%
cases:41.84%
controls:27.83%
cases:57.04%
controls:50.52%
277
2798
646
6432
337
2341
586
6889
285
496
638
8734
18
23
905
9207
131
483
791
8739
377
2530
524
6560
462
4196
348
4110
MCH [Entitic mass]
28539-5 [3035941]
-1.3e-02
5.3e-01
2.1e+00
2.1e+00
1.1e+00
6.2e-01
2.6e-01
cases:30.01%
controls:30.28%
cases:36.51%
controls:25.33%
cases:30.77%
controls:5.37%
cases:1.95%
controls:0.25%
cases:14.21%
controls:5.24%
cases:41.84%
controls:27.81%
cases:57.04%
controls:50.52%
277
2795
646
6435
337
2338
586
6892
284
496
639
8734
18
23
905
9207
131
483
791
8739
377
2528
524
6562
462
4196
348
4110
Smooth muscle Ab [Titer] in Serum
8095-2 [3007566]
1.1e+00
2.7e+00
—
—
—
2.1e+00
1.8e+00
cases:1.08%
controls:0.35%
cases:1.08%
controls:0.08%
—
—
—
—
—
—
cases:1.11%
controls:0.13%
cases:2.59%
controls:0.43%
10
32
913
9198
10
7
913
9223
—
—
—
10
12
891
9078
21
36
789
8270
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
6.5e-02
8.6e-01
2.6e+00
—
1.3e+00
1.0e+00
7.6e-01
cases:4.66%
controls:4.38%
cases:4.55%
controls:1.97%
cases:3.68%
controls:0.28%
—
—
cases:1.52%
controls:0.40%
cases:6.55%
controls:2.43%
cases:14.32%
controls:7.24%
43
404
880
8826
42
182
881
9048
34
26
889
9204
—
14
37
908
9185
59
221
842
8869
116
601
694
7705
Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
88518-6 [36304997]
1.1e+00
2.4e+00
—
—
—
2.4e+00
1.7e+00
cases:1.08%
controls:0.37%
cases:0.87%
controls:0.08%
—
—
—
—
—
—
cases:1.44%
controls:0.13%
cases:2.35%
controls:0.42%
10
34
913
9196
8
7
915
9223
—
—
—
13
12
888
9078
19
35
791
8271
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
1.9e-01
1.0e+00
2.3e+00
—
1.6e+00
8.7e-01
6.8e-01
cases:8.88%
controls:7.45%
cases:10.62%
controls:4.16%
cases:5.85%
controls:0.60%
—
—
cases:2.71%
controls:0.56%
cases:10.10%
controls:4.51%
cases:22.59%
controls:12.91%
82
688
841
8542
98
384
825
8846
54
55
869
9175
—
25
52
897
9170
91
410
810
8680
183
1072
627
7234
Physiotherapy
R4110 [2001310233]
3.1e-01
1.3e+00
—
—
2.4e+00
1.7e+00
1.1e+00
cases:5.63%
controls:4.20%
cases:4.98%
controls:1.45%
—
—
—
—
cases:1.95%
controls:0.17%
cases:6.66%
controls:1.34%
cases:10.86%
controls:3.85%
52
388
871
8842
46
134
877
9096
—
—
18
16
904
9206
60
122
841
8968
88
320
722
7986
General Surgery
2 [38004447]
3.8e-01
6.3e-01
6.8e-01
3.5e+00
1.2e+00
7.9e-01
3.0e-01
cases:22.97%
controls:17.00%
cases:9.75%
controls:5.45%
cases:1.41%
controls:0.72%
cases:2.06%
controls:0.07%
cases:2.17%
controls:0.66%
cases:10.32%
controls:4.95%
cases:17.28%
controls:13.45%
212
1569
711
7661
90
503
833
8727
13
66
910
9164
19
6
904
9224
20
61
902
9161
93
450
808
8640
140
1117
670
7189
Abnormal findings on diagnostic imaging of lung
R91 [45548995]
8.1e-01
2.2e+00
—
—
—
2.6e+00
1.6e+00
cases:1.52%
controls:0.68%
cases:2.28%
controls:0.26%
—
—
—
—
—
—
cases:3.11%
controls:0.23%
cases:4.69%
controls:1.00%
14
63
909
9167
21
24
902
9206
—
—
—
28
21
873
9069
38
83
772
8223
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
2.1e-01
9.5e-01
2.2e+00
—
1.7e+00
8.7e-01
6.7e-01
cases:8.13%
controls:6.70%
cases:9.21%
controls:3.78%
cases:4.98%
controls:0.57%
—
—
cases:2.49%
controls:0.48%
cases:8.55%
controls:3.77%
cases:18.89%
controls:10.62%
75
618
848
8612
85
349
838
8881
46
53
877
9177
—
23
44
899
9178
77
343
824
8747
153
882
657
7424
folic acid; oral, parenteral
B03BB01 [21601129]
4.7e-01
9.0e-01
—
1.0e+50
2.3e+00
2.1e+00
1.9e+00
cases:1.19%
controls:0.75%
cases:1.73%
controls:0.72%
—
—
cases:0.65%
controls:0.00%
cases:1.41%
controls:0.14%
cases:5.44%
controls:0.72%
cases:11.23%
controls:1.94%
11
69
912
9161
16
66
907
9164
—
6
0
917
9230
13
13
909
9209
49
65
852
9025
91
161
719
8145
folic acid
V04CX02 [715877]
4.7e-01
9.0e-01
—
1.0e+50
2.3e+00
2.1e+00
1.9e+00
cases:1.19%
controls:0.75%
cases:1.73%
controls:0.72%
—
—
cases:0.65%
controls:0.00%
cases:1.41%
controls:0.14%
cases:5.44%
controls:0.72%
cases:11.23%
controls:1.94%
11
69
912
9161
16
66
907
9164
—
6
0
917
9230
13
13
909
9209
49
65
852
9025
91
161
719
8145
Spirometry
127783003 [4133840]
1.0e+00
1.9e+00
—
1.0e+50
—
3.2e+00
3.1e+00
cases:1.08%
controls:0.40%
cases:0.65%
controls:0.10%
—
—
cases:0.65%
controls:0.00%
—
—
cases:3.33%
controls:0.14%
cases:6.05%
controls:0.30%
10
37
913
9193
6
9
917
9221
—
6
0
917
9230
—
30
13
871
9077
49
25
761
8281
Faecal incontinence
R15 [45573014]
1.0e+00
2.2e+00
—
—
—
2.2e+00
1.9e+00
cases:0.65%
controls:0.24%
cases:0.65%
controls:0.08%
—
—
—
—
—
—
cases:0.78%
controls:0.09%
cases:1.73%
controls:0.26%
6
22
917
9208
6
7
917
9223
—
—
—
7
8
894
9082
14
22
796
8284
Other seropositive rheumatoid arthritis
M05.8 [45538634]
7.6e-01
1.1e+00
1.1e+00
—
1.9e+00
1.2e+00
1.2e+00
cases:2.71%
controls:1.29%
cases:2.93%
controls:0.96%
cases:0.98%
controls:0.31%
—
—
cases:1.63%
controls:0.24%
cases:3.00%
controls:0.96%
cases:4.69%
controls:1.40%
25
119
898
9111
27
89
896
9141
9
29
914
9201
—
15
22
907
9200
27
87
874
9003
38
116
772
8190
IgG subclass 4 [Mass/volume] in Serum
2469-5 [3024980]
1.9e+00
—
1.0e+50
—
—
2.2e+00
2.1e+00
cases:1.08%
controls:0.16%
—
—
cases:0.65%
controls:0.00%
—
—
—
—
cases:0.67%
controls:0.08%
cases:1.48%
controls:0.18%
10
15
913
9215
—
6
0
917
9230
—
—
6
7
895
9083
12
15
798
8291
Osmolality of Urine
2695-5 [3026782]
-4.9e-02
7.2e-01
2.6e+00
—
1.6e+00
1.0e+00
8.2e-01
cases:3.14%
controls:3.29%
cases:2.38%
controls:1.17%
cases:2.38%
controls:0.17%
—
—
cases:0.98%
controls:0.20%
cases:3.33%
controls:1.22%
cases:8.27%
controls:3.83%
29
304
894
8926
22
108
901
9122
22
16
901
9214
—
9
18
913
9204
30
111
871
8979
67
318
743
7988
IgA [Mass/volume] in Serum or Plasma
2458-8 [3007164]
4.5e-01
1.6e+00
—
—
2.2e+00
1.3e+00
9.5e-01
cases:4.23%
controls:2.74%
cases:4.66%
controls:0.98%
—
—
—
—
cases:0.87%
controls:0.10%
cases:3.55%
controls:0.96%
cases:9.51%
controls:3.90%
39
253
884
8977
43
90
880
9140
—
—
8
9
914
9213
32
87
869
9003
77
324
733
7982
Pain in joint
M25.5 [45586941]
5.2e-01
1.7e+00
2.7e+00
—
1.4e+00
9.4e-01
4.4e-01
cases:6.61%
controls:4.02%
cases:7.80%
controls:1.45%
cases:1.30%
controls:0.09%
—
—
cases:0.87%
controls:0.22%
cases:3.66%
controls:1.46%
cases:8.27%
controls:5.49%
61
371
862
8859
72
134
851
9096
12
8
911
9222
—
8
20
914
9202
33
133
868
8957
67
456
743
7850
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
4.4e-01
9.2e-01
1.2e+00
—
1.5e+00
1.0e+00
8.0e-01
cases:10.62%
controls:7.12%
cases:6.61%
controls:2.74%
cases:1.52%
controls:0.48%
—
—
cases:1.95%
controls:0.43%
cases:6.77%
controls:2.50%
cases:13.95%
controls:6.78%
98
657
825
8573
61
253
862
8977
14
44
909
9186
—
18
40
904
9182
61
227
840
8863
113
563
697
7743
felodipine; oral
C08CA02 [21601748]
7.0e-01
7.6e-01
7.0e-01
—
1.4e+00
1.4e+00
1.6e+00
cases:3.36%
controls:1.70%
cases:2.71%
controls:1.29%
cases:0.87%
controls:0.43%
—
—
cases:1.63%
controls:0.41%
cases:5.66%
controls:1.47%
cases:8.52%
controls:1.81%
31
157
892
9073
25
119
898
9111
8
40
915
9190
—
15
38
907
9184
51
134
850
8956
69
150
741
8156
Neurology
13 [38004458]
2.4e-01
5.9e-01
1.0e+00
2.8e+00
7.8e-01
6.4e-01
7.9e-01
cases:11.92%
controls:9.61%
cases:6.83%
controls:3.89%
cases:1.73%
controls:0.62%
cases:0.87%
controls:0.05%
cases:1.52%
controls:0.70%
cases:7.55%
controls:4.14%
cases:18.52%
controls:9.37%
110
887
813
8343
63
359
860
8871
16
57
907
9173
8
5
915
9225
14
65
908
9157
68
376
833
8714
150
778
660
7528
Laboratory Visit
OMOP4822461 [32036]
-1.9e-02
3.6e-01
1.6e+00
2.5e+00
1.1e+00
3.7e-01
1.3e-01
cases:33.37%
controls:33.79%
cases:40.63%
controls:32.35%
cases:33.80%
controls:9.69%
cases:5.31%
controls:0.47%
cases:23.75%
controls:9.81%
cases:44.28%
controls:35.40%
cases:58.64%
controls:55.57%
308
3119
615
6111
375
2986
548
6244
312
894
611
8336
49
43
874
9187
219
905
703
8317
399
3218
502
5872
475
4616
335
3690
pantoprazole; oral, parenteral
A02BC02 [21600097]
3.8e-01
8.8e-01
8.5e-01
—
1.6e+00
1.2e+00
9.1e-01
cases:22.32%
controls:16.39%
cases:18.74%
controls:8.70%
cases:4.12%
controls:1.81%
—
—
cases:7.70%
controls:1.73%
cases:25.97%
controls:9.37%
cases:38.77%
controls:20.29%
206
1513
717
7717
173
803
750
8427
38
167
885
9063
—
71
160
851
9062
234
852
667
8238
314
1685
496
6621
Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
35559-4 [3035797]
—
3.2e+00
—
—
—
2.5e+00
1.2e+00
—
—
cases:1.63%
controls:0.07%
—
—
—
—
—
—
cases:1.11%
controls:0.09%
cases:1.36%
controls:0.40%
—
15
6
908
9224
—
—
—
10
8
891
9082
11
33
799
8273
Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2865-4 [3015322]
—
3.3e+00
—
—
—
2.4e+00
1.0e+00
—
—
cases:2.06%
controls:0.08%
—
—
—
—
—
—
cases:1.22%
controls:0.11%
cases:1.60%
controls:0.58%
—
19
7
904
9223
—
—
—
11
10
890
9080
13
48
797
8258
Bacteria [Presence] in Urine
87829-8 [36304419]
5.3e-02
8.2e-01
2.9e+00
—
1.3e+00
1.0e+00
9.4e-01
cases:3.90%
controls:3.71%
cases:3.79%
controls:1.70%
cases:3.36%
controls:0.18%
—
—
cases:0.98%
controls:0.27%
cases:5.22%
controls:1.97%
cases:12.84%
controls:5.44%
36
342
887
8888
35
157
888
9073
31
17
892
9213
—
9
25
913
9197
47
179
854
8911
104
452
706
7854
rituximab
L01FA01 [955167]
—
—
—
—
—
3.1e+00
2.6e+00
—
—
—
—
—
—
—
—
—
—
cases:1.22%
controls:0.06%
cases:1.73%
controls:0.13%
—
—
—
—
—
11
5
890
9085
14
11
796
8295
Dentistry
C5 [903277]
7.7e-01
8.6e-01
2.3e+00
—
1.8e+00
1.6e+00
9.7e-01
cases:4.12%
controls:1.95%
cases:1.84%
controls:0.79%
cases:0.65%
controls:0.07%
—
—
cases:0.54%
controls:0.09%
cases:2.77%
controls:0.57%
cases:4.69%
controls:1.83%
38
180
885
9050
17
73
906
9157
6
6
917
9224
—
5
8
917
9214
25
52
876
9038
38
152
772
8154
Foot and toes X-ray examination
NH3AA [2001308267]
5.9e-01
2.5e+00
—
1.0e+50
1.0e+50
1.9e+00
1.3e+00
cases:1.52%
controls:0.85%
cases:2.17%
controls:0.18%
—
—
cases:2.38%
controls:0.00%
cases:0.54%
controls:0.00%
cases:1.55%
controls:0.24%
cases:3.70%
controls:1.07%
14
78
909
9152
20
17
903
9213
—
22
0
901
9230
5
0
917
9222
14
22
887
9068
30
89
780
8217
Neutrophil cytoplasmic Ab [Units/volume] in Serum
5128-4 [3001334]
1.1e+00
3.5e+00
1.0e+50
—
—
2.1e+00
1.0e+00
cases:1.30%
controls:0.46%
cases:2.49%
controls:0.08%
cases:1.73%
controls:0.00%
—
—
—
—
cases:0.89%
controls:0.11%
cases:1.48%
controls:0.53%
12
42
911
9188
23
7
900
9223
16
0
907
9230
—
—
8
10
893
9080
12
44
798
8262
Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2868-8 [3005229]
—
3.4e+00
—
—
—
2.2e+00
9.5e-01
—
—
cases:2.17%
controls:0.08%
—
—
—
—
—
—
cases:1.22%
controls:0.13%
cases:1.60%
controls:0.63%
—
20
7
903
9223
—
—
—
11
12
890
9078
13
52
797
8254
Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32730-4 [3043723]
—
3.4e+00
—
—
—
2.2e+00
9.5e-01
—
—
cases:2.17%
controls:0.08%
—
—
—
—
—
—
cases:1.22%
controls:0.13%
cases:1.60%
controls:0.63%
—
20
7
903
9223
—
—
—
11
12
890
9078
13
52
797
8254
Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32731-2 [3043747]
—
3.4e+00
—
—
—
2.2e+00
9.7e-01
—
—
cases:2.17%
controls:0.08%
—
—
—
—
—
—
cases:1.22%
controls:0.13%
cases:1.60%
controls:0.61%
—
20
7
903
9223
—
—
—
11
12
890
9078
13
51
797
8255
Dry eye syndrome
H04.10 [2000502254]
1.0e+00
1.8e+00
—
—
—
1.6e+00
1.2e+00
cases:2.60%
controls:0.96%
cases:2.28%
controls:0.39%
—
—
—
—
—
—
cases:2.11%
controls:0.44%
cases:6.30%
controls:1.93%
24
89
899
9141
21
36
902
9194
—
—
—
19
40
882
9050
51
160
759
8146
Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
50796-2 [3029338]
—
3.2e+00
—
—
—
2.4e+00
1.2e+00
—
—
cases:1.52%
controls:0.07%
—
—
—
—
—
—
cases:1.00%
controls:0.09%
cases:1.36%
controls:0.41%
—
14
6
909
9224
—
—
—
9
8
892
9082
11
34
799
8272
Vascular Surgery
77 [38004496]
7.0e-01
1.4e+00
2.3e+00
—
—
8.3e-01
1.2e+00
cases:4.33%
controls:2.20%
cases:3.14%
controls:0.81%
cases:1.08%
controls:0.11%
—
—
—
—
cases:2.22%
controls:0.98%
cases:8.89%
controls:2.90%
40
203
883
9027
29
75
894
9155
10
10
913
9220
—
—
20
89
881
9001
72
241
738
8065
Erythrocytes [Presence] in Urine
33051-4 [3045424]
-1.0e+50
1.8e+00
—
—
—
2.0e+00
1.7e+00
cases:0.00%
controls:0.10%
cases:0.87%
controls:0.14%
—
—
—
—
—
—
cases:0.89%
controls:0.12%
cases:4.57%
controls:0.88%
0
9
923
9221
8
13
915
9217
—
—
—
8
11
893
9079
37
73
773
8233
Case Management Agency
251B00000X [38004193]
1.4e-01
2.5e-01
5.9e-01
3.2e+00
1.0e+00
4.7e-01
2.7e-01
cases:60.78%
controls:57.29%
cases:56.99%
controls:50.76%
cases:31.09%
controls:19.99%
cases:24.49%
controls:1.33%
cases:40.46%
controls:19.64%
cases:65.04%
controls:53.84%
cases:78.64%
controls:73.83%
561
5288
362
3942
526
4685
397
4545
287
1845
636
7385
226
123
697
9107
373
1811
549
7411
586
4894
315
4196
637
6132
173
2174
Dyspnoea
R06.0 [45558449]
5.4e-01
1.4e+00
1.8e+00
—
—
1.4e+00
8.8e-01
cases:4.77%
controls:2.83%
cases:3.90%
controls:0.95%
cases:0.87%
controls:0.14%
—
—
—
—
cases:4.22%
controls:1.11%
cases:8.64%
controls:3.79%
44
261
879
8969
36
88
887
9142
8
13
915
9217
—
—
38
101
863
8989
70
315
740
7991
Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2874-6 [3023465]
—
3.3e+00
—
—
—
2.1e+00
1.1e+00
—
—
cases:1.95%
controls:0.08%
—
—
—
—
—
—
cases:1.11%
controls:0.13%
cases:1.48%
controls:0.52%
—
18
7
905
9223
—
—
—
10
12
891
9078
12
43
798
8263
omeprazole; oral, parenteral
A02BC01 [21600096]
6.2e-01
1.1e+00
1.1e+00
—
1.3e+00
1.2e+00
1.1e+00
cases:7.91%
controls:4.42%
cases:4.88%
controls:1.74%
cases:1.08%
controls:0.36%
—
—
cases:1.63%
controls:0.43%
cases:5.99%
controls:1.86%
cases:10.12%
controls:3.61%
73
408
850
8822
45
161
878
9069
10
33
913
9197
—
15
40
907
9182
54
169
847
8921
82
300
728
8006
Hypothyroidism, unspecified
E03.9 [45537945]
5.1e-01
8.6e-01
1.7e+00
—
2.5e+00
1.2e+00
7.4e-01
cases:3.25%
controls:1.97%
cases:2.28%
controls:0.98%
cases:0.76%
controls:0.14%
—
—
cases:1.63%
controls:0.14%
cases:3.11%
controls:0.91%
cases:6.17%
controls:3.05%
30
182
893
9048
21
90
902
9140
7
13
916
9217
—
15
13
907
9209
28
83
873
9007
50
253
760
8053
12 lead EKG panel
34534-8 [3044889]
8.4e-03
6.0e-01
2.0e+00
1.0e+50
1.2e+00
7.5e-01
7.2e-01
cases:13.54%
controls:13.45%
cases:12.46%
controls:7.23%
cases:6.50%
controls:0.92%
cases:0.76%
controls:0.00%
cases:2.39%
controls:0.72%
cases:14.10%
controls:7.19%
cases:34.20%
controls:20.26%
125
1241
798
7989
115
667
808
8563
60
85
863
9145
7
0
916
9230
22
66
900
9156
127
654
774
8436
277
1683
533
6623
lansoprazole; oral
A02BC03 [21600098]
6.4e-01
1.0e+00
1.1e+00
—
1.5e+00
1.2e+00
9.5e-01
cases:8.88%
controls:4.89%
cases:6.50%
controls:2.49%
cases:1.30%
controls:0.46%
—
—
cases:2.28%
controls:0.53%
cases:7.33%
controls:2.27%
cases:10.99%
controls:4.54%
82
451
841
8779
60
230
863
9000
12
42
911
9188
—
21
49
901
9173
66
206
835
8884
89
377
721
7929
Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 [40763571]
3.4e-01
1.3e+00
2.2e+00
—
1.4e+00
1.2e+00
6.6e-01
cases:1.95%
controls:1.40%
cases:2.38%
controls:0.67%
cases:0.65%
controls:0.08%
—
—
cases:0.65%
controls:0.16%
cases:2.66%
controls:0.84%
cases:5.43%
controls:2.88%
18
129
905
9101
22
62
901
9168
6
7
917
9223
—
6
15
916
9207
24
76
877
9014
44
239
766
8067
Care involving use of rehabilitation procedure, unspecified
Z50.9 [45595525]
1.1e+00
1.8e+00
—
—
—
2.0e+00
1.5e+00
cases:0.65%
controls:0.23%
cases:0.76%
controls:0.13%
—
—
—
—
—
—
cases:0.89%
controls:0.12%
cases:1.73%
controls:0.40%
6
21
917
9209
7
12
916
9218
—
—
—
8
11
893
9079
14
33
796
8273
Feet X-ray examination with load
NH3EA [2001308283]
—
—
—
1.0e+50
—
2.9e+00
2.3e+00
—
—
—
—
—
—
cases:1.73%
controls:0.00%
—
—
cases:1.00%
controls:0.06%
cases:1.48%
controls:0.14%
—
—
—
16
0
907
9230
—
9
5
892
9085
12
12
798
8294
Outpatient Hospital
22 [8756]
3.2e-01
6.6e-01
1.0e+00
—
1.7e+00
7.6e-01
7.9e-01
cases:30.44%
controls:24.05%
cases:12.57%
controls:6.91%
cases:1.95%
controls:0.72%
—
—
cases:3.80%
controls:0.72%
cases:12.43%
controls:6.22%
cases:31.11%
controls:17.07%
281
2220
642
7010
116
638
807
8592
18
66
905
9164
—
35
66
887
9156
112
565
789
8525
252
1418
558
6888
calcium (different salts in combination); oral
A12AA20 [21600872]
6.5e-01
8.4e-01
2.1e-01
—
1.1e+00
1.3e+00
1.4e+00
cases:15.82%
controls:8.89%
cases:15.06%
controls:7.09%
cases:1.95%
controls:1.59%
—
—
cases:5.10%
controls:1.82%
cases:22.64%
controls:7.50%
cases:34.44%
controls:11.52%
146
821
777
8409
139
654
784
8576
18
147
905
9083
—
47
168
875
9054
204
682
697
8408
279
957
531
7349
Inpatient Hospital
21 [8717]
2.7e-01
6.3e-01
1.2e+00
—
1.7e+00
7.4e-01
6.5e-01
cases:36.29%
controls:30.39%
cases:16.03%
controls:9.20%
cases:3.58%
controls:1.06%
—
—
cases:5.64%
controls:1.13%
cases:16.09%
controls:8.36%
cases:34.81%
controls:21.78%
335
2805
588
6425
148
849
775
8381
33
98
890
9132
—
52
104
870
9118
145
760
756
8330
282
1809
528
6497
Hepatitis B virus surface Ag [Presence] in Serum
5195-3 [3019284]
-1.0e-01
1.1e+00
—
—
2.6e+00
8.5e-01
6.6e-01
cases:2.17%
controls:2.39%
cases:2.60%
controls:0.90%
—
—
—
—
cases:0.87%
controls:0.07%
cases:2.22%
controls:0.96%
cases:5.19%
controls:2.76%
20
221
903
9009
24
83
899
9147
—
—
8
6
914
9216
20
87
881
9003
42
229
768
8077
CBC panel - Blood by Automated count
58410-2 [40761511]
3.8e-02
4.4e-01
1.4e+00
2.1e+00
8.8e-01
4.0e-01
2.3e-01
cases:26.65%
controls:25.92%
cases:24.59%
controls:17.40%
cases:11.48%
controls:3.10%
cases:0.76%
controls:0.10%
cases:6.94%
controls:2.99%
cases:25.31%
controls:18.49%
cases:46.05%
controls:40.39%
246
2392
677
6838
227
1606
696
7624
106
286
817
8944
7
9
916
9221
64
276
858
8946
228
1681
673
7409
373
3355
437
4951
Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
51435-6 [3029713]
—
2.9e+00
—
—
—
2.2e+00
1.0e+00
—
—
cases:1.63%
controls:0.09%
—
—
—
—
—
—
cases:1.11%
controls:0.12%
cases:1.48%
controls:0.54%
—
15
8
908
9222
—
—
—
10
11
891
9079
12
45
798
8261
Specific gravity of Urine by Refractometry
5810-7 [3019150]
3.5e-02
8.6e-01
2.8e+00
—
1.1e+00
1.0e+00
4.8e-01
cases:4.23%
controls:4.08%
cases:5.20%
controls:2.26%
cases:4.77%
controls:0.30%
—
—
cases:0.87%
controls:0.30%
cases:7.33%
controls:2.76%
cases:12.22%
controls:7.91%
39
377
884
8853
48
209
875
9021
44
28
879
9202
—
8
28
914
9194
66
251
835
8839
99
657
711
7649
Protein electrophoresis panel - Serum or Plasma
24351-9 [3004588]
9.0e-02
2.9e+00
—
—
—
2.2e+00
6.9e-01
cases:0.76%
controls:0.69%
cases:3.47%
controls:0.20%
—
—
—
—
—
—
cases:2.33%
controls:0.25%
cases:2.22%
controls:1.13%
7
64
916
9166
32
18
891
9212
—
—
—
21
23
880
9067
18
94
792
8212
Spirometry study
18759-1 [3000492]
6.1e-01
1.2e+00
—
—
—
2.1e+00
1.8e+00
cases:2.28%
controls:1.25%
cases:1.41%
controls:0.43%
—
—
—
—
—
—
cases:4.11%
controls:0.52%
cases:9.75%
controls:1.75%
21
115
902
9115
13
40
910
9190
—
—
—
37
47
864
9043
79
145
731
8161
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
1.8e-01
1.2e+00
2.1e+00
—
9.0e-01
1.1e+00
6.2e-01
cases:7.91%
controls:6.72%
cases:10.18%
controls:3.23%
cases:4.23%
controls:0.53%
—
—
cases:1.08%
controls:0.44%
cases:9.32%
controls:3.29%
cases:18.02%
controls:10.56%
73
620
850
8610
94
298
829
8932
39
49
884
9181
—
10
41
912
9181
84
299
817
8791
146
877
664
7429
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]
4.9e-03
1.3e+00
—
—
2.1e+00
1.1e+00
5.5e-01
cases:2.28%
controls:2.26%
cases:3.58%
controls:1.04%
—
—
—
—
cases:0.76%
controls:0.10%
cases:3.44%
controls:1.17%
cases:6.91%
controls:4.09%
21
209
902
9021
33
96
890
9134
—
—
7
9
915
9213
31
106
870
8984
56
340
754
7966
sildenafil; oral
G04BE03 [21602648]
2.6e-02
2.8e-01
—
—
2.0e+00
1.4e+00
1.5e+00
cases:1.30%
controls:1.27%
cases:1.08%
controls:0.82%
—
—
—
—
cases:1.08%
controls:0.14%
cases:3.22%
controls:0.80%
cases:6.79%
controls:1.60%
12
117
911
9113
10
76
913
9154
—
—
10
13
912
9209
29
73
872
9017
55
133
755
8173
Thorax CT examination
GD1AD [2001303618]
—
1.7e+00
—
1.0e+50
—
2.8e+00
2.1e+00
—
—
cases:0.54%
controls:0.10%
—
—
cases:0.65%
controls:0.00%
—
—
cases:2.00%
controls:0.12%
cases:3.83%
controls:0.48%
—
5
9
918
9221
—
6
0
917
9230
—
18
11
883
9079
31
40
779
8266
Emergency Room Visit
ER [9203]
3.9e-01
8.6e-01
1.3e+00
—
1.1e+00
6.9e-01
5.8e-01
cases:38.89%
controls:30.17%
cases:20.59%
controls:9.87%
cases:4.55%
controls:1.28%
—
—
cases:3.58%
controls:1.21%
cases:17.54%
controls:9.65%
cases:39.38%
controls:26.67%
359
2785
564
6445
190
911
733
8319
42
118
881
9112
—
33
112
889
9110
158
877
743
8213
319
2215
491
6091
pH of Specimen
17433-4 [3019225]
2.8e-01
9.2e-01
2.2e+00
—
—
9.5e-01
7.4e-01
cases:1.95%
controls:1.48%
cases:2.17%
controls:0.88%
cases:0.98%
controls:0.11%
—
—
—
—
cases:2.22%
controls:0.87%
cases:4.32%
controls:2.12%
18
137
905
9093
20
81
903
9149
9
10
914
9220
—
—
20
79
881
9011
35
176
775
8130
Atherosclerosis of arteries of extremities
I70.2 [45538421]
6.7e-01
1.3e+00
2.3e+00
—
1.6e+00
8.5e-01
1.1e+00
cases:1.63%
controls:0.83%
cases:1.84%
controls:0.49%
cases:1.08%
controls:0.11%
—
—
cases:0.65%
controls:0.13%
cases:1.33%
controls:0.57%
cases:3.58%
controls:1.18%
15
77
908
9153
17
45
906
9185
10
10
913
9220
—
6
12
916
9210
12
52
889
9038
29
98
781
8208
alendronic acid; oral
M05BA04 [21604152]
9.1e-01
1.1e+00
—
—
1.5e+00
1.5e+00
1.2e+00
cases:2.71%
controls:1.11%
cases:2.17%
controls:0.72%
—
—
—
—
cases:0.98%
controls:0.23%
cases:3.44%
controls:0.79%
cases:5.06%
controls:1.50%
25
102
898
9128
20
66
903
9164
—
—
9
21
913
9201
31
72
870
9018
41
125
769
8181
Arthritis, unspecified
M13.9 [45567463]
9.4e-01
2.2e+00
—
—
—
1.6e+00
7.4e-01
cases:1.84%
controls:0.73%
cases:1.95%
controls:0.23%
—
—
—
—
—
—
cases:1.33%
controls:0.26%
cases:1.60%
controls:0.77%
17
67
906
9163
18
21
905
9209
—
—
—
12
24
889
9066
13
64
797
8242
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
1.5e-01
5.9e-01
1.4e+00
—
1.5e+00
7.2e-01
4.5e-01
cases:5.85%
controls:5.06%
cases:4.55%
controls:2.58%
cases:1.30%
controls:0.31%
—
—
cases:1.08%
controls:0.24%
cases:4.99%
controls:2.49%
cases:13.58%
controls:9.14%
54
467
869
8763
42
238
881
8992
12
29
911
9201
—
10
22
912
9200
45
226
856
8864
110
759
700
7547
EKG study
11524-6 [3013512]
1.5e-01
2.3e-01
2.0e+00
—
1.4e+00
8.4e-01
4.8e-01
cases:5.42%
controls:4.70%
cases:3.58%
controls:2.87%
cases:2.49%
controls:0.36%
—
—
cases:1.63%
controls:0.41%
cases:6.33%
controls:2.84%
cases:13.70%
controls:8.91%
50
434
873
8796
33
265
890
8965
23
33
900
9197
—
15
38
907
9184
57
258
844
8832
111
740
699
7566
Diaphragmatic hernia without obstruction or gangrene
K44.9 [45533596]
1.1e+00
1.8e+00
—
—
2.3e+00
1.8e+00
8.4e-01
cases:2.17%
controls:0.75%
cases:1.52%
controls:0.26%
—
—
—
—
cases:0.54%
controls:0.05%
cases:1.33%
controls:0.22%
cases:2.22%
controls:0.98%
20
69
903
9161
14
24
909
9206
—
—
5
5
917
9217
12
20
889
9070
18
81
792
8225
Immunoglobulin light chains.free panel - Serum
57778-3 [40760888]
—
2.0e+00
—
—
—
2.5e+00
1.2e+00
—
—
cases:0.65%
controls:0.09%
—
—
—
—
—
—
cases:1.11%
controls:0.09%
cases:1.11%
controls:0.33%
—
6
8
917
9222
—
—
—
10
8
891
9082
9
27
801
8279
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
-8.0e-02
7.5e-01
2.6e+00
—
9.2e-01
9.8e-01
9.9e-01
cases:2.82%
controls:3.04%
cases:2.38%
controls:1.14%
cases:2.38%
controls:0.18%
—
—
cases:0.65%
controls:0.26%
cases:3.88%
controls:1.50%
cases:10.62%
controls:4.23%
26
281
897
8949
22
105
901
9125
22
17
901
9213
—
6
24
916
9198
35
136
866
8954
86
351
724
7955
Extensive CT examination of arteria pulmonalis
FB1BD [2001302407]
8.7e-01
2.6e+00
—
—
—
2.0e+00
9.5e-01
cases:1.52%
controls:0.64%
cases:1.41%
controls:0.11%
—
—
—
—
—
—
cases:0.78%
controls:0.11%
cases:1.36%
controls:0.53%
14
59
909
9171
13
10
910
9220
—
—
—
7
10
894
9080
11
44
799
8262
IgG subclass 3 [Mass/volume] in Serum
2468-7 [3024139]
2.2e+00
—
—
—
—
—
2.3e+00
cases:0.76%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
cases:1.11%
controls:0.11%
7
8
916
9222
—
—
—
—
—
9
9
801
8297
IgG subclass 2 [Mass/volume] in Serum
2467-9 [3028192]
2.2e+00
—
—
—
—
—
2.3e+00
cases:0.76%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
cases:1.11%
controls:0.11%
7
8
916
9222
—
—
—
—
—
9
9
801
8297
IgG subclass 1 [Mass/volume] in Serum
2466-1 [3027135]
2.2e+00
—
—
—
—
—
2.3e+00
cases:0.76%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
cases:1.11%
controls:0.11%
7
8
916
9222
—
—
—
—
—
9
9
801
8297
Procedure duration 90 to 119 minutes
ZXE13 [2001311404]
-1.0e+50
—
—
—
—
2.3e+00
2.1e+00
cases:0.00%
controls:0.40%
—
—
—
—
—
—
—
—
cases:0.78%
controls:0.08%
cases:1.11%
controls:0.13%
0
37
923
9193
—
—
—
—
7
7
894
9083
9
11
801
8295
Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
7852-7 [3010130]
—
2.6e+00
—
—
—
—
1.8e+00
—
—
cases:0.76%
controls:0.05%
—
—
—
—
—
—
—
—
cases:0.86%
controls:0.14%
—
7
5
916
9225
—
—
—
—
7
12
803
8294
Kappa light chains.free [Mass/volume] in Serum
36916-5 [3034860]
—
2.0e+00
—
—
—
2.4e+00
7.2e-01
—
—
cases:0.87%
controls:0.12%
—
—
—
—
—
—
cases:1.22%
controls:0.11%
cases:1.11%
controls:0.54%
—
8
11
915
9219
—
—
—
11
10
890
9080
9
45
801
8261
Myoglobin [Mass/volume] in Serum or Plasma
2639-3 [3005895]
5.8e-01
—
—
—
—
2.7e+00
1.7e+00
cases:0.54%
controls:0.30%
—
—
—
—
—
—
—
—
cases:1.44%
controls:0.10%
cases:2.47%
controls:0.48%
5
28
918
9202
—
—
—
—
13
9
888
9081
20
40
790
8266
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]
2.4e-01
1.3e+00
2.1e+00
—
—
1.8e+00
1.3e+00
cases:1.41%
controls:1.12%
cases:1.84%
controls:0.50%
cases:0.54%
controls:0.07%
—
—
—
—
cases:2.44%
controls:0.43%
cases:4.57%
controls:1.34%
13
103
910
9127
17
46
906
9184
5
6
918
9224
—
—
22
39
879
9051
37
111
773
8195
Lambda light chains.free [Mass/volume] in Serum or Plasma
33944-0 [3047169]
—
2.0e+00
—
—
—
2.3e+00
7.0e-01
—
—
cases:0.87%
controls:0.12%
—
—
—
—
—
—
cases:1.11%
controls:0.11%
cases:1.11%
controls:0.55%
—
8
11
915
9219
—
—
—
10
10
891
9080
9
46
801
8260
Procedure duration 50 to 59 minutes
ZXE06 [2001311400]
4.7e-01
—
—
—
—
2.7e+00
1.6e+00
cases:0.76%
controls:0.48%
—
—
—
—
—
—
—
—
cases:0.78%
controls:0.06%
cases:0.99%
controls:0.19%
7
44
916
9186
—
—
—
—
7
5
894
9085
8
16
802
8290
Measurement of bone density from two or more locations with X-ray
NK6QA [2001308500]
4.7e-01
1.2e+00
—
1.0e+50
—
2.3e+00
2.0e+00
cases:1.30%
controls:0.81%
cases:0.98%
controls:0.29%
—
—
cases:0.65%
controls:0.00%
—
—
cases:3.00%
controls:0.32%
cases:4.81%
controls:0.67%
12
75
911
9155
9
27
914
9203
—
6
0
917
9230
—
27
29
874
9061
39
56
771
8250
Chronic respiratory failure
J96.1 [45557632]
2.0e+00
1.7e+00
—
—
—
2.5e+00
1.8e+00
cases:0.54%
controls:0.08%
cases:0.54%
controls:0.10%
—
—
—
—
—
—
cases:0.78%
controls:0.07%
cases:0.86%
controls:0.14%
5
7
918
9223
5
9
918
9221
—
—
—
7
6
894
9084
7
12
803
8294
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]
1.7e-01
9.9e-01
1.7e+00
—
—
9.0e-01
6.7e-01
cases:3.90%
controls:3.32%
cases:4.44%
controls:1.69%
cases:1.08%
controls:0.21%
—
—
—
—
cases:4.11%
controls:1.71%
cases:10.99%
controls:5.95%
36
306
887
8924
41
156
882
9074
10
19
913
9211
—
—
37
155
864
8935
89
494
721
7812
sulfamethoxazole and trimethoprim
J01EE01 [21602961]
3.8e-01
1.5e+00
—
—
—
2.8e+00
1.4e+00
cases:0.65%
controls:0.44%
cases:0.76%
controls:0.16%
—
—
—
—
—
—
cases:1.11%
controls:0.07%
cases:1.73%
controls:0.45%
6
41
917
9189
7
15
916
9215
—
—
—
10
6
891
9084
14
37
796
8269
Centromere Ab [Units/volume] in Serum
8068-9 [3038026]
—
—
1.0e+50
—
1.0e+50
—
4.1e+00
—
—
—
—
cases:1.95%
controls:0.00%
—
—
cases:0.87%
controls:0.00%
—
—
cases:3.46%
controls:0.06%
—
—
18
0
905
9230
—
8
0
914
9222
—
28
5
782
8301
Spondylolisthesis
M43.1 [45606219]
1.1e+00
1.7e+00
—
—
—
2.3e+00
4.8e-01
cases:1.08%
controls:0.35%
cases:0.87%
controls:0.15%
—
—
—
—
—
—
cases:1.22%
controls:0.12%
cases:0.74%
controls:0.46%
10
32
913
9198
8
14
915
9216
—
—
—
11
11
890
9079
6
38
804
8268
Musculoskeletal disease other
L99 [2002000718]
—
—
—
—
—
2.3e+00
1.7e+00
—
—
—
—
—
—
—
—
—
—
cases:0.78%
controls:0.08%
cases:1.23%
controls:0.22%
—
—
—
—
—
7
7
894
9083
10
18
800
8288
esomeprazole; oral, parenteral
A02BC05 [21600100]
4.6e-01
6.7e-01
7.3e-01
—
1.2e+00
9.6e-01
7.9e-01
cases:13.22%
controls:8.81%
cases:8.78%
controls:4.69%
cases:2.06%
controls:1.01%
—
—
cases:3.25%
controls:1.05%
cases:11.10%
controls:4.57%
cases:19.14%
controls:9.69%
122
813
801
8417
81
433
842
8797
19
93
904
9137
—
30
97
892
9125
100
415
801
8675
155
805
655
7501
triamcinolone and antiinfectives
S02CA04 [21605176]
1.1e+00
1.4e+00
—
—
—
1.5e+00
1.4e+00
cases:1.63%
controls:0.54%
cases:0.87%
controls:0.21%
—
—
—
—
—
—
cases:1.11%
controls:0.24%
cases:1.73%
controls:0.45%
15
50
908
9180
8
19
915
9211
—
—
—
10
22
891
9068
14
37
796
8269
Observation for other suspected cardiovascular diseases
Z03.5 [45590692]
6.5e-01
1.4e+00
—
—
—
2.8e+00
1.2e+00
cases:1.63%
controls:0.86%
cases:0.65%
controls:0.16%
—
—
—
—
—
—
cases:2.11%
controls:0.13%
cases:2.96%
controls:0.90%
15
79
908
9151
6
15
917
9215
—
—
—
19
12
882
9078
24
75
786
8231
pregabalin; oral
N02BF02 [955152]
2.9e-01
8.0e-01
1.4e+00
—
9.5e-01
8.2e-01
9.4e-01
cases:5.09%
controls:3.85%
cases:3.68%
controls:1.69%
cases:1.84%
controls:0.44%
—
—
cases:1.19%
controls:0.47%
cases:4.11%
controls:1.85%
cases:9.75%
controls:4.06%
47
355
876
8875
34
156
889
9074
17
41
906
9189
—
11
43
911
9179
37
168
864
8922
79
337
731
7969
Procedure duration 60 to 89 minutes
ZXE11 [2001311402]
2.1e-01
—
—
—
—
2.6e+00
1.4e+00
cases:0.76%
controls:0.62%
—
—
—
—
—
—
—
—
cases:1.44%
controls:0.11%
cases:1.36%
controls:0.34%
7
57
916
9173
—
—
—
—
13
10
888
9080
11
28
799
8278
Abdominal ultrasound examination
JN3AE [2001305555]
1.6e-01
1.2e+00
—
—
—
1.6e+00
1.2e+00
cases:1.52%
controls:1.30%
cases:1.52%
controls:0.47%
—
—
—
—
—
—
cases:1.89%
controls:0.40%
cases:3.83%
controls:1.17%
14
120
909
9110
14
43
909
9187
—
—
—
17
36
884
9054
31
97
779
8209
Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
2742-5 [3034780]
5.3e-01
2.2e+00
—
—
—
1.7e+00
8.6e-01
cases:0.98%
controls:0.57%
cases:2.38%
controls:0.26%
—
—
—
—
—
—
cases:1.00%
controls:0.18%
cases:1.36%
controls:0.58%
9
53
914
9177
22
24
901
9206
—
—
—
9
16
892
9074
11
48
799
8258
Kappa light chains/Lambda light chains [Mass Ratio] in Serum
15189-4 [3007778]
—
1.9e+00
—
—
—
2.1e+00
8.2e-01
—
—
cases:0.76%
controls:0.12%
—
—
—
—
—
—
cases:0.89%
controls:0.11%
cases:1.11%
controls:0.49%
—
7
11
916
9219
—
—
—
8
10
893
9080
9
41
801
8265
Atherosclerotic heart disease
I25.1 [45596196]
4.4e-01
9.7e-01
1.3e+00
—
1.5e+00
8.2e-01
6.1e-01
cases:3.58%
controls:2.33%
cases:3.14%
controls:1.21%
cases:0.98%
controls:0.27%
—
—
cases:1.08%
controls:0.24%
cases:2.77%
controls:1.24%
cases:6.17%
controls:3.46%
33
215
890
9015
29
112
894
9118
9
25
914
9205
—
10
22
912
9200
25
113
876
8977
50
287
760
8019
nystatin; oral
A07AA02 [21600604]
9.6e-01
1.2e+00
—
—
—
1.7e+00
1.2e+00
cases:1.95%
controls:0.76%
cases:1.19%
controls:0.35%
—
—
—
—
—
—
cases:1.89%
controls:0.34%
cases:3.09%
controls:0.92%
18
70
905
9160
11
32
912
9198
—
—
—
17
31
884
9059
25
76
785
8230
Interstitial pulmonary disease, unspecified
J84.9 [45543277]
1.4e+00
—
1.0e+50
—
—
3.9e+00
—
cases:0.54%
controls:0.13%
—
—
cases:0.65%
controls:0.00%
—
—
—
—
cases:2.66%
controls:0.06%
—
—
5
12
918
9218
—
6
0
917
9230
—
—
24
5
877
9085
—
Tissue transglutaminase IgA Ab [Units/volume] in Serum
31017-7 [3019050]
3.5e-01
9.1e-01
2.5e+00
—
—
3.5e-01
4.9e-01
cases:4.77%
controls:3.39%
cases:3.03%
controls:1.25%
cases:0.65%
controls:0.05%
—
—
—
—
cases:1.89%
controls:1.34%
cases:8.40%
controls:5.33%
44
313
879
8917
28
115
895
9115
6
5
917
9225
—
—
17
122
884
8968
68
443
742
7863
Intravenous
ZX120 [2001311495]
7.1e-01
1.2e+00
1.4e+00
—
1.7e+00
2.0e+00
1.9e+00
cases:1.63%
controls:0.80%
cases:1.19%
controls:0.36%
cases:0.54%
controls:0.14%
—
—
cases:0.65%
controls:0.12%
cases:2.44%
controls:0.35%
cases:4.94%
controls:0.76%
15
74
908
9156
11
33
912
9197
5
13
918
9217
—
6
11
916
9211
22
32
879
9058
40
63
770
8243
Foot and toes extensive X-ray examination
NH3BA [2001308270]
8.9e-01
-1.0e+50
—
—
—
2.3e+00
1.5e+00
cases:0.76%
controls:0.31%
cases:0.00%
controls:0.11%
—
—
—
—
—
—
cases:0.67%
controls:0.07%
cases:1.73%
controls:0.37%
7
29
916
9201
0
10
923
9220
—
—
—
6
6
895
9084
14
31
796
8275
Specific gravity of Urine by Test strip
5811-5 [3000330]
1.1e-01
1.3e+00
2.5e+00
—
1.7e+00
8.8e-01
5.5e-02
cases:0.65%
controls:0.59%
cases:1.30%
controls:0.36%
cases:1.08%
controls:0.09%
—
—
cases:0.54%
controls:0.10%
cases:1.11%
controls:0.46%
cases:1.73%
controls:1.64%
6
54
917
9176
12
33
911
9197
10
8
913
9222
—
5
9
917
9213
10
42
891
9048
14
136
796
8170
Skin Pathology biopsy report
65754-4 [40768443]
1.1e-01
2.2e+00
—
—
—
1.6e+00
7.7e-01
cases:0.76%
controls:0.68%
cases:1.30%
controls:0.15%
—
—
—
—
—
—
cases:1.11%
controls:0.22%
cases:1.85%
controls:0.87%
7
63
916
9167
12
14
911
9216
—
—
—
10
20
891
9070
15
72
795
8234
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]
0.0e+00
1.7e+00
-1.0e+50
—
—
1.4e+00
6.6e-01
cases:0.98%
controls:0.98%
cases:1.84%
controls:0.36%
cases:0.00%
controls:0.05%
—
—
—
—
cases:1.89%
controls:0.46%
cases:4.20%
controls:2.22%
9
90
914
9140
17
33
906
9197
0
5
923
9225
—
—
17
42
884
9048
34
184
776
8122
Borrelia burgdorferi IgG Ab [Units/volume] in Serum
7817-0 [3016888]
-7.3e-02
2.8e+00
—
—
—
—
9.5e-01
cases:0.87%
controls:0.93%
cases:2.38%
controls:0.15%
—
—
—
—
—
—
—
—
cases:2.84%
controls:1.12%
8
86
915
9144
22
14
901
9216
—
—
—
—
23
93
787
8213
Fever, unspecified
R50.9 [45582716]
6.5e-01
1.7e+00
—
—
—
1.3e+00
8.2e-01
cases:1.95%
controls:1.03%
cases:1.95%
controls:0.38%
—
—
—
—
—
—
cases:1.33%
controls:0.39%
cases:3.21%
controls:1.44%
18
95
905
9135
18
35
905
9195
—
—
—
12
35
889
9055
26
120
784
8186
Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
13956-8 [3014162]
1.2e+00
2.2e+00
—
—
—
1.5e+00
1.5e+00
cases:1.08%
controls:0.34%
cases:0.76%
controls:0.09%
—
—
—
—
—
—
cases:0.55%
controls:0.12%
cases:1.60%
controls:0.35%
10
31
913
9199
7
8
916
9222
—
—
—
5
11
896
9079
13
29
797
8277
Myeloperoxidase IgG Ab [Units/volume] in Serum
48404-8 [3049804]
1.1e+00
3.7e+00
1.0e+50
—
—
—
1.1e+00
cases:0.87%
controls:0.30%
cases:2.17%
controls:0.05%
cases:0.87%
controls:0.00%
—
—
—
—
—
—
cases:1.11%
controls:0.39%
8
28
915
9202
20
5
903
9225
8
0
915
9230
—
—
—
9
32
801
8274
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
-9.0e-02
4.5e-01
1.8e+00
1.3e+00
9.8e-01
4.4e-01
4.1e-02
cases:21.34%
controls:22.89%
cases:25.24%
controls:17.72%
cases:19.61%
controls:3.77%
cases:0.87%
controls:0.23%
cases:8.89%
controls:3.52%
cases:27.41%
controls:19.60%
cases:38.40%
controls:37.42%
197
2113
726
7117
233
1636
690
7594
181
348
742
8882
8
21
915
9209
82
325
840
8897
247
1782
654
7308
311
3108
499
5198
Ankylosing spondylitis
M45 [45591841]
1.2e+00
1.5e+00
—
—
—
2.2e+00
1.5e+00
cases:0.65%
controls:0.21%
cases:0.65%
controls:0.15%
—
—
—
—
—
—
cases:0.89%
controls:0.10%
cases:1.11%
controls:0.25%
6
19
917
9211
6
14
917
9216
—
—
—
8
9
893
9081
9
21
801
8285
Doppler ultrasound examination of heart
FM1DE [2001303299]
8.6e-01
4.9e-01
—
—
—
1.5e+00
1.3e+00
cases:2.28%
controls:0.98%
cases:0.65%
controls:0.40%
—
—
—
—
—
—
cases:1.33%
controls:0.29%
cases:3.46%
controls:0.99%
21
90
902
9140
6
37
917
9193
—
—
—
12
26
889
9064
28
82
782
8224
cefalexin; oral
J01DB01 [21602870]
4.6e-01
6.9e-01
1.0e+00
—
4.3e-01
7.0e-01
7.9e-01
cases:38.46%
controls:28.36%
cases:16.90%
controls:9.23%
cases:2.93%
controls:1.05%
—
—
cases:1.84%
controls:1.20%
cases:15.87%
controls:8.58%
cases:43.70%
controls:26.05%
355
2618
568
6612
156
852
767
8378
27
97
896
9133
—
17
111
905
9111
143
780
758
8310
354
2164
456
6142
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
-2.3e-01
9.7e-01
1.9e+00
—
5.5e-01
8.4e-01
3.8e-01
cases:4.33%
controls:5.38%
cases:5.85%
controls:2.30%
cases:2.06%
controls:0.33%
—
—
cases:0.54%
controls:0.31%
cases:5.44%
controls:2.43%
cases:11.48%
controls:8.11%
40
497
883
8733
54
212
869
9018
19
30
904
9200
—
5
29
917
9193
49
221
852
8869
93
674
717
7632
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
2.6e-01
3.5e-01
3.5e-01
2.2e+00
2.6e-01
4.5e-01
4.1e-01
cases:37.38%
controls:31.42%
cases:22.32%
controls:16.85%
cases:3.79%
controls:2.71%
cases:0.87%
controls:0.10%
cases:3.36%
controls:2.60%
cases:24.64%
controls:17.24%
cases:50.25%
controls:40.25%
345
2900
578
6330
206
1555
717
7675
35
250
888
8980
8
9
915
9221
31
240
891
8982
222
1567
679
7523
407
3343
403
4963
Calcium [Moles/volume] in Serum or Plasma
2000-8 [3015377]
3.7e-02
8.3e-01
1.8e+00
—
—
6.4e-01
4.0e-01
cases:5.31%
controls:5.12%
cases:4.44%
controls:1.99%
cases:2.17%
controls:0.38%
—
—
—
—
cases:4.77%
controls:2.57%
cases:11.36%
controls:7.93%
49
473
874
8757
41
184
882
9046
20
35
903
9195
—
—
43
234
858
8856
92
659
718
7647
levofloxacin; inhalant, oral, parenteral
J01MA12 [21603019]
4.6e-01
1.3e+00
—
—
—
1.5e+00
8.4e-01
cases:2.93%
controls:1.87%
cases:1.84%
controls:0.53%
—
—
—
—
—
—
cases:2.55%
controls:0.57%
cases:4.81%
controls:2.14%
27
173
896
9057
17
49
906
9181
—
—
—
23
52
878
9038
39
178
771
8128
Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
27811-9 [3000515]
5.9e-01
2.1e+00
—
—
—
—
1.5e+00
cases:0.76%
controls:0.42%
cases:0.87%
controls:0.11%
—
—
—
—
—
—
—
—
cases:1.85%
controls:0.42%
7
39
916
9191
8
10
915
9220
—
—
—
—
15
35
795
8271
Thrombin time
3243-3 [3036489]
4.2e-01
2.2e+00
—
—
—
—
1.3e+00
cases:0.76%
controls:0.50%
cases:0.98%
controls:0.11%
—
—
—
—
—
—
—
—
cases:1.98%
controls:0.53%
7
46
916
9184
9
10
914
9220
—
—
—
—
16
44
794
8262
Borrelia burgdorferi IgM Ab [Units/volume] in Serum
7818-8 [3008230]
1.3e-01
2.6e+00
—
—
—
8.8e-01
8.9e-01
cases:1.19%
controls:1.05%
cases:2.38%
controls:0.17%
—
—
—
—
—
—
cases:0.55%
controls:0.23%
cases:2.96%
controls:1.24%
11
97
912
9133
22
16
901
9214
—
—
—
5
21
896
9069
24
103
786
8203
Hemoglobin [Mass/volume] in Capillary blood
30352-9 [3006184]
—
—
—
—
—
1.7e+00
1.8e+00
—
—
—
—
—
—
—
—
—
—
cases:0.89%
controls:0.17%
cases:2.59%
controls:0.43%
—
—
—
—
—
8
15
893
9075
21
36
789
8270
Fungus identified in Specimen by Culture
580-1 [3000494]
2.7e-01
1.1e+00
—
—
—
1.3e+00
1.0e+00
cases:2.06%
controls:1.58%
cases:1.52%
controls:0.49%
—
—
—
—
—
—
cases:1.78%
controls:0.48%
cases:6.30%
controls:2.35%
19
146
904
9084
14
45
909
9185
—
—
—
16
44
885
9046
51
195
759
8111
Upper gastrointestinal surgery
106 [44777669]
3.4e-01
8.1e-01
1.3e+00
—
1.0e+00
6.9e-01
7.0e-01
cases:10.40%
controls:7.62%
cases:6.50%
controls:3.01%
cases:1.73%
controls:0.49%
—
—
cases:1.41%
controls:0.51%
cases:6.22%
controls:3.21%
cases:16.17%
controls:8.78%
96
703
827
8527
60
278
863
8952
16
45
907
9185
—
13
47
909
9175
56
292
845
8798
131
729
679
7577
Observation for other suspected diseases and conditions
Z03.8 [45585798]
1.3e+00
2.2e+00
—
—
—
—
—
cases:1.41%
controls:0.39%
cases:0.76%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
13
36
910
9194
7
8
916
9222
—
—
—
—
—
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
8.5e-03
1.3e+00
—
—
—
1.5e+00
6.8e-01
cases:1.30%
controls:1.29%
cases:2.06%
controls:0.56%
—
—
—
—
—
—
cases:2.77%
controls:0.65%
cases:5.93%
controls:3.09%
12
119
911
9111
19
52
904
9178
—
—
—
25
59
876
9031
48
257
762
8049
pimecrolimus
D11AH02 [21602339]
7.5e-01
—
—
—
—
2.2e+00
1.2e+00
cases:0.87%
controls:0.41%
—
—
—
—
—
—
—
—
cases:1.00%
controls:0.11%
cases:1.98%
controls:0.59%
8
38
915
9192
—
—
—
—
9
10
892
9080
16
49
794
8257
Norovirus RNA [Presence] in Stool by NAA with probe detection
7974-9 [3008909]
—
—
—
—
—
2.3e+00
1.1e+00
—
—
—
—
—
—
—
—
—
—
cases:0.78%
controls:0.08%
cases:1.60%
controls:0.54%
—
—
—
—
—
7
7
894
9083
13
45
797
8261
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
4.6e-02
1.7e+00
—
—
—
1.6e+00
5.9e-01
cases:0.98%
controls:0.93%
cases:1.84%
controls:0.34%
—
—
—
—
—
—
cases:2.22%
controls:0.44%
cases:4.20%
controls:2.36%
9
86
914
9144
17
31
906
9199
—
—
—
20
40
881
9050
34
196
776
8110
Cathetrisation of vein
TPH04 [2001309597]
1.4e-01
1.1e+00
—
—
—
1.3e+00
9.1e-01
cases:2.49%
controls:2.17%
cases:2.17%
controls:0.73%
—
—
—
—
—
—
cases:3.00%
controls:0.81%
cases:6.54%
controls:2.75%
23
200
900
9030
20
67
903
9163
—
—
—
27
74
874
9016
53
228
757
8078
Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
53017-0 [3041067]
—
—
1.0e+50
—
1.0e+50
—
3.3e+00
—
—
—
—
cases:2.17%
controls:0.00%
—
—
cases:1.30%
controls:0.00%
—
—
cases:3.58%
controls:0.13%
—
—
20
0
903
9230
—
12
0
910
9222
—
29
11
781
8295
Reticulocytes [#/volume] in Blood
14196-0 [3023520]
4.8e-01
1.8e+00
—
—
—
1.6e+00
6.4e-01
cases:1.08%
controls:0.67%
cases:2.28%
controls:0.40%
—
—
—
—
—
—
cases:2.00%
controls:0.43%
cases:2.72%
controls:1.46%
10
62
913
9168
21
37
902
9193
—
—
—
18
39
883
9051
22
121
788
8185
risedronic acid; oral
M05BA07 [21604155]
1.1e+00
1.5e+00
—
—
—
1.7e+00
1.6e+00
cases:1.19%
controls:0.40%
cases:0.98%
controls:0.23%
—
—
—
—
—
—
cases:1.22%
controls:0.22%
cases:2.22%
controls:0.47%
11
37
912
9193
9
21
914
9209
—
—
—
11
20
890
9070
18
39
792
8267
Anesthesiology Critical Care Medicine
OMOP4821991 [45756751]
4.0e-01
1.0e+00
—
—
—
1.5e+00
1.7e+00
cases:1.08%
controls:0.73%
cases:0.76%
controls:0.27%
—
—
—
—
—
—
cases:1.22%
controls:0.26%
cases:2.84%
controls:0.51%
10
67
913
9163
7
25
916
9205
—
—
—
11
24
890
9066
23
42
787
8264
Extensive medical or dental certificate
WZA10 [2001310880]
—
—
—
1.0e+50
—
3.3e+00
—
—
—
—
—
—
—
cases:0.65%
controls:0.00%
—
—
cases:1.44%
controls:0.06%
—
—
—
—
—
6
0
917
9230
—
13
5
888
9085
—
Osteoporosis, unspecified
M81.9 [45591963]
6.7e-01
2.1e+00
—
—
—
1.5e+00
1.2e+00
cases:0.76%
controls:0.39%
cases:0.76%
controls:0.10%
—
—
—
—
—
—
cases:0.67%
controls:0.15%
cases:2.47%
controls:0.75%
7
36
916
9194
7
9
916
9221
—
—
—
6
14
895
9076
20
62
790
8244
Aldolase [Enzymatic activity/volume] in Serum or Plasma
1761-6 [3027953]
—
—
1.0e+50
—
—
—
3.3e+00
—
—
—
—
cases:1.08%
controls:0.00%
—
—
—
—
—
—
cases:1.85%
controls:0.07%
—
—
10
0
913
9230
—
—
—
15
6
795
8300
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47598-8 [3048816]
3.6e-01
1.0e+00
2.3e+00
—
—
1.1e+00
1.1e+00
cases:1.41%
controls:0.99%
cases:1.52%
controls:0.54%
cases:0.54%
controls:0.05%
—
—
—
—
cases:1.55%
controls:0.51%
cases:4.32%
controls:1.52%
13
91
910
9139
14
50
909
9180
5
5
918
9225
—
—
14
46
887
9044
35
126
775
8180
amitriptyline; oral, parenteral
N06AA09 [21604696]
4.2e-01
6.9e-01
—
—
1.4e+00
6.8e-01
5.0e-01
cases:6.28%
controls:4.21%
cases:4.01%
controls:2.05%
—
—
—
—
cases:1.63%
controls:0.42%
cases:4.55%
controls:2.35%
cases:7.41%
controls:4.62%
58
389
865
8841
37
189
886
9041
—
—
15
39
907
9183
41
214
860
8876
60
384
750
7922
Extractable nuclear Ab [Presence] in Serum by Immunoblot
57431-9 [40760543]
—
1.0e+50
1.0e+50
—
1.0e+50
1.0e+50
3.2e+00
—
—
cases:2.06%
controls:0.00%
cases:4.66%
controls:0.00%
—
—
cases:0.65%
controls:0.00%
cases:1.66%
controls:0.00%
cases:2.10%
controls:0.08%
—
19
0
904
9230
43
0
880
9230
—
6
0
916
9222
15
0
886
9090
17
7
793
8299
Sialoadenitis
K11.2 [45586705]
1.6e+00
2.3e+00
—
—
—
—
1.6e+00
cases:1.19%
controls:0.24%
cases:0.54%
controls:0.05%
—
—
—
—
—
—
—
—
cases:1.60%
controls:0.33%
11
22
912
9208
5
5
918
9225
—
—
—
—
13
27
797
8279
alendronic acid and colecalciferol; oral
M05BB03 [21604160]
1.2e+00
1.5e+00
—
—
—
1.7e+00
1.5e+00
cases:1.08%
controls:0.31%
cases:0.76%
controls:0.16%
—
—
—
—
—
—
cases:0.89%
controls:0.17%
cases:1.11%
controls:0.24%
10
29
913
9201
7
15
916
9215
—
—
—
8
15
893
9075
9
20
801
8286
Ultrasound examination of upper part of abdomen
JN1AE [2001305517]
6.0e-01
1.2e+00
—
—
—
1.7e+00
1.5e+00
cases:1.41%
controls:0.78%
cases:0.65%
controls:0.21%
—
—
—
—
—
—
cases:1.44%
controls:0.26%
cases:4.07%
controls:0.93%
13
72
910
9158
6
19
917
9211
—
—
—
13
24
888
9066
33
77
777
8229
Oral Surgery
19 [38004464]
3.0e-01
1.1e+00
—
—
—
1.9e+00
1.3e+00
cases:1.19%
controls:0.89%
cases:0.76%
controls:0.25%
—
—
—
—
—
—
cases:1.55%
controls:0.23%
cases:2.59%
controls:0.73%
11
82
912
9148
7
23
916
9207
—
—
—
14
21
887
9069
21
61
789
8245
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
9.2e-03
3.2e-01
7.3e-01
2.1e+00
4.7e-01
1.9e-01
9.2e-02
cases:25.24%
controls:25.07%
cases:24.27%
controls:18.92%
cases:7.15%
controls:3.58%
cases:1.19%
controls:0.14%
cases:4.88%
controls:3.11%
cases:23.53%
controls:20.34%
cases:44.32%
controls:42.05%
233
2314
690
6916
224
1746
699
7484
66
330
857
8900
11
13
912
9217
45
287
877
8935
212
1849
689
7241
359
3493
451
4813
Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
53019-6 [3041423]
—
—
1.0e+50
—
1.0e+50
—
3.2e+00
—
—
—
—
cases:1.84%
controls:0.00%
—
—
cases:0.98%
controls:0.00%
—
—
cases:2.84%
controls:0.12%
—
—
17
0
906
9230
—
9
0
913
9222
—
23
10
787
8296
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
7.7e-02
7.7e-01
1.1e+00
—
6.3e-01
7.8e-01
5.3e-01
cases:8.56%
controls:7.97%
cases:9.10%
controls:4.43%
cases:2.17%
controls:0.74%
—
—
cases:1.41%
controls:0.76%
cases:9.32%
controls:4.49%
cases:20.00%
controls:12.85%
79
736
844
8494
84
409
839
8821
20
68
903
9162
—
13
70
909
9152
84
408
817
8682
162
1067
648
7239
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
-1.1e-03
3.0e-01
7.2e-01
2.1e+00
4.7e-01
1.8e-01
8.2e-02
cases:25.24%
controls:25.27%
cases:24.16%
controls:19.14%
cases:7.15%
controls:3.60%
cases:1.19%
controls:0.14%
cases:4.99%
controls:3.18%
cases:23.64%
controls:20.62%
cases:44.32%
controls:42.31%
233
2332
690
6898
223
1767
700
7463
66
332
857
8898
11
13
912
9217
46
293
876
8929
213
1874
688
7216
359
3514
451
4792
Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection
6521-9 [3009595]
—
—
—
—
—
—
3.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.36%
controls:0.06%
—
—
—
—
—
—
11
5
799
8301
Lumbar spine X-ray examination without contrast
NA3AA [2001307026]
6.0e-01
7.7e-01
—
—
—
1.7e+00
1.4e+00
cases:1.41%
controls:0.78%
cases:0.65%
controls:0.30%
—
—
—
—
—
—
cases:1.22%
controls:0.22%
cases:3.58%
controls:0.92%
13
72
910
9158
6
28
917
9202
—
—
—
11
20
890
9070
29
76
781
8230
One hour or less
ZXE00 [2001311394]
4.5e-01
7.7e-01
—
—
1.6e+00
1.1e+00
8.4e-01
cases:9.64%
controls:6.38%
cases:3.68%
controls:1.73%
—
—
—
—
cases:0.76%
controls:0.15%
cases:3.77%
controls:1.35%
cases:8.52%
controls:3.88%
89
589
834
8641
34
160
889
9070
—
—
7
14
915
9208
34
123
867
8967
69
322
741
7984
Heart failure, unspecified
I50.9 [45576879]
5.8e-01
9.2e-01
—
—
2.0e+00
1.1e+00
3.9e-01
cases:1.52%
controls:0.86%
cases:1.41%
controls:0.56%
—
—
—
—
cases:0.76%
controls:0.11%
cases:1.66%
controls:0.54%
cases:2.35%
controls:1.60%
14
79
909
9151
13
52
910
9178
—
—
7
10
915
9212
15
49
886
9041
19
133
791
8173
Spirometry for bronchospasm with prolonged evaluation after bronchodilator
113016006 [4010399]
3.3e-01
9.8e-01
—
—
—
2.0e+00
1.1e+00
cases:2.17%
controls:1.56%
cases:1.63%
controls:0.62%
—
—
—
—
—
—
cases:3.55%
controls:0.48%
cases:5.43%
controls:1.95%
20
144
903
9086
15
57
908
9173
—
—
—
32
44
869
9046
44
162
766
8144

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
584
1192
11.35
320.06
2.0
1.3
1893.51
404.92
titre
45.93
388
252
324
319
15.00
307.83
1.7
1.1
6.98
1.82
u/ml
2.37
26
16
408
168
42.25
307.65
1.6
1.1
30.82
16.24
u/ml
—
58
5
433
239
32.82
307.65
1.7
1.1
7.77
6.17
u/ml
—
29
7
338
178
29.14
307.65
1.6
1.2
4.70
—
u/ml
—
12
0
351
183
30.07
307.65
1.7
1.1
37.21
32.44
u/ml
0.12
62
14
425
221
34.36
307.65
1.8
1.2
8.23
3.19
u/ml
1.61
156
21
429
221
34.96
307.65
1.7
1.1
3.31
2.67
u/ml
0.25
104
12
310
227
19.91
307.65
2.4
1.2
1.09
1.23
g/l
7.51
299
213
310
214
21.15
307.65
2.4
1.2
0.20
0.25
g/l
7.18
298
203
436
322
24.45
307.65
2.6
1.3
6.83
5.17
iu/ml
0.55
142
61
708
2541
8.31
202.18
5.5
3.0
717.49
1016.05
ng/l
1.98
664
2147
137
54
29.54
200.52
1.4
1.1
—
—
—
0
0
135
52
30.16
199.15
1.4
1.1
—
—
—
0
0
97
23
46.93
163.83
2.8
1.2
8.69
8.60
ug/l
0.04
97
23
842
4400
10.01
137.35
15.8
5.7
0.57
0.56
e9/l
0.68
814
3747
843
4412
10.08
137.23
15.9
5.8
0.04
0.04
e9/l
1.15
815
3754
843
4496
9.72
131.71
15.9
5.8
1.69
1.92
e9/l
8.97
819
3927
847
4561
9.92
130.21
16.3
6.1
0.19
0.19
e9/l
0.20
823
3951
280
629
5.92
124.33
3.8
2.9
10.28
10.40
g/l
0.15
266
578
637
2876
4.79
115.58
14.4
5.7
—
—
—
0
0
773
4054
6.18
115.45
15.2
5.8
58.05
56.84
%
2.49
767
3869
113
94
13.53
115.14
1.6
1.2
—
—
—
0
0
772
4051
6.14
115.03
16.0
5.9
9.13
8.68
%
4.46
764
3786
769
4042
6.03
113.76
15.9
5.9
3.03
2.82
%
2.09
761
3773
776
4144
6.08
111.53
15.7
5.9
27.34
28.38
%
2.28
767
3915
594
2620
4.46
109.30
3.5
2.1
102.63
193.79
u/l
3.21
578
2484
761
4037
5.71
109.21
16.2
5.9
0.79
0.70
%
4.92
754
3754
847
4958
8.37
106.74
18.8
9.4
3.84
3.96
e9/l
1.11
817
4304
244
594
5.20
96.97
4.7
3.0
114.00
175.90
ng/l
2.51
235
540
215
505
5.23
88.56
1.8
1.8
1.43
1.31
g/l
0.46
200
462
776
4582
5.04
86.35
6.8
3.9
6.85
5.14
estimate
0.09
200
956
768
4535
4.84
84.52
6.8
3.9
0.00
0.00
estimate
0.50
198
928
772
4631
4.79
81.70
6.8
3.9
0.00
0.35
estimate
0.53
200
904
662
3645
3.78
77.74
5.5
3.5
6.30
6.24
ph
0.70
349
2051
472
2128
3.45
76.09
3.8
2.6
317.13
326.95
umol/l
1.26
439
1879
297
1091
3.52
64.79
3.9
3.2
4.97
4.96
e9/l
0.00
261
953
231
741
3.81
61.62
6.2
4.0
0.47
0.71
%
1.06
68
216
390
1763
3.08
59.23
1.4
1.3
38.27
30.30
iu/ml
0.45
165
543
413
1937
3.02
58.59
9.5
4.5
—
—
—
0
0
233
778
3.66
58.27
6.9
4.0
0.82
1.10
%
0.84
68
234
156
390
4.60
58.26
2.4
2.1
0.00
0.01
estimate
0.50
52
121
43
20
22.49
58.05
1.3
1.1
—
—
—
0
0
43
20
22.49
58.05
1.3
1.1
—
—
—
0
0
43
20
22.49
58.05
1.3
1.1
—
—
—
0
0
224
744
3.64
56.30
7.3
4.4
0.02
0.15
%
1.20
56
174
223
739
3.65
56.24
7.0
4.1
0.09
0.14
%
0.42
57
195
114
232
5.46
54.19
1.4
1.2
1019.29
1067.78
titre
—
14
9
666
4166
3.07
53.68
3.7
2.5
80.68
78.91
nmol/l
0.92
630
3762
879
6646
6.21
50.17
16.7
7.8
77.31
78.86
u/l
0.40
874
6308
107
229
5.15
47.90
1.4
1.2
90.00
84.35
titre
—
10
23
462
2505
2.67
47.00
7.2
4.0
0.00
0.00
estimate
0.99
197
890
65
86
8.05
46.78
2.3
2.3
—
—
—
0
0
226
855
3.17
45.21
2.5
1.5
—
—
—
0
0
113
270
4.62
44.24
1.2
1.1
—
—
—
0
0
80
144
5.98
43.17
3.4
3.1
3.86
4.32
e9/l
1.08
80
144
285
1281
2.76
41.20
1.4
1.2
—
—
—
0
0
600
3838
2.57
41.19
21.6
10.8
0.00
0.00
e9/l
0.19
547
3129
656
4379
2.66
41.14
9.6
6.7
1.21
1.22
mmol/l
0.96
577
3789
92
197
5.07
41.03
2.0
2.0
122.66
128.97
g/l
0.87
32
157
213
828
3.04
40.23
2.4
2.1
0.00
0.03
estimate
0.78
58
155
359
1831
2.56
39.94
1.7
1.5
2.23
2.36
g/l
0.67
248
1103
70
121
6.17
39.32
1.5
1.2
7.25
6.00
u/ml
0.14
36
47
514
3112
2.44
39.01
6.3
3.6
54.96
90.09
e6/l
1.05
368
2148
603
3923
2.51
39.00
8.6
5.9
1.22
1.22
mmol/l
0.38
577
3625
461
2667
2.43
38.63
5.1
3.8
7.39
7.40
ph
3.33
354
1902
102
260
4.28
36.60
3.0
2.1
110.90
234.87
ug/l
3.25
95
246
321
1634
2.47
35.01
1.3
1.3
12.66
11.04
u/ml
0.15
127
613
205
848
2.81
34.07
1.4
1.5
—
—
—
0
0
82
187
4.71
33.83
3.6
2.9
57.59
59.32
%
0.56
82
187
281
1388
2.46
32.33
3.7
2.4
11.13
13.13
umol/l
4.83
272
1296
174
678
2.92
32.19
2.1
3.0
65.05
66.94
g/l
2.27
162
624
574
3849
2.27
31.75
6.8
4.6
35.72
36.01
g/l
0.68
550
3616
527
3447
2.21
30.54
6.8
3.8
0.03
0.08
estimate
0.55
180
768
207
920
2.60
29.50
2.4
1.6
—
—
—
0
0
381
2217
2.21
29.32
3.8
2.2
2.90
2.86
mg/l
0.11
348
1898
245
1184
2.45
29.19
3.6
2.4
19.90
22.38
%
1.67
233
1112
244
1178
2.45
29.12
2.7
1.9
—
—
—
0
0
259
1293
2.39
28.63
3.6
2.3
2.35
2.35
g/l
0.01
249
1194
63
139
4.79
26.98
1.6
1.6
0.50
0.75
g/l
0.94
49
118
371
2199
2.14
26.65
4.4
2.9
—
0.00
estimate
—
0
5
42
64
6.82
26.56
1.9
2.3
1145.29
1129.95
e6/l
0.03
35
58
326
1840
2.18
26.53
4.0
2.5
3.77
7.09
e6/l
5.92
313
1685
231
1130
2.39
26.49
1.5
1.6
—
—
—
0
0
383
2314
2.11
26.01
4.6
3.0
0.20
0.43
e6/l
2.93
315
1681
424
2675
2.07
25.49
4.8
3.0
18.40
73.60
e6/l
1.43
363
2030
267
1431
2.21
24.41
3.5
2.7
0.73
1.16
e6/l
2.66
181
722
180
830
2.45
23.28
2.8
2.1
0.20
0.21
g/l
1.73
168
779
394
2481
2.01
23.24
5.6
3.2
0.00
0.04
estimate
0.69
178
751
140
573
2.70
23.19
1.3
1.4
—
—
—
0
0
42
74
5.90
23.06
1.3
1.3
0.47
0.36
g/l
1.09
33
60
42
74
5.90
23.06
1.3
1.3
2.86
2.83
g/l
0.04
33
60
42
74
5.90
23.06
1.3
1.3
8.18
6.77
g/l
0.57
33
61
353
2195
1.98
21.10
5.1
4.0
—
—
—
0
0
613
4613
1.95
20.33
8.6
6.4
10.03
10.76
umol/l
1.13
591
4403
173
837
2.31
19.85
1.8
2.1
344.24
389.34
nmol/l
1.53
160
776
39
74
5.46
19.80
1.3
1.3
—
—
—
0
0
183
913
2.25
19.49
2.7
2.6
1.89
1.84
%
0.26
169
828
342
2149
1.93
19.48
1.4
1.3
0.55
1.41
u/ml
2.72
82
582
50
121
4.31
19.08
1.3
1.5
150.00
159.69
au/ml
—
9
34
86
302
3.03
18.81
2.0
2.2
10.30
10.31
g/l
0.01
80
273
203
1072
2.14
18.69
5.8
4.9
1.05
1.04
mmol/l
0.12
185
984
401
2696
1.85
18.21
10.3
6.0
—
—
—
0
0
149
701
2.34
18.14
2.6
2.7
71.91
72.61
e9/l
0.08
115
515
519
3787
1.83
17.97
15.0
13.0
1.19
1.20
inr
0.15
442
3112
27
15
18.50
17.85
1.1
1.3
—
—
—
0
0
200
1074
2.10
17.52
2.2
1.4
—
—
—
0
0
235
1339
2.01
17.51
1.5
1.8
—
—
—
0
0
51
140
3.79
16.42
1.4
1.5
—
—
—
0
0
27
43
6.44
16.35
1.4
2.3
353.47
484.31
e6/l
0.75
19
36
312
1993
1.85
16.29
7.2
4.1
1.02
1.78
kg/l
0.50
249
1313
97
402
2.58
15.49
1.3
1.2
—
—
—
0
0
27
46
6.01
15.32
1.6
2.4
199.10
229.29
e6/l
0.23
21
41
37
87
4.39
14.65
1.8
1.6
52.41
58.22
%
0.34
22
55
86
350
2.60
14.23
2.0
1.8
1.51
1.54
g/l
0.12
78
308
543
4177
1.71
14.21
4.4
3.0
104.61
104.69
ug/l
0.00
513
3908
438
3182
1.71
14.14
3.3
3.6
2.35
2.36
mmol/l
1.24
406
2908
30
62
4.97
13.87
1.4
1.1
117.50
80.00
titre
—
8
8
30
62
4.97
13.87
1.7
1.3
—
—
—
0
0
28
55
5.22
13.70
1.8
1.7
44.18
36.33
%
0.34
13
32
167
917
2.00
13.49
10.8
7.9
4.85
5.10
kpa
2.85
161
889
133
673
2.14
13.39
2.7
2.2
0.23
0.56
e6/l
1.11
124
635
439
3224
1.68
13.37
5.1
3.6
26.22
43.50
ng/l
0.81
309
2181
50
156
3.33
13.31
1.0
1.2
—
—
—
0
0
166
919
1.98
13.08
11.0
7.9
7.44
7.41
ph
3.60
101
507
31
70
4.55
12.92
1.7
1.3
2281.89
1830.56
e6/l
0.20
18
43
39
106
3.80
12.75
1.3
1.2
—
—
—
0
0
898
8232
3.18
12.45
32.5
14.7
18.31
22.61
mg/l
4.58
811
6726
253
1625
1.76
12.41
5.2
3.8
218.74
309.04
ng/l
0.50
202
1207
228
1421
1.80
12.39
5.3
3.1
0.82
0.82
mmol/l
0.01
211
1350
200
1199
1.85
12.33
2.0
2.2
174.24
120.68
ug/g
1.05
163
952
706
5946
1.76
12.28
6.4
4.0
—
7215.57
—
0
14
162
908
1.95
12.27
11.1
7.9
0.86
1.06
mmol/l
0.29
138
756
39
109
3.69
12.26
3.0
2.9
—
—
—
0
0
29
65
4.57
12.20
1.7
1.4
—
—
—
0
0
127
655
2.09
12.12
9.3
6.6
9.10
9.06
mmol/l
0.02
120
633
675
5624
1.72
12.09
6.9
4.7
168.56
1541.28
e6/l
—
9
71
69
273
2.65
12.08
2.4
3.8
59.33
66.25
mg/l
0.10
62
232
402
2943
1.64
11.99
5.2
3.1
31.00
31.12
u/l
0.03
388
2772
70
280
2.62
11.99
1.5
1.4
314.91
296.47
ug/g
0.30
38
158
68
273
2.61
11.57
2.5
3.8
30.72
55.07
mg/l
0.98
60
232
92
426
2.29
11.48
2.5
2.3
—
—
—
0
0
352
2532
1.62
11.03
1.9
1.7
21.11
21.26
nmol/l
0.07
314
2123
242
1584
1.71
10.91
4.0
2.7
479.52
504.44
mosm/kgh2o
1.23
227
1397
109
553
2.10
10.84
1.3
1.3
37.17
41.45
au/ml
—
9
44
27
63
4.38
10.82
1.7
1.3
6241.75
159140.77
e6/l
0.69
12
30
128
690
1.99
10.79
4.0
3.7
1.23
1.23
mmol/l
0.80
119
596
37
110
3.46
10.64
2.3
1.3
—
—
—
0
0
37
110
3.46
10.64
2.3
1.3
—
—
—
0
0
37
110
3.46
10.64
2.3
1.3
—
—
—
0
0
37
110
3.46
10.64
2.3
1.3
—
—
—
0
0
49
173
2.93
10.63
1.3
1.7
—
—
—
0
0
61
244
2.60
10.46
2.2
3.7
6.36
4.31
ratio
0.24
34
135
376
2777
1.59
10.41
3.1
2.4
59.13
63.10
u/l
0.60
345
2563
115
609
2.01
10.17
2.6
2.5
28.03
26.39
au/ml
0.07
17
59
27
68
4.06
9.82
1.8
1.8
—
—
—
0
0
284
1984
1.62
9.79
2.1
1.7
1.34
1.09
mg/l
0.41
233
1548
23
52
4.51
9.59
2.8
2.9
45.56
39.19
%
0.65
16
26
70
313
2.34
9.48
2.1
1.9
1.35
2.05
ug/l
0.33
61
285
210
1370
1.69
9.43
1.8
1.7
1185.54
1200.72
nmol/l
0.09
168
1018
20
25
8.15
9.37
1.2
1.4
29.40
28.64
s
0.15
20
25
69
309
2.33
9.31
3.0
2.1
21.25
20.90
s
0.14
60
279
37
120
3.17
9.30
3.2
3.3
2.08
1.37
%
0.27
37
111
51
200
2.64
9.12
1.7
1.6
4755.50
11526.96
e6/l
1.16
38
141
34
106
3.29
9.11
2.2
2.6
—
—
—
0
0
40
138
2.98
9.06
1.3
1.3
307.50
253.17
u/ml
0.54
24
78
96
500
2.03
8.88
6.1
3.3
7.41
7.42
ph
0.91
86
420
481
3848
1.51
8.80
2.3
2.1
98.53
97.66
pmol/l
0.13
253
1925
593
4962
1.53
8.74
7.5
4.7
6.38
6.60
mmol/l
1.73
577
4709
113
638
1.88
8.26
1.3
1.3
71.39
216.92
u/ml
2.48
106
590
15
15
10.14
8.04
4.1
3.1
—
—
—
0
0
27
79
3.49
7.99
3.1
2.9
58.94
58.15
%
0.06
27
73
18
25
7.32
7.98
2.4
2.0
30.44
31.24
%
0.06
18
25
294
2159
1.53
7.85
6.5
3.8
92.40
92.63
%
0.06
285
2110
117
679
1.83
7.83
6.7
3.8
—
—
—
0
0
156
987
1.70
7.74
2.8
2.6
5.65
7.06
umol/l
0.75
142
866
193
1299
1.61
7.51
4.2
2.8
2.88
3.33
e6/l
0.20
102
587
118
699
1.79
7.38
13.8
7.9
—
—
—
0
0
24
69
3.54
7.30
1.6
1.5
242597.19
131913.82
e6/l
0.17
16
45
34
122
2.85
7.23
1.2
1.1
—
—
—
0
0
17
26
6.64
7.13
1.2
1.3
—
—
—
0
0
21
59
3.62
6.62
1.7
1.4
—
—
—
0
0
12
12
10.11
6.54
2.8
8.0
6.88
4.88
kpa
0.47
12
12
121
753
1.70
6.35
1.2
1.2
—
—
—
0
0
159
1061
1.60
6.35
1.3
1.3
—
—
—
0
0
361
2868
1.42
6.12
3.9
3.1
—
—
—
0
0
241
1782
1.47
5.98
1.7
1.7
28985970.81
35330189.84
pmol/l
0.07
207
1486
116
726
1.68
5.96
3.6
3.4
72.92
80.75
ng/l
0.74
101
627
40
173
2.37
5.91
2.3
4.6
—
—
—
0
0
50
238
2.16
5.90
1.2
1.3
—
—
—
0
0
12
15
8.09
5.85
1.0
1.1
—
—
—
0
0
12
15
8.09
5.85
1.0
1.0
—
—
—
0
0
374
3032
1.39
5.48
4.9
3.4
—
0.67
—
0
9
126
830
1.60
5.29
4.0
3.3
7.39
7.39
ph
0.35
78
469
36
157
2.34
5.25
5.9
2.4
83.66
90.11
%
1.63
36
151
242
1845
1.42
4.99
2.7
2.8
2.46
2.46
mmol/l
0.37
220
1684
757
6951
1.46
4.97
5.3
4.7
15.24
14.74
pmol/l
7.27
706
6427
16
37
4.38
4.95
1.6
1.4
1.40
7.00
%
—
5
8
16
37
4.38
4.95
1.6
3.8
826.31
1279.84
u/ml
0.47
16
37
24
90
2.71
4.77
1.7
2.5
0.66
1.19
g/24h
0.88
15
55
64
361
1.83
4.74
5.6
3.3
—
—
—
0
0
101
657
1.60
4.47
2.6
2.3
15.81
6.39
ug/l
0.58
85
580
11
19
5.84
4.45
1.1
1.4
—
—
—
0
0
33
150
2.24
4.41
1.5
1.5
—
—
—
0
0
24
95
2.57
4.32
1.2
1.2
—
—
—
0
0
118
805
1.53
4.25
4.1
3.2
1.51
1.91
mmol/l
0.57
104
692
77
474
1.68
4.24
4.4
3.1
23.81
24.34
mmol/l
0.81
77
468
120
823
1.53
4.22
4.7
3.9
7.35
7.35
ph
0.02
97
574
21
80
2.66
4.08
1.2
2.5
—
—
—
0
0
19
69
2.79
4.04
1.1
1.2
—
—
—
0
0
32
151
2.16
3.94
5.5
3.4
—
—
—
0
0
43
229
1.92
3.84
3.1
3.2
1.33
2.25
index
0.70
15
114
27
122
2.25
3.70
1.0
1.0
—
—
—
0
0
48
270
1.82
3.64
3.4
3.0
300.23
293.36
mg/l
0.03
22
109
15
52
2.92
3.47
1.1
1.1
—
—
—
0
0
29
141
2.09
3.35
5.8
3.6
2.35
2.91
mmol/l
0.53
24
96
458
4018
1.27
3.33
3.7
2.7
—
—
estimate
—
0
0
279
3331
0.77
3.33
2.8
3.2
—
—
—
0
0
70
458
1.57
3.08
1.1
1.1
—
126.60
titre
—
0
10
835
7966
1.44
3.07
6.7
5.8
2.04
1.89
mu/l
2.48
787
7412
41
687
0.58
3.02
1.6
1.8
3.35
3.48
mmol/l
0.34
28
499
18
75
2.43
2.98
1.7
1.1
90.61
110.99
pmol/l
1.07
18
75
116
849
1.42
2.96
2.4
2.3
32.33
38.86
u/l
1.20
103
703
30
156
1.95
2.92
4.6
2.8
34.96
33.59
umol/l
0.10
25
140
71
474
1.54
2.87
1.5
1.2
—
—
—
0
0
6
9
6.70
2.87
1.3
1.2
—
—
—
0
0
34
189
1.83
2.74
1.2
1.5
2.50
14.99
e6/l
1.59
26
139
34
191
1.81
2.65
1.3
1.5
394.52
548.09
e6/l
0.14
27
147
9
25
3.62
2.58
2.3
1.3
—
—
—
0
0
29
509
0.56
2.55
2.3
1.7
—
—
—
0
0
8
21
3.83
2.46
3.1
2.5
3.88
6.23
ug/l
—
8
21
322
2794
1.23
2.36
3.3
2.3
—
—
—
0
0
14
59
2.39
2.30
1.4
1.2
—
—
—
0
0
17
79
2.17
2.25
2.9
3.0
12.67
12.49
index
—
9
45
11
41
2.70
2.21
1.4
1.1
0.56
0.51
ratio
—
5
23
10
36
2.80
2.14
1.1
1.3
113.10
153.42
nmol/l
—
10
36
102
781
1.34
2.03
1.6
1.4
—
—
—
0
0
11
44
2.52
2.01
2.5
3.5
14.71
16.49
%
1.14
11
44
20
104
1.94
2.01
11.8
6.4
13.83
12.27
mg/l
0.74
20
98
26
435
0.59
1.97
1.1
1.1
—
—
—
0
0
16
77
2.10
1.97
1.1
1.1
—
—
—
0
0
5
11
4.56
1.94
1.0
1.1
—
—
—
0
0
6
16
3.77
1.93
2.7
1.4
—
—
—
0
0
24
135
1.80
1.92
1.3
1.2
0.75
13.70
nmol/l
0.49
24
130
5
143
0.35
1.88
1.2
1.5
—
—
—
0
0
9
34
2.66
1.87
5.1
2.4
—
—
—
0
0
18
93
1.95
1.86
1.4
1.2
—
—
—
0
0
870
8466
1.39
1.83
28.5
17.4
139.38
139.71
mmol/l
3.11
862
8313
50
347
1.47
1.77
2.0
3.1
23.34
1058.55
u/ml
1.62
44
306
6
18
3.35
1.75
1.2
1.3
22.30
29.38
g/l
—
6
13
9
36
2.51
1.74
1.2
1.9
—
—
—
0
0
7
24
2.93
1.72
3.4
4.3
53.57
51.83
%
—
7
24
91
705
1.32
1.70
3.3
2.6
6.15
6.10
ph
0.23
56
470
19
104
1.84
1.68
3.1
2.3
32.47
31.89
pg
0.23
19
104
7
25
2.81
1.65
1.4
2.0
36.41
41.80
g/l
—
7
25
19
327
0.57
1.64
1.5
1.3
—
—
—
0
0
20
113
1.79
1.61
1.3
1.2
—
—
nmol/l
—
0
0
39
264
1.50
1.58
1.4
1.3
234.10
228.02
miu/ml
0.04
17
130
7
26
2.70
1.58
2.7
2.5
0.60
0.63
mmol/l
—
7
26
36
241
1.51
1.54
2.2
2.5
—
—
—
0
0
5
15
3.35
1.52
1.0
1.4
—
—
—
0
0
868
8477
1.33
1.46
28.7
17.6
3.94
3.95
mmol/l
0.56
859
8303
28
180
1.57
1.44
1.3
1.5
—
—
—
0
0
5
16
3.14
1.44
1.0
1.1
0.02
0.02
u/ml
—
5
16
261
2315
1.18
1.43
1.4
1.4
—
—
—
0
0
7
29
2.42
1.39
2.4
2.4
—
—
—
0
0
19
310
0.60
1.37
1.1
1.2
1.57
1.60
g/l
0.23
19
310
39
273
1.45
1.37
9.4
10.2
—
—
—
0
0
9
41
2.21
1.37
1.1
1.2
—
—
—
0
0
5
18
2.79
1.28
1.4
3.9
—
—
—
0
0
11
55
2.01
1.27
1.2
1.5
13.49
9.95
umol/l
0.88
11
49
15
84
1.80
1.27
2.3
2.0
—
—
—
0
0
9
45
2.01
1.23
2.0
3.2
0.67
0.84
index
—
9
45
396
3669
1.14
1.16
2.3
2.1
—
—
—
0
0
21
319
0.65
1.15
1.1
1.2
0.92
0.90
g/l
0.15
21
319
600
5715
1.14
1.13
4.6
3.3
55.44
45.60
u/l
2.15
566
5385
7
30
2.34
1.12
1.1
1.0
—
—
—
0
0
31
218
1.44
1.10
1.1
1.2
—
—
—
0
0
9
48
1.88
1.00
1.4
1.3
—
—
—
0
0
23
156
1.49
0.99
1.1
1.1
—
—
—
0
0
43
327
1.33
0.99
1.9
2.4
13.57
12.60
nmol/l
0.26
36
299
12
69
1.75
0.96
1.3
1.2
—
—
—
0
0
11
62
1.78
0.94
1.3
1.9
1.83
2.13
u/field
—
6
32
7
37
1.90
0.94
2.0
1.7
—
—
—
0
0
53
419
1.28
0.94
2.5
2.0
—
—
—
0
0
6
27
2.23
0.93
1.2
1.1
—
—
—
0
0
11
63
1.75
0.90
1.2
1.2
—
1.17
—
0
7
80
668
1.22
0.89
1.4
1.7
—
—
—
0
0
8
43
1.87
0.87
1.1
1.1
1279.25
1557.70
miu/ml
—
8
43
42
531
0.78
0.82
1.7
1.4
37.21
30.43
iu/l
0.55
35
456
22
156
1.42
0.79
1.1
1.1
—
—
—
0
0
0
25
0.00
0.79
0.0
1.2
—
1000.00
—
0
6
35
270
1.31
0.77
5.3
3.9
1.04
1.34
mmol/l
2.41
35
265
14
93
1.51
0.69
2.9
2.5
—
—
—
0
0
33
258
1.29
0.68
1.7
2.0
2214.21
6076.67
u/l
—
9
99
779
7938
0.89
0.66
5.8
6.3
38.08
39.01
mmol/mol
1.23
741
7445
862
8503
1.17
0.64
24.5
13.3
—
—
—
0
0
44
360
1.23
0.63
1.5
1.6
5.82
12.49
u/ml
—
5
73
5
30
1.67
0.61
1.0
1.8
67.80
81.10
nmol/24h
—
5
30
33
263
1.26
0.60
1.3
1.2
—
—
—
0
0
8
54
1.49
0.57
1.3
1.4
95.25
74.72
umol/l
—
8
54
40
329
1.23
0.57
1.0
1.1
—
—
—
0
0
19
250
0.76
0.54
1.1
1.3
—
—
—
0
0
6
38
1.58
0.54
1.2
1.7
—
—
—
0
0
9
60
1.50
0.54
1.1
1.7
59.33
110.85
ng/l
—
9
60
40
332
1.21
0.53
1.9
1.6
0.25
0.35
mg/l
0.82
19
141
51
435
1.18
0.51
4.0
3.5
1.02
1.02
ratio
0.32
46
400
9
64
1.41
0.51
1.1
1.6
6.50
7.81
ug/l
—
9
55
13
92
1.42
0.50
1.2
1.8
—
—
—
0
0
78
691
1.14
0.49
1.2
1.2
133.27
136.71
u/ml
0.02
23
283
18
232
0.77
0.46
1.1
1.3
—
—
—
0
0
68
602
1.14
0.44
2.1
3.3
4.27
4.47
pmol/l
1.01
58
535
20
157
1.28
0.43
2.3
1.9
—
—
—
0
0
10
70
1.43
0.42
1.4
1.6
—
—
—
0
0
20
250
0.80
0.41
1.1
1.3
—
—
—
0
0
20
250
0.80
0.41
1.1
1.3
—
—
—
0
0
5
33
1.52
0.41
2.0
2.4
40.12
54.23
umol/l
—
5
26
20
249
0.80
0.40
1.1
1.3
—
—
—
0
0
5
34
1.47
0.40
1.2
1.5
97.60
148.67
mmol/24h
—
5
34
102
933
1.10
0.40
2.4
4.3
4.10
26.09
ug/l
1.69
85
745
13
97
1.34
0.39
2.5
1.9
184.54
206.32
pmol/l
0.39
13
92
0
19
0.00
0.39
0.0
1.1
—
37.04
—
0
19
839
8302
1.10
0.38
5.0
5.2
4.63
4.76
mmol/l
3.58
795
7748
24
197
1.22
0.38
2.0
1.7
—
—
—
0
0
13
100
1.30
0.33
1.5
1.1
—
—
—
0
0
901
8957
1.15
0.33
48.2
23.1
4.35
4.44
e12/l
7.68
896
8764
901
8957
1.15
0.33
48.3
23.1
6.59
6.58
e9/l
0.07
896
8763
79
859
0.91
0.31
1.8
1.4
—
—
—
0
0
10
75
1.34
0.30
1.2
1.1
—
—
—
0
0
15
182
0.82
0.26
2.1
2.3
29.47
81.81
ug/min
—
7
104
17
203
0.83
0.26
4.6
4.5
—
—
—
0
0
11
87
1.27
0.24
3.7
2.5
—
—
—
0
0
12
97
1.24
0.23
1.2
1.7
16.33
26.80
ng/l
1.74
12
97
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
52.60
—
0
10
13
156
0.83
0.21
1.0
1.0
0.93
3.38
u/ml
—
7
83
0
14
0.00
0.20
0.0
3.6
—
—
—
0
0
6
48
1.25
0.20
1.0
1.2
131.17
484.31
u/l
—
6
42
31
280
1.11
0.18
1.7
1.7
330.92
294.07
mu/l
0.32
26
254
15
128
1.17
0.18
1.2
1.2
—
—
—
0
0
832
8271
1.05
0.17
4.9
5.1
1.60
1.54
mmol/l
2.89
783
7675
847
8424
1.06
0.17
5.5
5.9
2.61
2.77
mmol/l
5.93
800
7844
13
150
0.86
0.14
1.0
1.0
1.35
1.63
u/ml
—
6
61
7
89
0.78
0.14
1.9
2.5
1.20
1.19
mmol/l
—
7
89
7
90
0.78
0.14
1.9
2.5
106.57
105.41
mmol/l
—
7
90
7
90
0.78
0.14
1.9
2.5
3.93
3.99
mmol/l
—
7
90
300
2942
1.03
0.14
3.4
3.2
6.23
7.01
mmol/l
2.90
252
2496
20
181
1.11
0.12
1.1
1.1
0.61
1.47
u/ml
1.39
13
96
13
146
0.89
0.10
1.2
1.2
—
—
—
0
0
15
135
1.11
0.09
1.9
1.8
46.60
41.81
nmol/l
0.45
15
130
5
48
1.04
0.09
1.2
1.4
1.34
1.39
promille
—
5
37
290
2860
1.02
0.09
3.9
4.0
17.82
7.32
mg/mmol
1.05
161
1674
378
3738
1.02
0.09
1.9
1.9
1.27
1.34
mmol/l
1.26
314
3179
25
267
0.93
0.08
1.6
1.9
3.11
25.44
iu/l
—
9
110
5
62
0.81
0.08
1.0
1.0
1115.00
728.98
ng/l
—
5
40
5
62
0.81
0.08
1.0
1.0
422.20
336.56
ng/l
—
5
41
794
7910
1.02
0.08
4.2
4.3
1.17
1.27
mmol/l
5.50
745
7260
10
88
1.14
0.08
1.2
1.7
—
—
—
0
0
12
133
0.90
0.07
1.3
1.2
—
—
—
0
0
6
70
0.86
0.07
1.2
1.0
—
—
—
0
0
104
1062
0.98
0.06
5.4
5.2
2.35
2.22
ug/l
0.08
94
949
118
1159
1.02
0.05
1.3
1.3
—
—
—
0
0
65
635
1.03
0.04
3.2
3.1
0.61
0.73
ug/l
0.88
40
395
283
2812
1.01
0.03
3.4
3.3
71.05
37.04
mg/l
0.98
156
1678
10
108
0.93
0.03
1.0
1.3
—
—
—
0
0
65
641
1.02
0.02
1.1
1.3
—
—
—
0
0
13
123
1.06
0.01
1.1
1.0
1.09
5.47
u/ml
—
6
46
810
8090
1.01
0.01
4.9
5.2
5.59
5.89
mmol/l
12.80
756
7429
17
164
1.04
0.00
3.6
3.7
23.78
22.38
mg/l
—
9
111
10
96
1.04
0.00
1.1
1.1
—
—
—
0
0
13
133
0.98
0.00
1.1
1.1
—
—
—
0
0
13
127
1.02
0.00
1.2
1.0
0.27
2.85
u/ml
—
6
56
18
177
1.02
0.00
5.0
1.7
0.83
0.82
nmol/l
0.02
18
148
15
145
1.04
0.00
1.1
1.0
0.32
1.75
u/ml
—
8
68
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
0.03
—
0
5
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
6.1
—
8.15
—
0
8
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.2
—
0.52
—
0
5
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
292.98
—
0
5
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
30.86
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint M13_SYSTSLCE and mortality.

Females

Parameter HR [95% CI] p-value
M13_SYSTSLCE 2.306 [2.03, 2.62] < 0.001
Birth year 0.995 [0.99, 1.0] 0.224

During the follow-up period (1.1.1998 — 31.12.2019), 615 out of 2768 females with M13_SYSTSLCE died.

Males

Parameter HR [95% CI] p-value
M13_SYSTSLCE 2.516 [2.0, 3.17] < 0.001
Birth year 0.991 [0.98, 1.0] 0.068

During the follow-up period (1.1.1998 — 31.12.2019), 197 out of 642 males with M13_SYSTSLCE died.

Mortality risk

Mortality risk for people of age

years, who have M13_SYSTSLCE.

N-year risk Females Males
1 0.252% 0.559%
5 1.311% 3.123%
10 3.181% 8.172%
15 6.414% 15.352%
20 11.51% 24.944%

Relationships between endpoints

↥

Index endpoint: M13_SYSTSLCE – Systemic sclerosis

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data